report_id,country,region,bacterial_species,antibiotic,year,resistance_rate,mortality_rate,infection_type,sample_size
1,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2022,48.2,11.7,community,300
2,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2023,45.0,12.9,hospital,300
3,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2021,33.6,9.9,community,200
4,Nigeria,Africa,Escherichia coli,Amoxicillin,2021,35.2,7.3,hospital,300
5,USA,North America,Escherichia coli,Amoxicillin,2023,28.7,4.2,community,150
6,Brazil,South America,Staphylococcus aureus,Amoxicillin,2019,34.7,9.0,hospital,300
7,Brazil,South America,Escherichia coli,Ceftriaxone,2019,30.4,9.1,community,100
8,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2022,66.5,10.5,hospital,200
9,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,47.9,9.8,hospital,100
10,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2023,33.3,7.7,community,300
11,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2021,50.0,6.0,community,100
12,China,East Asia,Klebsiella pneumoniae,Vancomycin,2023,34.4,8.8,hospital,150
13,China,East Asia,Escherichia coli,Vancomycin,2020,38.1,2.8,community,100
14,Australia,Oceania,Staphylococcus aureus,Meropenem,2021,14.5,0.5,community,100
15,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,33.6,11.0,hospital,300
16,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2022,78.3,10.7,community,300
17,South Africa,Africa,Staphylococcus aureus,Meropenem,2019,32.0,2.5,hospital,200
18,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2019,49.4,5.0,hospital,150
19,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2022,50.5,12.8,community,300
20,Brazil,South America,Escherichia coli,Ceftriaxone,2021,31.9,2.6,community,250
21,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2022,63.6,14.8,community,200
22,Nigeria,Africa,Escherichia coli,Amoxicillin,2019,42.7,10.4,hospital,200
23,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2020,37.8,6.4,community,250
24,France,Europe,Staphylococcus aureus,Meropenem,2023,24.4,4.7,hospital,300
25,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2020,39.8,6.1,community,300
26,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2021,18.6,0.5,hospital,250
27,Nigeria,Africa,Escherichia coli,Vancomycin,2020,46.6,12.6,hospital,200
28,France,Europe,Escherichia coli,Vancomycin,2022,21.2,1.5,hospital,150
29,South Africa,Africa,Acinetobacter baumannii,Meropenem,2020,45.0,8.9,hospital,100
30,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2023,68.7,15.4,hospital,150
31,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2023,34.5,5.3,hospital,200
32,France,Europe,Escherichia coli,Ciprofloxacin,2023,23.7,6.8,community,250
33,France,Europe,Pseudomonas aeruginosa,Vancomycin,2023,29.8,7.3,community,150
34,France,Europe,Acinetobacter baumannii,Amoxicillin,2019,24.9,5.0,community,100
35,France,Europe,Escherichia coli,Ceftriaxone,2019,15.8,0.5,community,300
36,France,Europe,Klebsiella pneumoniae,Amoxicillin,2019,15.3,0.5,hospital,150
37,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2018,48.1,6.2,community,150
38,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2019,36.9,11.6,hospital,100
39,France,Europe,Staphylococcus aureus,Ciprofloxacin,2022,18.9,2.0,hospital,300
40,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,48.5,12.5,hospital,100
41,Japan,East Asia,Acinetobacter baumannii,Meropenem,2020,31.6,3.9,hospital,200
42,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2023,49.2,8.8,community,150
43,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,11.2,1.7,hospital,100
44,Germany,Europe,Escherichia coli,Ceftriaxone,2023,29.1,7.6,community,100
45,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2023,54.1,11.4,hospital,200
46,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2021,37.7,5.5,hospital,300
47,Germany,Europe,Pseudomonas aeruginosa,Vancomycin,2021,21.9,7.3,hospital,250
48,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2018,36.8,5.8,hospital,250
49,Germany,Europe,Pseudomonas aeruginosa,Vancomycin,2019,25.3,1.8,hospital,300
50,India,Southeast Asia,Escherichia coli,Vancomycin,2018,59.7,9.1,community,250
51,France,Europe,Staphylococcus aureus,Ciprofloxacin,2021,27.9,6.0,community,150
52,Australia,Oceania,Escherichia coli,Ceftriaxone,2020,17.2,6.1,community,250
53,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2021,55.2,10.8,hospital,200
54,USA,North America,Pseudomonas aeruginosa,Vancomycin,2023,24.6,6.4,community,250
55,South Africa,Africa,Escherichia coli,Ceftriaxone,2022,68.4,13.2,hospital,300
56,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2020,45.9,6.9,hospital,200
57,USA,North America,Escherichia coli,Amoxicillin,2021,17.9,1.0,hospital,150
58,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2022,44.0,6.5,hospital,300
59,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2022,26.5,4.0,hospital,300
60,China,East Asia,Escherichia coli,Ceftriaxone,2018,38.2,9.5,hospital,150
61,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2018,19.5,0.5,community,150
62,Nigeria,Africa,Klebsiella pneumoniae,Amoxicillin,2019,61.6,16.3,community,200
63,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2018,17.3,8.1,community,300
64,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2019,67.3,16.3,community,250
65,Japan,East Asia,Escherichia coli,Amoxicillin,2018,19.0,5.3,hospital,200
66,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2018,62.4,16.0,hospital,250
67,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2023,70.6,12.9,community,150
68,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2020,28.8,4.1,community,300
69,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2019,19.1,0.5,community,100
70,Japan,East Asia,Escherichia coli,Meropenem,2021,20.8,6.0,community,100
71,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2019,44.9,6.7,hospital,300
72,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2023,27.9,3.9,community,150
73,Australia,Oceania,Escherichia coli,Ceftriaxone,2023,20.2,2.4,hospital,150
74,Brazil,South America,Escherichia coli,Amoxicillin,2022,36.0,6.0,community,200
75,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2021,22.4,6.5,hospital,300
76,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2022,30.7,3.9,community,300
77,Nigeria,Africa,Escherichia coli,Meropenem,2018,37.3,11.7,community,300
78,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2018,30.7,5.6,community,200
79,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2020,35.0,7.1,hospital,150
80,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2019,57.5,10.5,hospital,300
81,Brazil,South America,Acinetobacter baumannii,Meropenem,2020,45.8,4.5,community,200
82,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2018,22.0,8.3,community,150
83,Germany,Europe,Escherichia coli,Ciprofloxacin,2018,21.4,4.3,community,300
84,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2021,15.2,0.5,community,250
85,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2022,78.9,14.2,hospital,100
86,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2021,44.5,10.3,hospital,150
87,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2019,14.6,0.5,hospital,200
88,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2023,23.1,0.6,hospital,250
89,Brazil,South America,Escherichia coli,Vancomycin,2019,47.9,4.8,hospital,150
90,Brazil,South America,Escherichia coli,Ceftriaxone,2021,30.4,4.7,community,150
91,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2022,63.1,9.8,hospital,200
92,Australia,Oceania,Escherichia coli,Meropenem,2018,11.5,0.5,hospital,200
93,South Africa,Africa,Staphylococcus aureus,Meropenem,2018,28.4,3.6,community,100
94,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2021,47.2,6.4,hospital,250
95,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2023,46.1,9.6,hospital,300
96,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2018,62.5,16.7,hospital,100
97,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,56.1,8.8,hospital,150
98,France,Europe,Acinetobacter baumannii,Meropenem,2018,21.8,4.2,hospital,300
99,China,East Asia,Staphylococcus aureus,Amoxicillin,2020,26.5,6.1,hospital,150
100,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2020,66.8,10.1,hospital,200
101,Australia,Oceania,Escherichia coli,Ceftriaxone,2020,12.2,1.3,community,100
102,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2021,23.3,7.4,community,200
103,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,40.3,7.0,community,150
104,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2020,34.4,8.3,hospital,300
105,China,East Asia,Staphylococcus aureus,Amoxicillin,2021,41.1,4.0,community,300
106,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2021,49.5,7.6,community,100
107,India,Southeast Asia,Escherichia coli,Ceftriaxone,2020,38.0,4.3,community,200
108,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2018,15.1,0.5,hospital,300
109,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2020,22.7,4.4,hospital,300
110,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,33.4,10.4,community,300
111,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2022,31.1,5.5,hospital,250
112,India,Southeast Asia,Escherichia coli,Vancomycin,2018,35.9,7.0,hospital,150
113,Germany,Europe,Klebsiella pneumoniae,Meropenem,2018,15.9,6.4,hospital,150
114,Brazil,South America,Acinetobacter baumannii,Meropenem,2020,50.0,7.1,hospital,150
115,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2021,14.4,5.6,community,100
116,France,Europe,Escherichia coli,Vancomycin,2018,23.8,9.2,community,250
117,Nigeria,Africa,Escherichia coli,Meropenem,2022,47.8,10.8,community,150
118,Brazil,South America,Escherichia coli,Ceftriaxone,2021,50.3,13.1,community,200
119,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2018,37.8,5.6,hospital,100
120,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2020,35.1,8.5,hospital,300
121,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,50.7,11.9,community,100
122,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2019,40.2,10.4,community,150
123,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2018,43.2,5.1,hospital,100
124,France,Europe,Acinetobacter baumannii,Meropenem,2018,29.8,3.7,community,200
125,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2022,45.5,7.8,hospital,100
126,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,70.4,17.3,hospital,150
127,India,Southeast Asia,Escherichia coli,Meropenem,2020,68.5,16.7,hospital,200
128,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2018,39.3,11.3,hospital,300
129,Japan,East Asia,Staphylococcus aureus,Vancomycin,2022,38.1,4.7,community,150
130,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2020,13.5,1.5,hospital,100
131,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2022,42.1,6.7,community,250
132,France,Europe,Escherichia coli,Ciprofloxacin,2022,30.2,9.6,community,300
133,USA,North America,Staphylococcus aureus,Meropenem,2018,21.9,0.5,community,200
134,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2023,33.3,11.6,hospital,150
135,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2023,41.5,3.6,hospital,300
136,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2021,24.8,1.7,community,150
137,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2019,24.1,6.5,hospital,100
138,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2018,11.0,1.8,hospital,250
139,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,47.0,5.8,hospital,100
140,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,10.1,4.7,community,250
141,China,East Asia,Acinetobacter baumannii,Meropenem,2022,30.2,1.3,hospital,150
142,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2021,22.0,3.8,community,300
143,South Africa,Africa,Escherichia coli,Vancomycin,2018,49.5,9.7,hospital,200
144,Japan,East Asia,Acinetobacter baumannii,Meropenem,2019,27.4,2.4,hospital,100
145,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2020,14.3,0.5,community,300
146,India,Southeast Asia,Escherichia coli,Meropenem,2021,58.8,9.2,community,100
147,France,Europe,Klebsiella pneumoniae,Vancomycin,2020,14.6,4.8,community,100
148,France,Europe,Escherichia coli,Ciprofloxacin,2018,26.7,8.8,community,150
149,France,Europe,Klebsiella pneumoniae,Vancomycin,2022,18.3,0.5,community,150
150,USA,North America,Acinetobacter baumannii,Meropenem,2022,22.0,5.1,community,250
151,China,East Asia,Staphylococcus aureus,Amoxicillin,2019,28.4,6.0,community,150
152,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,30.5,4.3,hospital,150
153,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2020,44.9,7.3,community,100
154,Germany,Europe,Escherichia coli,Ciprofloxacin,2020,30.0,8.0,hospital,100
155,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2018,13.0,2.4,community,150
156,Japan,East Asia,Acinetobacter baumannii,Meropenem,2019,23.2,6.0,community,300
157,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2018,5.9,3.7,hospital,300
158,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2022,20.7,1.4,community,150
159,USA,North America,Acinetobacter baumannii,Vancomycin,2018,5.2,0.6,community,200
160,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2021,70.8,15.8,community,300
161,China,East Asia,Escherichia coli,Amoxicillin,2019,19.6,5.9,community,250
162,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2020,22.2,0.6,hospital,250
163,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2020,29.8,10.8,hospital,250
164,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2018,40.7,10.8,community,150
165,Nigeria,Africa,Escherichia coli,Meropenem,2020,34.5,4.1,hospital,300
166,Australia,Oceania,Escherichia coli,Ceftriaxone,2022,13.4,4.3,community,300
167,India,Southeast Asia,Escherichia coli,Amoxicillin,2018,47.1,12.9,hospital,150
168,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2022,57.1,7.5,hospital,150
169,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2018,24.6,4.9,hospital,100
170,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,56.7,13.6,hospital,300
171,Australia,Oceania,Escherichia coli,Ceftriaxone,2018,5.6,0.5,community,100
172,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2019,38.3,8.6,hospital,150
173,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2018,8.7,4.9,community,300
174,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2020,43.5,13.5,hospital,200
175,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2020,19.2,6.2,hospital,100
176,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2021,36.9,3.8,hospital,100
177,USA,North America,Pseudomonas aeruginosa,Vancomycin,2020,14.7,2.6,community,200
178,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2023,69.9,15.5,community,100
179,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2021,63.3,9.1,hospital,150
180,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2020,23.0,1.5,community,200
181,Brazil,South America,Escherichia coli,Vancomycin,2021,50.8,6.7,hospital,100
182,India,Southeast Asia,Escherichia coli,Meropenem,2021,74.4,15.5,hospital,150
183,Japan,East Asia,Escherichia coli,Ciprofloxacin,2019,26.8,1.9,hospital,200
184,USA,North America,Staphylococcus aureus,Vancomycin,2020,26.2,1.0,community,250
185,USA,North America,Staphylococcus aureus,Vancomycin,2021,11.1,6.3,community,200
186,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,21.5,8.7,community,150
187,France,Europe,Klebsiella pneumoniae,Vancomycin,2018,14.0,7.5,hospital,300
188,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2019,44.8,7.6,hospital,200
189,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2023,73.6,14.2,hospital,250
190,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2020,25.8,3.7,hospital,150
191,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2019,33.9,6.9,community,300
192,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,31.0,3.4,community,300
193,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2022,33.2,7.6,hospital,150
194,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2022,55.4,14.9,hospital,200
195,Germany,Europe,Escherichia coli,Amoxicillin,2018,19.8,5.6,community,100
196,USA,North America,Escherichia coli,Amoxicillin,2021,29.7,2.0,hospital,200
197,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2018,35.7,4.8,community,100
198,India,Southeast Asia,Escherichia coli,Ceftriaxone,2021,48.5,6.6,hospital,300
199,China,East Asia,Escherichia coli,Vancomycin,2021,44.4,5.3,community,250
200,Brazil,South America,Staphylococcus aureus,Meropenem,2022,34.8,6.5,community,100
201,China,East Asia,Escherichia coli,Amoxicillin,2020,42.6,3.5,community,100
202,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2022,74.7,14.3,community,100
203,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,64.6,15.7,hospital,200
204,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2020,30.4,2.5,community,100
205,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2023,60.9,15.2,community,150
206,France,Europe,Klebsiella pneumoniae,Meropenem,2019,31.6,7.4,community,100
207,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,34.6,11.9,community,150
208,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2018,36.7,3.6,hospital,200
209,Germany,Europe,Acinetobacter baumannii,Meropenem,2022,21.8,7.9,hospital,150
210,USA,North America,Escherichia coli,Meropenem,2020,9.6,3.7,community,300
211,Japan,East Asia,Staphylococcus aureus,Vancomycin,2019,34.7,4.3,hospital,100
212,Australia,Oceania,Escherichia coli,Ceftriaxone,2023,32.6,3.2,community,300
213,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2018,14.3,0.5,community,150
214,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2023,44.9,13.6,community,300
215,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2021,23.4,8.7,hospital,250
216,Japan,East Asia,Acinetobacter baumannii,Meropenem,2020,33.3,5.3,community,250
217,France,Europe,Escherichia coli,Vancomycin,2023,33.6,5.9,hospital,150
218,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,28.6,3.4,community,150
219,China,East Asia,Staphylococcus aureus,Amoxicillin,2023,45.9,8.9,community,100
220,France,Europe,Staphylococcus aureus,Amoxicillin,2019,30.7,1.4,hospital,200
221,China,East Asia,Acinetobacter baumannii,Meropenem,2019,22.7,8.9,hospital,150
222,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2018,33.8,3.4,hospital,250
223,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2020,21.9,9.0,community,200
224,China,East Asia,Escherichia coli,Ciprofloxacin,2023,27.7,1.7,community,150
225,France,Europe,Staphylococcus aureus,Vancomycin,2022,20.1,1.5,community,250
226,China,East Asia,Escherichia coli,Amoxicillin,2020,19.5,8.8,community,150
227,France,Europe,Escherichia coli,Amoxicillin,2020,20.5,8.1,community,300
228,India,Southeast Asia,Escherichia coli,Meropenem,2019,62.7,13.3,hospital,150
229,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2021,25.8,8.9,community,100
230,Japan,East Asia,Staphylococcus aureus,Meropenem,2018,30.9,8.4,community,300
231,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2022,22.0,7.3,community,150
232,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2020,34.7,11.3,hospital,250
233,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,30.8,3.7,hospital,150
234,China,East Asia,Staphylococcus aureus,Meropenem,2021,38.7,7.5,hospital,150
235,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,27.0,4.7,community,300
236,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,34.1,9.6,community,300
237,Australia,Oceania,Escherichia coli,Vancomycin,2020,8.2,2.6,community,150
238,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,33.3,9.9,hospital,300
239,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2019,15.4,3.9,hospital,200
240,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2018,41.6,6.3,community,250
241,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,37.6,6.9,community,300
242,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2020,35.0,6.0,community,250
243,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,32.3,4.0,community,100
244,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2018,7.4,3.6,community,150
245,Japan,East Asia,Escherichia coli,Amoxicillin,2020,30.2,3.8,community,250
246,USA,North America,Klebsiella pneumoniae,Vancomycin,2019,17.8,7.7,community,250
247,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2018,24.5,7.5,hospital,150
248,Brazil,South America,Klebsiella pneumoniae,Meropenem,2023,48.9,8.3,hospital,200
249,India,Southeast Asia,Escherichia coli,Vancomycin,2023,74.0,10.3,hospital,150
250,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2023,79.1,12.3,community,200
251,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2023,23.5,6.4,community,100
252,USA,North America,Klebsiella pneumoniae,Meropenem,2019,15.0,1.0,community,200
253,China,East Asia,Klebsiella pneumoniae,Vancomycin,2023,40.8,7.4,community,300
254,France,Europe,Acinetobacter baumannii,Amoxicillin,2023,26.2,5.5,community,200
255,Germany,Europe,Pseudomonas aeruginosa,Vancomycin,2023,24.9,9.8,community,150
256,China,East Asia,Staphylococcus aureus,Ceftriaxone,2018,26.7,8.9,hospital,200
257,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2020,60.5,15.1,hospital,300
258,USA,North America,Acinetobacter baumannii,Meropenem,2018,7.0,5.3,community,200
259,Japan,East Asia,Escherichia coli,Ciprofloxacin,2019,29.6,4.5,community,200
260,China,East Asia,Escherichia coli,Meropenem,2019,41.7,9.2,hospital,250
261,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2018,16.6,5.3,hospital,250
262,USA,North America,Acinetobacter baumannii,Meropenem,2021,27.3,3.9,community,200
263,Brazil,South America,Pseudomonas aeruginosa,Ciprofloxacin,2023,33.7,3.1,community,250
264,Australia,Oceania,Escherichia coli,Meropenem,2021,27.9,6.5,hospital,200
265,South Africa,Africa,Escherichia coli,Vancomycin,2021,34.4,11.7,hospital,250
266,China,East Asia,Staphylococcus aureus,Vancomycin,2021,29.3,8.8,community,100
267,India,Southeast Asia,Escherichia coli,Meropenem,2023,54.6,15.8,hospital,150
268,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2018,46.8,10.4,hospital,250
269,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2022,18.1,0.5,hospital,250
270,Germany,Europe,Staphylococcus aureus,Amoxicillin,2018,24.9,9.9,community,200
271,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2019,30.8,10.0,community,300
272,Germany,Europe,Acinetobacter baumannii,Vancomycin,2020,29.2,10.5,community,100
273,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2018,19.2,5.3,hospital,150
274,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2019,50.2,14.5,hospital,100
275,Japan,East Asia,Staphylococcus aureus,Meropenem,2022,43.6,6.0,hospital,100
276,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,37.6,10.2,community,150
277,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2021,52.4,6.5,community,300
278,China,East Asia,Klebsiella pneumoniae,Vancomycin,2021,37.6,6.3,community,100
279,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2021,14.2,0.5,hospital,250
280,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,16.2,1.4,hospital,300
281,South Africa,Africa,Escherichia coli,Amoxicillin,2018,61.5,9.5,hospital,250
282,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2020,36.8,8.0,hospital,150
283,South Africa,Africa,Escherichia coli,Meropenem,2018,27.6,3.2,community,150
284,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,20.5,7.3,hospital,100
285,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,31.0,10.9,hospital,250
286,USA,North America,Staphylococcus aureus,Amoxicillin,2019,22.8,0.5,hospital,200
287,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2020,50.6,11.1,hospital,200
288,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2023,45.5,11.0,community,250
289,USA,North America,Escherichia coli,Ciprofloxacin,2019,26.9,7.9,hospital,200
290,Australia,Oceania,Acinetobacter baumannii,Meropenem,2019,10.8,5.2,hospital,100
291,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2018,52.8,11.7,community,150
292,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2022,54.9,10.5,hospital,150
293,France,Europe,Staphylococcus aureus,Ciprofloxacin,2019,28.5,3.3,community,100
294,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,18.9,0.5,hospital,200
295,France,Europe,Escherichia coli,Ceftriaxone,2022,25.9,4.0,hospital,150
296,India,Southeast Asia,Acinetobacter baumannii,Meropenem,2019,65.1,11.8,hospital,100
297,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2021,17.2,7.1,community,150
298,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2023,44.8,13.1,community,200
299,China,East Asia,Acinetobacter baumannii,Amoxicillin,2023,44.4,11.0,community,300
300,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2018,12.0,3.5,hospital,200
301,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2020,48.4,13.5,hospital,300
302,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2019,38.7,6.3,hospital,300
303,USA,North America,Klebsiella pneumoniae,Meropenem,2019,14.4,0.5,hospital,150
304,Nigeria,Africa,Escherichia coli,Ceftriaxone,2021,33.6,2.2,community,100
305,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,14.3,5.6,community,150
306,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2019,44.8,5.4,hospital,150
307,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2022,29.4,9.5,community,250
308,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2019,11.5,4.6,community,200
309,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2019,56.4,15.7,hospital,100
310,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2018,38.7,5.4,community,300
311,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2020,13.1,6.6,hospital,100
312,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2021,27.6,4.1,community,100
313,USA,North America,Pseudomonas aeruginosa,Vancomycin,2021,19.5,5.7,community,250
314,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2022,42.4,6.7,hospital,100
315,China,East Asia,Klebsiella pneumoniae,Meropenem,2023,36.1,7.5,community,150
316,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,46.0,5.3,community,150
317,Nigeria,Africa,Escherichia coli,Vancomycin,2018,50.0,7.0,hospital,200
318,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2020,43.8,9.7,hospital,200
319,France,Europe,Staphylococcus aureus,Meropenem,2019,23.7,7.0,community,150
320,China,East Asia,Staphylococcus aureus,Ceftriaxone,2018,29.3,10.4,community,300
321,France,Europe,Escherichia coli,Vancomycin,2020,24.2,8.9,community,150
322,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2019,42.5,9.0,community,150
323,Brazil,South America,Staphylococcus aureus,Meropenem,2018,40.8,12.8,hospital,200
324,Brazil,South America,Escherichia coli,Ceftriaxone,2020,34.5,10.5,hospital,100
325,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2019,56.2,12.7,community,200
326,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2019,29.5,10.6,hospital,150
327,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2023,54.0,8.0,community,200
328,Brazil,South America,Escherichia coli,Amoxicillin,2020,31.1,5.7,community,150
329,Japan,East Asia,Staphylococcus aureus,Ciprofloxacin,2021,38.3,9.5,community,300
330,China,East Asia,Escherichia coli,Ciprofloxacin,2019,20.6,4.6,community,200
331,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2021,37.7,9.0,community,250
332,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2020,41.9,10.8,hospital,200
333,Germany,Europe,Acinetobacter baumannii,Meropenem,2019,27.4,8.9,community,150
334,USA,North America,Klebsiella pneumoniae,Amoxicillin,2020,12.3,5.4,community,100
335,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,29.8,6.5,hospital,200
336,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2022,42.5,7.8,community,150
337,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2018,23.1,7.0,community,100
338,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2019,54.1,12.6,hospital,300
339,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2021,33.9,9.2,community,150
340,South Africa,Africa,Escherichia coli,Meropenem,2018,49.6,8.2,hospital,150
341,USA,North America,Klebsiella pneumoniae,Meropenem,2018,20.7,0.5,community,300
342,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2023,19.5,1.0,community,150
343,South Africa,Africa,Escherichia coli,Ciprofloxacin,2021,62.2,10.9,hospital,300
344,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2020,48.4,11.0,community,250
345,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2018,36.5,8.4,hospital,300
346,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2022,15.1,0.5,community,200
347,France,Europe,Staphylococcus aureus,Ceftriaxone,2022,38.1,11.7,community,150
348,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2023,66.2,16.9,hospital,100
349,USA,North America,Escherichia coli,Vancomycin,2021,23.3,6.0,hospital,150
350,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2023,23.1,6.4,hospital,200
351,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2018,17.4,0.5,community,200
352,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,16.9,0.5,community,300
353,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,32.7,2.0,hospital,300
354,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2023,34.7,8.5,community,250
355,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2022,28.0,5.9,community,250
356,USA,North America,Staphylococcus aureus,Meropenem,2022,30.2,6.6,community,100
357,China,East Asia,Pseudomonas aeruginosa,Meropenem,2023,35.7,5.3,community,100
358,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2021,47.2,14.2,hospital,300
359,Nigeria,Africa,Escherichia coli,Amoxicillin,2023,41.2,7.8,hospital,100
360,China,East Asia,Escherichia coli,Ciprofloxacin,2018,16.4,7.3,hospital,200
361,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2019,29.7,7.0,hospital,200
362,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,29.8,10.1,hospital,150
363,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2019,47.9,11.4,community,150
364,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2018,30.3,6.8,community,200
365,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2019,38.7,12.4,community,100
366,Germany,Europe,Acinetobacter baumannii,Vancomycin,2019,21.9,5.7,community,250
367,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2020,16.6,5.7,hospital,300
368,France,Europe,Escherichia coli,Meropenem,2021,20.4,3.1,community,100
369,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2023,33.5,6.5,hospital,200
370,Germany,Europe,Acinetobacter baumannii,Meropenem,2019,16.8,4.2,hospital,150
371,South Africa,Africa,Acinetobacter baumannii,Meropenem,2020,37.4,12.1,community,100
372,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2018,43.8,13.2,community,100
373,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2021,63.6,8.5,community,100
374,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2020,12.9,0.5,community,300
375,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2021,34.3,4.1,hospital,150
376,USA,North America,Escherichia coli,Vancomycin,2020,27.7,1.5,community,250
377,France,Europe,Staphylococcus aureus,Vancomycin,2019,13.7,2.0,hospital,100
378,China,East Asia,Staphylococcus aureus,Vancomycin,2019,39.8,7.1,hospital,300
379,Germany,Europe,Escherichia coli,Meropenem,2020,26.9,6.9,community,100
380,South Africa,Africa,Escherichia coli,Vancomycin,2023,63.9,12.3,community,150
381,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,18.0,0.5,community,250
382,South Africa,Africa,Escherichia coli,Ceftriaxone,2019,43.2,7.1,hospital,300
383,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2018,22.5,7.5,community,250
384,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2018,27.4,7.8,hospital,100
385,USA,North America,Staphylococcus aureus,Vancomycin,2021,14.1,3.4,hospital,200
386,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2020,57.2,12.5,hospital,200
387,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2022,72.4,17.9,hospital,200
388,Germany,Europe,Acinetobacter baumannii,Meropenem,2020,29.7,8.0,community,150
389,India,Southeast Asia,Escherichia coli,Amoxicillin,2022,75.7,16.9,community,200
390,France,Europe,Pseudomonas aeruginosa,Vancomycin,2020,26.2,0.9,hospital,300
391,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2019,53.4,8.8,hospital,200
392,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2022,47.8,7.2,hospital,150
393,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2023,34.5,3.7,community,200
394,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2018,45.6,8.5,community,200
395,USA,North America,Acinetobacter baumannii,Ceftriaxone,2023,30.6,9.9,community,300
396,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2020,47.4,11.6,community,200
397,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,31.3,7.9,hospital,300
398,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,43.1,9.1,community,150
399,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2020,54.4,10.0,community,250
400,France,Europe,Acinetobacter baumannii,Vancomycin,2023,37.7,10.7,hospital,200
401,France,Europe,Staphylococcus aureus,Ciprofloxacin,2020,28.0,7.2,community,100
402,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2018,20.7,3.3,community,200
403,Germany,Europe,Staphylococcus aureus,Meropenem,2023,30.3,7.8,community,250
404,Germany,Europe,Klebsiella pneumoniae,Ciprofloxacin,2022,31.1,5.4,hospital,300
405,France,Europe,Pseudomonas aeruginosa,Vancomycin,2020,24.7,9.0,community,100
406,France,Europe,Klebsiella pneumoniae,Meropenem,2022,28.9,10.2,community,100
407,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2019,66.2,13.5,hospital,200
408,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2023,20.3,7.9,community,100
409,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2021,30.6,1.4,community,100
410,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2023,16.4,0.5,hospital,300
411,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2019,19.2,4.3,community,150
412,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2019,22.3,2.9,community,200
413,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2022,18.6,0.5,community,250
414,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2023,73.5,12.5,community,300
415,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2019,22.8,2.1,hospital,300
416,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2020,31.5,3.1,community,150
417,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,49.1,14.1,hospital,100
418,China,East Asia,Staphylococcus aureus,Ceftriaxone,2020,28.0,7.6,community,250
419,Australia,Oceania,Escherichia coli,Meropenem,2018,8.4,0.5,community,100
420,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2019,42.5,9.3,community,200
421,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,24.9,8.4,community,150
422,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2023,52.1,5.7,hospital,200
423,USA,North America,Staphylococcus aureus,Ciprofloxacin,2020,20.5,3.3,community,250
424,France,Europe,Acinetobacter baumannii,Amoxicillin,2019,29.1,7.1,community,300
425,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2018,20.3,0.5,hospital,300
426,USA,North America,Acinetobacter baumannii,Amoxicillin,2023,20.4,5.4,hospital,250
427,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2019,38.4,9.2,community,200
428,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2019,22.6,9.2,community,100
429,France,Europe,Klebsiella pneumoniae,Meropenem,2021,25.0,1.1,community,150
430,France,Europe,Klebsiella pneumoniae,Vancomycin,2021,24.3,4.5,community,250
431,China,East Asia,Staphylococcus aureus,Vancomycin,2018,35.0,11.0,community,200
432,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2019,64.7,12.0,hospital,100
433,Australia,Oceania,Escherichia coli,Meropenem,2021,23.4,7.7,hospital,300
434,Germany,Europe,Klebsiella pneumoniae,Meropenem,2019,30.7,1.8,community,150
435,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2020,24.8,7.0,community,250
436,China,East Asia,Escherichia coli,Ciprofloxacin,2022,42.2,6.2,hospital,300
437,China,East Asia,Pseudomonas aeruginosa,Meropenem,2023,38.5,7.2,hospital,250
438,China,East Asia,Staphylococcus aureus,Amoxicillin,2019,35.8,11.6,hospital,250
439,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2023,16.9,4.5,hospital,150
440,Germany,Europe,Escherichia coli,Vancomycin,2020,14.9,0.5,hospital,250
441,USA,North America,Escherichia coli,Ceftriaxone,2018,15.5,5.9,hospital,100
442,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2021,39.1,6.9,hospital,200
443,China,East Asia,Acinetobacter baumannii,Meropenem,2018,27.2,5.8,community,300
444,USA,North America,Staphylococcus aureus,Ceftriaxone,2020,24.5,6.8,community,100
445,Brazil,South America,Escherichia coli,Ciprofloxacin,2019,41.7,5.8,hospital,300
446,Australia,Oceania,Escherichia coli,Vancomycin,2021,23.6,6.1,hospital,200
447,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2019,55.7,10.3,hospital,100
448,South Africa,Africa,Escherichia coli,Amoxicillin,2023,70.0,12.3,community,200
449,France,Europe,Klebsiella pneumoniae,Meropenem,2019,30.7,1.4,hospital,300
450,France,Europe,Acinetobacter baumannii,Ceftriaxone,2019,22.1,8.6,hospital,250
451,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2023,18.2,0.8,hospital,150
452,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,66.1,9.9,community,100
453,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2023,52.7,7.0,hospital,200
454,Japan,East Asia,Escherichia coli,Meropenem,2022,33.5,2.1,hospital,100
455,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,35.7,5.3,hospital,150
456,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2022,21.3,2.0,community,200
457,India,Southeast Asia,Escherichia coli,Ceftriaxone,2021,77.9,14.9,community,300
458,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2021,32.7,9.3,community,200
459,Australia,Oceania,Escherichia coli,Meropenem,2020,23.9,0.9,hospital,200
460,USA,North America,Escherichia coli,Ceftriaxone,2019,16.2,4.7,hospital,100
461,China,East Asia,Escherichia coli,Amoxicillin,2023,36.5,7.7,community,250
462,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2023,21.0,8.6,community,250
463,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2022,47.9,6.2,community,200
464,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2021,56.3,12.0,hospital,150
465,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2018,39.3,3.6,hospital,200
466,USA,North America,Escherichia coli,Ciprofloxacin,2023,24.3,6.9,community,150
467,Germany,Europe,Acinetobacter baumannii,Vancomycin,2021,26.1,3.7,community,300
468,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2018,43.3,4.8,community,100
469,USA,North America,Acinetobacter baumannii,Vancomycin,2023,27.1,3.3,hospital,300
470,Japan,East Asia,Escherichia coli,Vancomycin,2022,49.5,14.0,hospital,300
471,China,East Asia,Acinetobacter baumannii,Vancomycin,2020,20.8,6.3,hospital,200
472,France,Europe,Staphylococcus aureus,Vancomycin,2020,29.9,4.7,community,200
473,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2018,58.7,13.8,hospital,250
474,China,East Asia,Escherichia coli,Meropenem,2021,26.4,2.5,hospital,100
475,South Africa,Africa,Escherichia coli,Meropenem,2020,57.1,14.2,hospital,300
476,Brazil,South America,Klebsiella pneumoniae,Meropenem,2023,44.2,4.9,community,250
477,USA,North America,Escherichia coli,Amoxicillin,2020,12.8,1.7,community,300
478,Germany,Europe,Staphylococcus aureus,Vancomycin,2019,19.4,3.1,community,200
479,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2022,55.7,9.4,hospital,150
480,Germany,Europe,Staphylococcus aureus,Amoxicillin,2022,38.5,4.2,hospital,300
481,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2018,8.9,3.0,community,100
482,Brazil,South America,Escherichia coli,Amoxicillin,2023,26.9,3.1,hospital,100
483,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2020,31.4,5.5,community,300
484,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2018,29.7,4.6,community,150
485,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2018,29.0,1.4,community,300
486,Australia,Oceania,Staphylococcus aureus,Meropenem,2022,15.3,1.2,community,100
487,Germany,Europe,Escherichia coli,Vancomycin,2020,32.3,6.9,community,250
488,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2020,30.6,5.4,hospital,150
489,Nigeria,Africa,Staphylococcus aureus,Meropenem,2023,43.5,12.3,hospital,200
490,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2021,23.3,8.7,community,100
491,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,48.6,11.4,hospital,100
492,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2018,11.8,3.5,hospital,250
493,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2019,32.6,4.0,hospital,250
494,Brazil,South America,Staphylococcus aureus,Vancomycin,2018,43.9,10.2,community,150
495,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2023,36.0,10.4,community,250
496,USA,North America,Klebsiella pneumoniae,Amoxicillin,2021,27.9,2.0,community,250
497,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2021,48.6,5.0,hospital,300
498,France,Europe,Staphylococcus aureus,Meropenem,2021,21.2,1.7,community,200
499,Germany,Europe,Staphylococcus aureus,Vancomycin,2021,24.1,4.9,community,100
500,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2023,35.1,10.1,community,150
501,Brazil,South America,Klebsiella pneumoniae,Meropenem,2018,38.4,4.6,community,300
502,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,30.1,7.1,hospital,150
503,Japan,East Asia,Escherichia coli,Ceftriaxone,2018,20.8,7.9,hospital,250
504,Germany,Europe,Staphylococcus aureus,Vancomycin,2023,35.6,12.1,hospital,200
505,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2019,46.5,5.0,hospital,100
506,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2023,51.6,6.2,hospital,200
507,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,58.5,7.3,hospital,300
508,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2021,48.2,10.8,community,100
509,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2020,27.3,7.1,community,300
510,South Africa,Africa,Escherichia coli,Ceftriaxone,2018,28.9,5.3,hospital,250
511,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2023,47.5,10.7,hospital,150
512,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2018,18.7,4.8,hospital,300
513,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2018,32.7,3.9,community,150
514,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2021,35.5,8.2,community,250
515,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2022,43.2,10.8,community,300
516,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2021,37.2,4.4,hospital,150
517,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2020,49.7,8.9,community,150
518,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2021,55.9,11.4,community,250
519,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2020,67.8,16.7,hospital,150
520,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,22.0,5.4,hospital,150
521,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2019,62.2,12.3,community,250
522,France,Europe,Klebsiella pneumoniae,Meropenem,2018,16.4,0.5,community,250
523,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2020,25.1,0.5,community,150
524,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2021,47.1,9.3,hospital,300
525,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,26.4,1.4,hospital,250
526,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2022,41.5,4.3,hospital,150
527,Australia,Oceania,Acinetobacter baumannii,Meropenem,2018,19.0,6.8,community,200
528,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,24.4,2.2,hospital,300
529,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2021,73.5,17.8,community,100
530,China,East Asia,Acinetobacter baumannii,Amoxicillin,2018,18.4,2.8,hospital,200
531,Brazil,South America,Acinetobacter baumannii,Meropenem,2022,53.6,8.5,community,150
532,India,Southeast Asia,Escherichia coli,Meropenem,2022,46.7,10.8,hospital,250
533,China,East Asia,Klebsiella pneumoniae,Meropenem,2023,34.2,10.8,community,150
534,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2019,57.8,7.3,hospital,300
535,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2021,41.1,11.1,community,150
536,Australia,Oceania,Escherichia coli,Ceftriaxone,2018,11.1,1.9,community,100
537,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2023,26.7,5.2,hospital,100
538,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2020,22.7,8.5,hospital,100
539,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2020,34.9,5.3,hospital,250
540,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,45.6,12.3,community,150
541,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2021,17.4,6.3,hospital,150
542,Australia,Oceania,Staphylococcus aureus,Vancomycin,2021,17.8,0.5,hospital,200
543,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,51.9,11.5,community,300
544,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2020,36.4,6.4,hospital,200
545,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2020,59.9,9.4,community,200
546,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,51.7,7.2,community,300
547,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,51.8,8.4,community,300
548,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2018,63.7,14.7,hospital,100
549,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2023,11.3,2.4,community,250
550,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,21.9,8.2,community,250
551,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,31.0,5.0,community,300
552,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2023,28.8,7.6,community,200
553,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2018,7.0,2.0,hospital,200
554,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2022,18.0,0.5,community,100
555,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2019,17.0,6.0,hospital,100
556,Germany,Europe,Escherichia coli,Vancomycin,2022,27.4,2.5,hospital,100
557,India,Southeast Asia,Escherichia coli,Vancomycin,2022,68.3,11.3,community,200
558,Japan,East Asia,Staphylococcus aureus,Meropenem,2021,45.5,6.7,community,300
559,Brazil,South America,Staphylococcus aureus,Meropenem,2020,42.9,10.5,community,100
560,Nigeria,Africa,Staphylococcus aureus,Meropenem,2018,63.6,9.5,hospital,150
561,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2020,23.2,2.1,community,250
562,USA,North America,Escherichia coli,Meropenem,2021,10.7,4.1,hospital,300
563,India,Southeast Asia,Escherichia coli,Amoxicillin,2023,47.6,6.1,community,200
564,Japan,East Asia,Escherichia coli,Meropenem,2021,30.1,6.3,community,150
565,China,East Asia,Klebsiella pneumoniae,Meropenem,2023,45.8,6.6,community,250
566,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,22.1,2.4,hospital,200
567,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,28.8,8.5,hospital,250
568,France,Europe,Staphylococcus aureus,Amoxicillin,2018,14.9,2.4,hospital,150
569,Japan,East Asia,Staphylococcus aureus,Vancomycin,2021,26.6,3.3,hospital,100
570,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2020,46.8,4.6,hospital,250
571,Germany,Europe,Acinetobacter baumannii,Meropenem,2023,27.6,4.0,hospital,100
572,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,39.4,7.1,hospital,100
573,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2019,46.7,8.2,hospital,300
574,Brazil,South America,Staphylococcus aureus,Meropenem,2023,35.6,9.5,community,150
575,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2018,6.9,5.7,community,300
576,Germany,Europe,Staphylococcus aureus,Amoxicillin,2023,31.6,4.6,hospital,200
577,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2020,56.3,15.4,hospital,150
578,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2018,19.3,3.8,hospital,100
579,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2021,58.0,16.1,community,200
580,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2018,20.4,4.0,hospital,250
581,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2018,32.7,8.6,community,300
582,Germany,Europe,Escherichia coli,Amoxicillin,2022,33.6,9.3,hospital,200
583,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2021,26.3,1.8,community,200
584,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2020,49.4,8.7,hospital,250
585,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2019,17.3,6.9,community,250
586,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2020,43.7,6.7,hospital,200
587,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2019,52.9,14.3,hospital,250
588,USA,North America,Escherichia coli,Ceftriaxone,2018,20.2,0.5,community,200
589,Germany,Europe,Staphylococcus aureus,Vancomycin,2021,15.9,2.9,hospital,150
590,Japan,East Asia,Escherichia coli,Ciprofloxacin,2019,41.3,8.5,community,150
591,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,40.2,8.4,community,300
592,South Africa,Africa,Staphylococcus aureus,Meropenem,2022,44.2,5.9,hospital,150
593,Japan,East Asia,Staphylococcus aureus,Ciprofloxacin,2023,40.1,3.3,community,100
594,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2023,25.3,2.6,community,100
595,Brazil,South America,Acinetobacter baumannii,Vancomycin,2022,41.9,6.2,community,250
596,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2021,23.0,8.0,hospital,250
597,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2021,26.0,2.3,community,200
598,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2018,49.8,14.1,hospital,250
599,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2021,30.3,10.1,community,250
600,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2019,71.6,15.3,community,250
601,Nigeria,Africa,Staphylococcus aureus,Meropenem,2021,37.4,2.7,hospital,200
602,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,57.6,16.1,community,200
603,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2018,34.3,2.4,hospital,100
604,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2023,33.2,9.9,hospital,100
605,India,Southeast Asia,Escherichia coli,Amoxicillin,2023,51.8,6.9,community,200
606,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2020,63.6,10.2,hospital,250
607,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2019,71.5,11.7,community,300
608,South Africa,Africa,Acinetobacter baumannii,Meropenem,2022,60.5,11.8,hospital,300
609,Germany,Europe,Klebsiella pneumoniae,Meropenem,2019,16.7,1.9,hospital,150
610,France,Europe,Pseudomonas aeruginosa,Vancomycin,2018,13.8,0.5,hospital,200
611,Japan,East Asia,Staphylococcus aureus,Vancomycin,2021,33.8,4.8,community,150
612,USA,North America,Staphylococcus aureus,Amoxicillin,2021,27.8,1.1,hospital,150
613,Brazil,South America,Acinetobacter baumannii,Vancomycin,2020,41.8,4.0,hospital,300
614,China,East Asia,Acinetobacter baumannii,Meropenem,2022,28.2,9.5,community,250
615,USA,North America,Klebsiella pneumoniae,Meropenem,2021,23.1,3.1,community,150
616,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2019,30.2,10.6,hospital,100
617,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,36.6,11.6,community,200
618,USA,North America,Escherichia coli,Ciprofloxacin,2021,22.4,4.7,hospital,200
619,France,Europe,Escherichia coli,Meropenem,2022,32.5,6.2,hospital,150
620,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2021,66.6,12.4,hospital,200
621,Nigeria,Africa,Escherichia coli,Meropenem,2022,54.3,5.9,community,250
622,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2021,72.9,10.0,community,100
623,India,Southeast Asia,Escherichia coli,Ceftriaxone,2018,69.3,11.0,hospital,300
624,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2021,67.6,11.3,hospital,200
625,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2018,28.3,7.5,community,250
626,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2019,65.9,13.6,hospital,100
627,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2021,33.8,4.3,community,200
628,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2018,17.1,5.9,hospital,250
629,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2022,41.9,9.5,community,300
630,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2021,23.0,5.9,hospital,300
631,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2022,33.5,10.7,community,200
632,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,22.1,3.5,community,150
633,China,East Asia,Klebsiella pneumoniae,Vancomycin,2022,44.9,5.5,community,300
634,Nigeria,Africa,Escherichia coli,Amoxicillin,2019,32.3,8.7,community,250
635,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2022,30.6,1.5,community,150
636,South Africa,Africa,Escherichia coli,Meropenem,2020,46.4,8.6,community,200
637,China,East Asia,Acinetobacter baumannii,Vancomycin,2020,44.6,8.0,hospital,100
638,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2018,63.1,10.7,community,300
639,France,Europe,Escherichia coli,Vancomycin,2020,20.6,4.3,community,200
640,Brazil,South America,Escherichia coli,Meropenem,2018,23.5,4.8,community,150
641,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2020,39.0,11.8,hospital,100
642,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,55.4,15.2,community,300
643,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2020,29.6,5.5,community,150
644,Brazil,South America,Staphylococcus aureus,Amoxicillin,2020,49.2,11.2,community,300
645,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,29.0,4.5,community,300
646,Japan,East Asia,Escherichia coli,Ciprofloxacin,2019,39.5,3.9,hospital,100
647,Germany,Europe,Escherichia coli,Meropenem,2022,15.3,4.4,hospital,300
648,USA,North America,Staphylococcus aureus,Amoxicillin,2019,22.7,7.2,hospital,250
649,Nigeria,Africa,Klebsiella pneumoniae,Amoxicillin,2019,35.3,9.3,hospital,150
650,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2021,26.2,1.5,community,150
651,Germany,Europe,Staphylococcus aureus,Vancomycin,2020,24.4,8.7,hospital,150
652,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2021,21.4,0.8,hospital,250
653,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2021,54.6,6.8,community,200
654,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2019,36.4,9.4,hospital,250
655,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2021,35.6,10.9,hospital,250
656,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2022,51.6,7.0,hospital,250
657,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2022,65.4,10.8,community,100
658,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2018,39.4,5.3,hospital,300
659,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2019,23.5,1.6,hospital,100
660,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2020,39.0,10.0,hospital,300
661,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2021,10.9,0.5,community,300
662,Germany,Europe,Staphylococcus aureus,Vancomycin,2023,36.7,8.8,community,250
663,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2023,54.2,12.4,community,300
664,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2022,68.6,15.3,community,100
665,China,East Asia,Acinetobacter baumannii,Amoxicillin,2023,37.4,3.4,hospital,150
666,USA,North America,Staphylococcus aureus,Ceftriaxone,2019,21.8,0.5,community,100
667,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2022,41.6,8.8,hospital,100
668,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2021,65.1,16.9,hospital,100
669,France,Europe,Escherichia coli,Meropenem,2023,23.8,3.4,community,300
670,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2022,27.0,2.4,community,200
671,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2018,68.6,12.6,hospital,150
672,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2020,31.8,9.8,hospital,200
673,USA,North America,Staphylococcus aureus,Vancomycin,2022,27.3,6.7,hospital,100
674,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2019,60.6,10.6,hospital,200
675,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2020,21.9,1.8,community,200
676,Japan,East Asia,Staphylococcus aureus,Vancomycin,2022,29.5,6.8,hospital,150
677,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2020,24.8,5.2,community,200
678,USA,North America,Staphylococcus aureus,Vancomycin,2022,22.2,8.1,community,100
679,China,East Asia,Staphylococcus aureus,Meropenem,2023,31.4,7.5,community,200
680,Australia,Oceania,Escherichia coli,Vancomycin,2018,10.8,5.6,community,250
681,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2019,39.3,7.8,community,150
682,France,Europe,Acinetobacter baumannii,Meropenem,2022,36.8,6.1,hospital,250
683,India,Southeast Asia,Acinetobacter baumannii,Meropenem,2018,34.6,7.8,hospital,100
684,India,Southeast Asia,Staphylococcus aureus,Meropenem,2020,62.1,9.3,community,150
685,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2022,26.6,4.2,hospital,150
686,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2019,43.4,6.5,hospital,250
687,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,19.6,3.8,community,300
688,Nigeria,Africa,Escherichia coli,Meropenem,2019,56.8,12.7,hospital,200
689,Japan,East Asia,Escherichia coli,Meropenem,2023,27.2,0.6,hospital,150
690,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2019,18.3,0.5,community,150
691,Brazil,South America,Escherichia coli,Amoxicillin,2018,40.8,12.6,hospital,300
692,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2022,37.7,3.6,hospital,200
693,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2019,28.5,1.6,community,250
694,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2019,14.0,0.5,hospital,150
695,Nigeria,Africa,Escherichia coli,Vancomycin,2019,40.1,6.3,hospital,150
696,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2018,26.5,3.4,hospital,300
697,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,18.3,5.6,community,150
698,USA,North America,Escherichia coli,Vancomycin,2019,8.3,0.7,community,200
699,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2021,35.5,9.6,community,300
700,China,East Asia,Staphylococcus aureus,Amoxicillin,2020,42.7,3.8,community,250
701,Nigeria,Africa,Escherichia coli,Vancomycin,2023,52.9,12.9,hospital,150
702,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2022,49.0,13.4,hospital,150
703,USA,North America,Pseudomonas aeruginosa,Meropenem,2022,16.3,7.4,community,300
704,China,East Asia,Staphylococcus aureus,Vancomycin,2023,33.1,4.7,community,100
705,South Africa,Africa,Escherichia coli,Vancomycin,2020,50.2,14.1,hospital,100
706,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2018,23.5,9.2,community,150
707,USA,North America,Staphylococcus aureus,Ceftriaxone,2019,12.5,0.5,hospital,300
708,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2022,38.4,11.5,community,100
709,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2023,51.2,12.3,community,150
710,France,Europe,Acinetobacter baumannii,Vancomycin,2021,22.6,9.3,community,300
711,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2019,65.8,13.4,community,100
712,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2023,27.7,5.8,community,250
713,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2019,46.7,10.0,community,100
714,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2021,31.2,5.6,community,200
715,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,16.8,5.0,community,150
716,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2021,43.9,4.1,hospital,250
717,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,17.7,0.5,hospital,150
718,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2022,75.6,12.7,community,100
719,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2018,64.8,9.6,community,150
720,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2018,11.4,3.7,hospital,250
721,Japan,East Asia,Escherichia coli,Ceftriaxone,2022,29.7,7.4,hospital,300
722,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2018,6.0,5.4,community,200
723,China,East Asia,Escherichia coli,Vancomycin,2022,47.5,13.6,hospital,200
724,USA,North America,Staphylococcus aureus,Ceftriaxone,2021,20.3,8.8,community,100
725,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2019,37.0,7.4,hospital,150
726,USA,North America,Acinetobacter baumannii,Amoxicillin,2018,23.3,1.7,community,300
727,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2018,20.4,0.9,community,100
728,China,East Asia,Escherichia coli,Meropenem,2021,32.4,5.9,community,200
729,USA,North America,Escherichia coli,Ciprofloxacin,2021,18.6,3.2,hospital,300
730,China,East Asia,Acinetobacter baumannii,Amoxicillin,2021,19.9,7.8,hospital,300
731,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2022,35.7,9.5,hospital,100
732,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2020,51.4,13.8,hospital,200
733,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2023,32.4,4.1,hospital,200
734,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2021,18.8,2.7,community,250
735,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2019,68.4,11.2,community,100
736,China,East Asia,Escherichia coli,Meropenem,2018,23.9,5.1,hospital,250
737,Brazil,South America,Staphylococcus aureus,Vancomycin,2019,43.5,12.1,community,150
738,Brazil,South America,Klebsiella pneumoniae,Meropenem,2019,22.1,8.6,hospital,100
739,France,Europe,Acinetobacter baumannii,Amoxicillin,2021,28.6,3.7,hospital,150
740,Australia,Oceania,Staphylococcus aureus,Vancomycin,2018,17.1,2.4,hospital,150
741,Germany,Europe,Escherichia coli,Meropenem,2021,30.5,9.1,community,250
742,South Africa,Africa,Escherichia coli,Amoxicillin,2022,41.8,3.4,community,200
743,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2022,23.8,2.4,community,100
744,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2019,23.4,8.6,hospital,250
745,Brazil,South America,Acinetobacter baumannii,Vancomycin,2020,40.0,6.2,community,250
746,France,Europe,Staphylococcus aureus,Meropenem,2021,29.2,5.3,community,150
747,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2022,18.4,6.1,hospital,300
748,Australia,Oceania,Escherichia coli,Amoxicillin,2020,13.4,6.1,community,300
749,South Africa,Africa,Escherichia coli,Meropenem,2022,36.3,10.3,hospital,150
750,USA,North America,Staphylococcus aureus,Ceftriaxone,2020,24.2,0.5,community,200
751,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2019,37.9,10.5,community,250
752,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2021,50.6,14.9,hospital,200
753,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2018,37.9,10.2,community,100
754,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2023,28.7,6.4,community,150
755,France,Europe,Escherichia coli,Ceftriaxone,2021,29.6,8.4,community,200
756,Brazil,South America,Staphylococcus aureus,Amoxicillin,2022,41.2,3.3,community,200
757,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2022,54.3,10.9,community,300
758,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2019,39.0,8.0,community,150
759,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2021,39.8,4.3,community,300
760,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2021,54.3,12.9,hospital,300
761,South Africa,Africa,Escherichia coli,Ceftriaxone,2018,39.4,4.3,community,300
762,China,East Asia,Acinetobacter baumannii,Amoxicillin,2022,25.7,2.4,community,150
763,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2019,57.8,13.5,hospital,100
764,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2022,53.0,7.3,hospital,250
765,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2018,41.9,5.7,community,150
766,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2022,54.2,15.8,community,150
767,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2022,36.4,10.5,hospital,200
768,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2018,8.2,3.7,hospital,100
769,France,Europe,Staphylococcus aureus,Vancomycin,2021,23.1,1.9,community,300
770,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2022,75.4,17.4,hospital,100
771,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2018,35.7,10.5,community,100
772,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2022,73.4,14.0,hospital,200
773,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2021,39.6,5.3,hospital,250
774,India,Southeast Asia,Escherichia coli,Meropenem,2018,45.6,9.0,community,200
775,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2022,28.5,5.6,community,300
776,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2021,24.9,0.7,hospital,250
777,Australia,Oceania,Escherichia coli,Amoxicillin,2022,24.9,6.5,hospital,300
778,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2022,30.5,8.2,community,200
779,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2022,63.4,12.1,hospital,250
780,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2022,59.1,10.5,community,250
781,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2022,70.9,12.7,hospital,200
782,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,48.0,8.3,community,150
783,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2019,19.8,0.5,community,250
784,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2018,26.1,6.3,community,200
785,USA,North America,Escherichia coli,Ciprofloxacin,2019,10.7,0.5,community,300
786,Germany,Europe,Escherichia coli,Ciprofloxacin,2021,23.0,0.5,hospital,300
787,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2021,36.5,2.4,community,300
788,Australia,Oceania,Escherichia coli,Ciprofloxacin,2019,20.8,0.5,community,250
789,China,East Asia,Klebsiella pneumoniae,Meropenem,2019,29.2,8.6,community,250
790,Japan,East Asia,Escherichia coli,Amoxicillin,2020,35.7,6.6,community,150
791,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2018,40.7,5.3,hospital,100
792,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,28.6,8.2,hospital,100
793,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2019,62.9,14.9,hospital,150
794,France,Europe,Escherichia coli,Ceftriaxone,2019,16.3,1.8,community,100
795,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2022,57.5,9.6,hospital,250
796,France,Europe,Staphylococcus aureus,Ciprofloxacin,2020,20.3,6.0,hospital,200
797,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2023,54.8,11.1,hospital,150
798,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2022,22.1,8.8,community,200
799,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2022,57.9,11.2,community,200
800,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2022,30.6,9.6,hospital,150
801,Brazil,South America,Acinetobacter baumannii,Meropenem,2023,52.5,5.8,hospital,100
802,USA,North America,Acinetobacter baumannii,Amoxicillin,2019,26.3,6.7,community,300
803,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2020,71.7,12.1,hospital,300
804,Japan,East Asia,Escherichia coli,Amoxicillin,2020,43.1,11.2,community,250
805,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2019,44.9,9.8,community,300
806,South Africa,Africa,Staphylococcus aureus,Meropenem,2023,36.1,6.6,community,300
807,Brazil,South America,Klebsiella pneumoniae,Meropenem,2021,43.2,11.2,community,300
808,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2022,28.8,10.2,community,250
809,South Africa,Africa,Staphylococcus aureus,Meropenem,2023,55.3,10.9,hospital,200
810,France,Europe,Escherichia coli,Vancomycin,2018,26.8,0.7,hospital,100
811,Nigeria,Africa,Escherichia coli,Vancomycin,2022,72.2,16.6,community,150
812,France,Europe,Klebsiella pneumoniae,Vancomycin,2023,34.7,6.8,community,200
813,USA,North America,Staphylococcus aureus,Ceftriaxone,2018,5.1,0.5,community,100
814,South Africa,Africa,Escherichia coli,Vancomycin,2023,46.4,11.3,community,300
815,South Africa,Africa,Escherichia coli,Ciprofloxacin,2020,40.4,12.6,community,100
816,South Africa,Africa,Staphylococcus aureus,Meropenem,2022,68.8,16.4,community,200
817,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2018,32.1,2.6,hospital,250
818,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2022,35.5,9.6,hospital,100
819,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2020,68.1,10.6,hospital,250
820,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2021,25.8,6.5,hospital,100
821,Japan,East Asia,Escherichia coli,Ceftriaxone,2018,15.3,0.5,community,300
822,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2023,54.0,8.5,community,200
823,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2020,42.6,5.8,community,100
824,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2023,47.5,9.5,community,100
825,France,Europe,Klebsiella pneumoniae,Vancomycin,2020,24.0,3.1,community,200
826,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2018,37.6,4.1,hospital,100
827,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,23.5,5.3,hospital,150
828,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2020,58.6,15.1,hospital,300
829,France,Europe,Pseudomonas aeruginosa,Meropenem,2022,30.3,3.7,community,300
830,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,17.1,0.5,community,150
831,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2022,23.2,4.8,hospital,150
832,Germany,Europe,Staphylococcus aureus,Vancomycin,2023,37.4,9.6,community,200
833,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2023,33.9,9.2,community,200
834,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,38.2,7.2,hospital,150
835,France,Europe,Klebsiella pneumoniae,Vancomycin,2019,20.0,2.7,hospital,250
836,France,Europe,Staphylococcus aureus,Meropenem,2023,36.6,2.6,community,200
837,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2020,23.1,7.4,hospital,150
838,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2018,25.4,3.0,hospital,150
839,Japan,East Asia,Staphylococcus aureus,Ciprofloxacin,2023,41.5,4.8,community,100
840,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2018,35.5,2.9,community,150
841,China,East Asia,Staphylococcus aureus,Ceftriaxone,2019,38.0,9.8,hospital,150
842,China,East Asia,Pseudomonas aeruginosa,Meropenem,2019,18.7,7.8,community,150
843,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2022,71.7,15.1,community,150
844,Germany,Europe,Escherichia coli,Vancomycin,2023,31.1,10.4,community,200
845,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2023,68.6,14.6,hospital,200
846,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2021,69.8,11.3,hospital,250
847,Australia,Oceania,Escherichia coli,Meropenem,2022,16.0,5.2,hospital,250
848,Germany,Europe,Escherichia coli,Amoxicillin,2023,23.9,1.3,hospital,200
849,China,East Asia,Acinetobacter baumannii,Amoxicillin,2023,34.4,4.4,community,150
850,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2023,38.7,7.8,community,200
851,Germany,Europe,Escherichia coli,Ceftriaxone,2019,12.2,2.2,hospital,150
852,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2020,13.2,0.5,community,300
853,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2022,54.8,14.7,hospital,250
854,Brazil,South America,Escherichia coli,Amoxicillin,2018,22.7,5.3,hospital,200
855,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2023,25.8,3.5,hospital,250
856,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,24.2,2.3,hospital,250
857,USA,North America,Klebsiella pneumoniae,Amoxicillin,2018,22.7,1.5,community,250
858,South Africa,Africa,Escherichia coli,Meropenem,2022,40.5,4.8,hospital,200
859,Nigeria,Africa,Staphylococcus aureus,Meropenem,2019,42.0,11.1,hospital,150
860,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,28.2,5.9,community,200
861,China,East Asia,Klebsiella pneumoniae,Vancomycin,2022,28.6,5.0,community,300
862,Nigeria,Africa,Escherichia coli,Amoxicillin,2020,61.7,9.5,community,300
863,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2018,29.6,5.4,hospital,150
864,USA,North America,Klebsiella pneumoniae,Amoxicillin,2022,26.3,3.7,community,150
865,France,Europe,Acinetobacter baumannii,Ceftriaxone,2018,26.0,1.7,community,200
866,France,Europe,Escherichia coli,Amoxicillin,2019,21.9,2.6,hospital,100
867,South Africa,Africa,Escherichia coli,Meropenem,2022,70.3,12.4,hospital,250
868,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,22.5,8.5,community,300
869,Brazil,South America,Escherichia coli,Vancomycin,2021,27.8,2.5,hospital,200
870,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2023,40.1,8.4,hospital,250
871,China,East Asia,Acinetobacter baumannii,Vancomycin,2022,43.3,6.5,hospital,300
872,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2018,13.6,0.5,community,250
873,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2022,44.0,13.2,hospital,250
874,USA,North America,Staphylococcus aureus,Ceftriaxone,2019,19.7,3.2,community,300
875,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,30.8,2.0,hospital,200
876,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2022,27.6,4.6,community,200
877,China,East Asia,Escherichia coli,Ciprofloxacin,2023,39.8,3.9,community,300
878,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,11.1,2.7,hospital,250
879,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,44.7,7.7,hospital,300
880,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2021,44.5,5.7,community,100
881,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2023,38.6,11.3,community,100
882,South Africa,Africa,Escherichia coli,Ceftriaxone,2018,55.7,7.3,hospital,250
883,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2020,56.3,7.3,hospital,100
884,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2020,39.7,8.9,hospital,200
885,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2023,21.1,1.8,community,250
886,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2023,71.4,13.8,hospital,200
887,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2022,31.3,5.9,community,100
888,Japan,East Asia,Acinetobacter baumannii,Meropenem,2021,33.6,5.9,community,300
889,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2018,42.5,8.9,hospital,150
890,USA,North America,Staphylococcus aureus,Ceftriaxone,2022,29.9,1.7,community,200
891,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2019,45.7,12.8,community,100
892,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,6.8,4.5,hospital,300
893,India,Southeast Asia,Escherichia coli,Vancomycin,2018,49.6,10.5,community,200
894,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2022,55.5,14.6,community,250
895,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,36.0,5.3,community,100
896,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2023,36.0,4.1,community,150
897,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2018,60.4,15.4,hospital,200
898,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2020,62.5,11.2,hospital,200
899,India,Southeast Asia,Escherichia coli,Ceftriaxone,2023,44.5,10.4,hospital,100
900,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2018,29.2,8.9,community,250
901,South Africa,Africa,Escherichia coli,Ceftriaxone,2018,30.9,9.7,hospital,250
902,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2022,19.7,0.5,hospital,150
903,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2020,25.1,6.4,community,100
904,Germany,Europe,Staphylococcus aureus,Meropenem,2019,23.0,9.2,community,200
905,USA,North America,Staphylococcus aureus,Vancomycin,2020,26.3,1.0,hospital,300
906,Germany,Europe,Acinetobacter baumannii,Meropenem,2020,17.0,6.4,hospital,300
907,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2022,46.3,9.0,hospital,250
908,Japan,East Asia,Escherichia coli,Amoxicillin,2023,44.5,9.4,community,100
909,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2019,35.0,11.5,hospital,300
910,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2020,56.6,7.7,hospital,250
911,China,East Asia,Acinetobacter baumannii,Vancomycin,2020,36.9,8.9,community,200
912,Germany,Europe,Acinetobacter baumannii,Vancomycin,2020,21.6,5.3,community,150
913,Brazil,South America,Escherichia coli,Vancomycin,2018,24.1,6.7,community,200
914,Australia,Oceania,Staphylococcus aureus,Vancomycin,2019,17.6,6.4,hospital,100
915,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,58.4,10.1,hospital,300
916,China,East Asia,Klebsiella pneumoniae,Meropenem,2022,44.9,5.0,hospital,150
917,USA,North America,Acinetobacter baumannii,Ceftriaxone,2019,24.0,8.7,community,300
918,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2021,45.1,11.6,hospital,200
919,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2019,23.1,2.0,community,200
920,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2020,47.4,13.0,hospital,300
921,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2021,39.3,10.7,community,300
922,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2018,39.5,7.9,hospital,250
923,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2019,33.6,5.0,hospital,300
924,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2019,49.3,13.3,hospital,100
925,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2022,71.1,13.2,community,100
926,Japan,East Asia,Staphylococcus aureus,Vancomycin,2021,34.3,6.5,hospital,250
927,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2021,20.6,7.9,hospital,250
928,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2022,24.6,8.8,community,150
929,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2018,21.3,6.8,community,200
930,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2018,11.7,2.7,hospital,100
931,Japan,East Asia,Staphylococcus aureus,Vancomycin,2019,24.0,9.2,hospital,300
932,France,Europe,Pseudomonas aeruginosa,Vancomycin,2020,19.5,7.9,community,300
933,China,East Asia,Acinetobacter baumannii,Vancomycin,2019,19.8,0.5,community,250
934,Brazil,South America,Acinetobacter baumannii,Vancomycin,2018,26.9,3.1,hospital,100
935,USA,North America,Escherichia coli,Amoxicillin,2020,25.5,6.3,community,300
936,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,18.9,1.7,hospital,200
937,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2023,23.9,6.1,community,150
938,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2023,32.9,6.1,community,300
939,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2018,15.6,0.5,community,300
940,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,34.1,7.4,hospital,200
941,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2021,9.5,0.5,community,200
942,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2021,24.9,0.5,hospital,100
943,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2018,62.9,9.4,hospital,200
944,France,Europe,Escherichia coli,Meropenem,2020,28.3,2.4,hospital,300
945,USA,North America,Staphylococcus aureus,Vancomycin,2023,17.0,4.9,community,200
946,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2023,50.3,14.6,hospital,250
947,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2022,30.1,2.6,community,150
948,France,Europe,Escherichia coli,Ceftriaxone,2018,17.3,0.5,community,300
949,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2023,39.5,9.9,hospital,150
950,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2019,43.7,8.1,hospital,200
951,China,East Asia,Klebsiella pneumoniae,Meropenem,2022,42.7,11.0,community,100
952,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2020,30.3,10.1,hospital,100
953,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2023,26.8,7.5,hospital,200
954,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2023,32.3,1.6,community,300
955,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,44.3,7.7,community,150
956,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2020,39.9,11.1,hospital,250
957,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2018,39.4,7.6,community,100
958,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2019,33.8,10.5,hospital,200
959,USA,North America,Staphylococcus aureus,Ceftriaxone,2021,14.9,5.3,hospital,200
960,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,27.5,6.3,hospital,250
961,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2023,50.0,7.9,hospital,150
962,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2020,26.8,10.0,community,300
963,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2020,41.4,5.2,community,150
964,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2021,72.4,10.9,community,150
965,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2021,19.5,7.0,hospital,100
966,Germany,Europe,Escherichia coli,Ciprofloxacin,2020,14.9,0.5,community,100
967,USA,North America,Pseudomonas aeruginosa,Vancomycin,2023,38.4,8.8,community,250
968,Australia,Oceania,Escherichia coli,Ciprofloxacin,2022,18.4,2.7,hospital,250
969,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2021,76.1,16.2,hospital,150
970,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2019,14.4,6.4,hospital,100
971,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2020,28.5,9.6,hospital,250
972,France,Europe,Klebsiella pneumoniae,Meropenem,2022,24.3,5.7,community,200
973,USA,North America,Pseudomonas aeruginosa,Vancomycin,2019,15.7,5.0,community,200
974,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2021,40.3,6.6,community,100
975,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2022,25.5,8.9,community,150
976,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2023,30.2,6.9,community,150
977,Germany,Europe,Acinetobacter baumannii,Vancomycin,2019,17.7,4.4,hospital,200
978,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2020,33.6,9.9,hospital,200
979,USA,North America,Escherichia coli,Vancomycin,2022,22.0,1.3,hospital,150
980,Brazil,South America,Escherichia coli,Ciprofloxacin,2020,37.7,9.6,community,100
981,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2018,19.8,5.4,hospital,250
982,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2021,34.2,7.7,hospital,150
983,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2019,54.4,7.4,community,250
984,Japan,East Asia,Escherichia coli,Meropenem,2020,40.0,3.4,community,150
985,USA,North America,Staphylococcus aureus,Ceftriaxone,2019,14.7,7.0,hospital,100
986,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2018,6.3,3.8,community,250
987,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2023,49.8,14.1,hospital,200
988,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2018,6.9,3.8,community,250
989,USA,North America,Staphylococcus aureus,Ciprofloxacin,2022,21.2,5.3,hospital,200
990,China,East Asia,Escherichia coli,Amoxicillin,2020,42.6,8.6,hospital,300
991,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2020,13.5,0.5,community,300
992,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2020,55.1,12.1,hospital,300
993,China,East Asia,Staphylococcus aureus,Meropenem,2022,26.2,9.9,community,300
994,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2023,31.7,8.9,community,100
995,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2023,69.4,11.6,hospital,150
996,South Africa,Africa,Escherichia coli,Vancomycin,2022,65.1,17.4,community,200
997,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,30.2,10.0,hospital,150
998,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2019,35.4,3.5,hospital,300
999,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2020,59.6,9.3,hospital,150
1000,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2020,16.4,3.7,hospital,150
1001,Japan,East Asia,Acinetobacter baumannii,Meropenem,2021,32.1,6.3,hospital,200
1002,Brazil,South America,Pseudomonas aeruginosa,Ciprofloxacin,2021,31.1,7.6,community,200
1003,USA,North America,Acinetobacter baumannii,Vancomycin,2020,13.8,5.7,hospital,150
1004,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2019,62.3,9.4,community,100
1005,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2018,44.4,11.8,hospital,250
1006,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,43.0,10.1,community,200
1007,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2022,49.4,11.1,hospital,200
1008,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2019,35.4,9.0,hospital,150
1009,France,Europe,Pseudomonas aeruginosa,Meropenem,2022,31.8,2.9,community,150
1010,China,East Asia,Escherichia coli,Ciprofloxacin,2019,34.4,9.3,community,100
1011,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2018,17.5,2.0,community,300
1012,China,East Asia,Escherichia coli,Meropenem,2021,34.9,10.4,community,200
1013,Japan,East Asia,Escherichia coli,Amoxicillin,2019,18.6,0.5,community,300
1014,Japan,East Asia,Escherichia coli,Amoxicillin,2018,36.2,4.6,hospital,300
1015,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,27.0,2.3,hospital,250
1016,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2020,17.0,0.5,hospital,300
1017,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2022,36.4,6.2,community,200
1018,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2022,44.2,4.4,community,150
1019,Brazil,South America,Acinetobacter baumannii,Vancomycin,2022,44.4,11.6,community,250
1020,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2023,25.0,8.9,community,150
1021,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2021,53.8,10.0,hospital,300
1022,China,East Asia,Staphylococcus aureus,Ceftriaxone,2020,36.9,10.8,community,300
1023,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2023,36.7,8.5,community,200
1024,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2021,38.4,12.1,community,200
1025,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2019,61.6,15.5,hospital,300
1026,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2022,25.4,8.5,hospital,300
1027,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,37.7,9.0,community,200
1028,Brazil,South America,Staphylococcus aureus,Amoxicillin,2019,30.1,6.7,community,150
1029,India,Southeast Asia,Escherichia coli,Amoxicillin,2022,56.1,14.8,hospital,200
1030,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2020,30.4,6.0,hospital,150
1031,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2018,12.8,0.5,community,100
1032,Brazil,South America,Escherichia coli,Ciprofloxacin,2021,53.1,9.3,community,300
1033,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2020,33.8,2.3,hospital,100
1034,France,Europe,Staphylococcus aureus,Ceftriaxone,2020,18.0,3.9,hospital,100
1035,South Africa,Africa,Acinetobacter baumannii,Meropenem,2021,50.9,14.8,hospital,100
1036,China,East Asia,Acinetobacter baumannii,Vancomycin,2022,33.4,2.6,hospital,300
1037,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2022,40.4,10.5,community,100
1038,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2021,48.4,12.6,hospital,100
1039,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2020,49.1,10.1,community,300
1040,Japan,East Asia,Escherichia coli,Ceftriaxone,2018,37.5,9.1,community,100
1041,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2021,26.7,7.6,community,200
1042,South Africa,Africa,Staphylococcus aureus,Vancomycin,2022,38.9,7.5,community,300
1043,China,East Asia,Klebsiella pneumoniae,Meropenem,2023,40.0,3.9,hospital,250
1044,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2021,62.3,8.3,community,250
1045,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2023,21.1,0.5,community,150
1046,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,44.7,4.4,hospital,100
1047,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2020,56.9,8.6,community,150
1048,Germany,Europe,Escherichia coli,Meropenem,2022,31.2,1.9,community,300
1049,Brazil,South America,Staphylococcus aureus,Vancomycin,2020,36.3,4.9,hospital,150
1050,USA,North America,Pseudomonas aeruginosa,Vancomycin,2023,25.2,3.3,community,200
1051,USA,North America,Staphylococcus aureus,Ciprofloxacin,2019,13.8,0.5,community,150
1052,China,East Asia,Staphylococcus aureus,Vancomycin,2019,30.0,1.0,community,150
1053,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2023,23.1,5.2,hospital,100
1054,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2022,23.5,6.1,community,100
1055,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2022,55.6,13.4,community,100
1056,France,Europe,Escherichia coli,Amoxicillin,2022,21.3,8.6,community,100
1057,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2020,30.9,9.0,hospital,150
1058,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2018,55.0,12.4,hospital,100
1059,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2018,26.7,9.8,community,150
1060,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2018,10.8,4.0,hospital,300
1061,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,45.4,11.9,community,250
1062,Brazil,South America,Escherichia coli,Ciprofloxacin,2023,63.0,10.2,hospital,150
1063,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,38.9,9.5,hospital,300
1064,France,Europe,Pseudomonas aeruginosa,Meropenem,2023,31.8,10.6,hospital,250
1065,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2022,32.9,7.4,community,200
1066,France,Europe,Escherichia coli,Vancomycin,2019,15.1,1.7,community,300
1067,China,East Asia,Staphylococcus aureus,Vancomycin,2023,33.1,4.0,hospital,200
1068,China,East Asia,Staphylococcus aureus,Vancomycin,2018,32.7,1.9,hospital,200
1069,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2021,22.1,3.9,community,200
1070,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2021,27.6,0.7,community,100
1071,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2020,30.7,4.5,hospital,250
1072,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2018,6.5,0.5,community,300
1073,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2018,38.1,6.0,hospital,150
1074,USA,North America,Escherichia coli,Amoxicillin,2021,26.0,8.5,community,300
1075,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2019,23.2,1.3,community,100
1076,Brazil,South America,Pseudomonas aeruginosa,Ciprofloxacin,2019,26.8,9.5,hospital,200
1077,China,East Asia,Escherichia coli,Meropenem,2022,33.6,3.6,hospital,300
1078,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2018,45.7,6.8,hospital,200
1079,Nigeria,Africa,Escherichia coli,Ceftriaxone,2020,57.0,12.6,community,250
1080,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2018,16.3,3.0,hospital,100
1081,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2018,22.2,3.9,community,250
1082,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2021,15.6,0.5,community,150
1083,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2021,53.2,8.4,community,100
1084,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2019,55.2,14.7,hospital,100
1085,China,East Asia,Escherichia coli,Meropenem,2020,27.5,7.4,community,250
1086,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2018,61.7,14.6,hospital,150
1087,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,26.3,7.6,community,300
1088,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,22.3,5.0,community,100
1089,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2022,13.0,1.1,hospital,200
1090,China,East Asia,Acinetobacter baumannii,Amoxicillin,2019,26.3,9.9,community,250
1091,USA,North America,Pseudomonas aeruginosa,Vancomycin,2021,12.0,2.4,hospital,150
1092,Nigeria,Africa,Escherichia coli,Ceftriaxone,2021,55.1,12.4,community,150
1093,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2019,36.9,10.6,community,100
1094,China,East Asia,Escherichia coli,Meropenem,2019,35.7,8.2,community,200
1095,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,43.0,7.1,community,100
1096,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2019,33.4,6.4,community,300
1097,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2021,34.2,3.4,hospital,100
1098,China,East Asia,Staphylococcus aureus,Meropenem,2020,35.4,4.7,community,100
1099,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2019,22.7,9.1,community,150
1100,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2021,32.2,2.5,hospital,150
1101,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2020,32.4,9.8,hospital,100
1102,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2023,27.4,4.8,community,250
1103,China,East Asia,Staphylococcus aureus,Ceftriaxone,2022,36.3,10.4,community,250
1104,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,25.7,1.2,hospital,150
1105,South Africa,Africa,Staphylococcus aureus,Vancomycin,2022,54.0,15.0,hospital,300
1106,South Africa,Africa,Escherichia coli,Amoxicillin,2021,53.4,9.8,hospital,300
1107,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,34.5,11.4,community,300
1108,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2022,23.7,1.4,community,300
1109,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2018,10.3,5.8,hospital,300
1110,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2022,43.3,12.3,community,100
1111,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2019,59.6,10.5,community,300
1112,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2018,22.5,5.3,community,150
1113,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2018,52.9,9.2,hospital,200
1114,Australia,Oceania,Staphylococcus aureus,Meropenem,2020,21.7,8.3,community,100
1115,Nigeria,Africa,Staphylococcus aureus,Meropenem,2018,56.6,12.5,hospital,250
1116,Nigeria,Africa,Escherichia coli,Amoxicillin,2023,46.4,12.6,community,250
1117,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,28.7,6.8,hospital,250
1118,China,East Asia,Klebsiella pneumoniae,Vancomycin,2021,25.8,1.1,community,150
1119,USA,North America,Staphylococcus aureus,Meropenem,2023,27.3,2.8,community,300
1120,Germany,Europe,Escherichia coli,Ceftriaxone,2023,43.6,7.4,hospital,200
1121,France,Europe,Klebsiella pneumoniae,Amoxicillin,2020,20.5,0.8,hospital,300
1122,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2023,72.8,17.5,hospital,150
1123,USA,North America,Acinetobacter baumannii,Vancomycin,2023,26.9,6.3,community,100
1124,South Africa,Africa,Escherichia coli,Amoxicillin,2019,50.0,13.8,hospital,300
1125,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2020,27.6,4.5,community,150
1126,USA,North America,Acinetobacter baumannii,Amoxicillin,2019,15.1,4.1,hospital,100
1127,Brazil,South America,Staphylococcus aureus,Meropenem,2020,48.6,9.0,community,250
1128,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2018,15.9,2.4,hospital,150
1129,USA,North America,Escherichia coli,Vancomycin,2023,30.1,3.5,community,100
1130,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2019,33.5,2.1,hospital,300
1131,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2021,60.4,12.7,community,250
1132,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,42.3,8.3,hospital,300
1133,France,Europe,Acinetobacter baumannii,Vancomycin,2021,21.6,9.1,hospital,250
1134,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2020,59.2,14.8,community,150
1135,China,East Asia,Klebsiella pneumoniae,Meropenem,2020,41.6,6.6,community,250
1136,India,Southeast Asia,Escherichia coli,Vancomycin,2023,81.7,20,community,150
1137,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2019,29.8,7.6,community,300
1138,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2020,29.2,5.8,hospital,100
1139,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,62.7,12.2,hospital,150
1140,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2022,65.2,8.6,community,100
1141,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2023,60.0,10.8,hospital,150
1142,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2020,64.3,15.3,community,250
1143,France,Europe,Acinetobacter baumannii,Ceftriaxone,2023,39.0,4.6,hospital,300
1144,Nigeria,Africa,Staphylococcus aureus,Meropenem,2019,66.2,15.4,community,300
1145,France,Europe,Escherichia coli,Vancomycin,2019,28.0,6.2,community,100
1146,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2023,62.0,12.7,hospital,250
1147,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2019,20.4,5.0,community,200
1148,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2023,15.2,5.1,community,250
1149,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2018,22.2,3.4,hospital,200
1150,Germany,Europe,Klebsiella pneumoniae,Ciprofloxacin,2019,23.8,9.4,community,150
1151,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,42.1,7.1,hospital,100
1152,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2022,44.8,5.6,hospital,250
1153,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2022,59.1,12.3,community,200
1154,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2019,57.5,12.5,hospital,200
1155,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2022,64.8,16.5,hospital,150
1156,France,Europe,Staphylococcus aureus,Amoxicillin,2022,37.6,12.5,community,150
1157,France,Europe,Escherichia coli,Vancomycin,2018,15.3,6.7,community,250
1158,USA,North America,Escherichia coli,Ceftriaxone,2023,24.4,2.4,hospital,250
1159,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2022,16.1,0.5,hospital,300
1160,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2022,72.5,10.8,hospital,250
1161,Germany,Europe,Escherichia coli,Ciprofloxacin,2023,20.7,6.0,community,200
1162,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2019,59.9,13.9,hospital,100
1163,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2022,68.9,17.0,hospital,150
1164,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2020,36.9,9.9,community,250
1165,USA,North America,Acinetobacter baumannii,Vancomycin,2022,34.1,4.8,community,100
1166,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,51.3,7.6,hospital,300
1167,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2018,34.8,9.7,community,100
1168,China,East Asia,Staphylococcus aureus,Vancomycin,2018,16.8,2.6,community,300
1169,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2018,27.0,5.9,hospital,100
1170,USA,North America,Escherichia coli,Ciprofloxacin,2022,20.9,3.2,hospital,200
1171,Germany,Europe,Acinetobacter baumannii,Meropenem,2019,25.5,4.0,community,300
1172,France,Europe,Acinetobacter baumannii,Ceftriaxone,2018,24.7,1.7,community,150
1173,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2019,30.5,4.6,hospital,300
1174,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2019,28.5,1.6,community,300
1175,Germany,Europe,Pseudomonas aeruginosa,Vancomycin,2022,25.6,1.4,community,300
1176,China,East Asia,Klebsiella pneumoniae,Meropenem,2018,16.4,0.5,community,150
1177,Japan,East Asia,Escherichia coli,Meropenem,2020,21.5,4.1,community,250
1178,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2021,65.8,12.0,hospital,300
1179,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,43.7,12.3,hospital,250
1180,Brazil,South America,Escherichia coli,Amoxicillin,2022,26.4,4.1,community,300
1181,Japan,East Asia,Acinetobacter baumannii,Meropenem,2023,33.4,4.5,community,300
1182,Germany,Europe,Escherichia coli,Ciprofloxacin,2019,22.9,7.7,community,150
1183,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,14.3,7.3,community,250
1184,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2021,16.9,2.7,hospital,200
1185,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2023,28.0,4.3,community,300
1186,India,Southeast Asia,Staphylococcus aureus,Meropenem,2021,67.1,17.1,hospital,250
1187,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2020,59.5,13.8,community,150
1188,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,5.3,3.9,hospital,200
1189,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,48.7,6.7,community,200
1190,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2021,32.0,10.7,hospital,100
1191,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2019,29.0,1.5,hospital,100
1192,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2021,25.8,9.2,community,100
1193,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2019,12.1,2.8,hospital,300
1194,Nigeria,Africa,Escherichia coli,Vancomycin,2019,41.8,3.6,hospital,100
1195,Germany,Europe,Acinetobacter baumannii,Meropenem,2023,34.5,6.2,community,200
1196,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2019,67.0,14.9,hospital,100
1197,Germany,Europe,Staphylococcus aureus,Vancomycin,2021,24.9,3.1,community,100
1198,France,Europe,Staphylococcus aureus,Vancomycin,2018,27.7,2.7,community,150
1199,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2023,18.8,0.5,hospital,300
1200,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2022,43.8,11.4,hospital,150
1201,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2020,23.2,6.6,community,300
1202,USA,North America,Pseudomonas aeruginosa,Vancomycin,2018,16.8,7.2,community,200
1203,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2021,70.0,9.1,community,150
1204,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2023,22.0,0.5,community,250
1205,France,Europe,Escherichia coli,Vancomycin,2022,36.5,9.2,community,250
1206,Nigeria,Africa,Escherichia coli,Meropenem,2021,47.2,10.7,hospital,300
1207,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2018,8.4,2.2,community,250
1208,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2023,32.4,1.5,community,100
1209,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2021,43.1,3.9,hospital,150
1210,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2021,27.3,8.5,community,300
1211,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2022,27.1,5.6,community,250
1212,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2020,38.8,9.3,hospital,100
1213,Brazil,South America,Pseudomonas aeruginosa,Ciprofloxacin,2022,32.6,5.7,community,200
1214,Australia,Oceania,Escherichia coli,Vancomycin,2022,16.7,7.6,community,100
1215,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2021,15.1,7.9,hospital,250
1216,USA,North America,Klebsiella pneumoniae,Meropenem,2018,24.6,5.3,hospital,100
1217,USA,North America,Acinetobacter baumannii,Amoxicillin,2022,17.8,5.6,community,150
1218,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,11.2,4.1,hospital,250
1219,France,Europe,Klebsiella pneumoniae,Amoxicillin,2018,21.3,4.0,hospital,300
1220,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2023,20.0,0.5,hospital,200
1221,USA,North America,Acinetobacter baumannii,Amoxicillin,2018,13.7,3.6,hospital,150
1222,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2021,54.6,8.3,community,150
1223,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2022,35.2,2.7,community,100
1224,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2023,40.4,6.4,hospital,100
1225,Japan,East Asia,Escherichia coli,Ceftriaxone,2018,38.4,11.5,community,300
1226,China,East Asia,Escherichia coli,Meropenem,2019,26.1,5.3,community,300
1227,Japan,East Asia,Staphylococcus aureus,Vancomycin,2018,23.7,6.9,hospital,100
1228,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2023,19.9,8.7,hospital,100
1229,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2023,44.8,11.0,hospital,300
1230,USA,North America,Klebsiella pneumoniae,Amoxicillin,2021,19.1,7.0,hospital,200
1231,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2022,53.8,7.8,community,300
1232,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2023,80.8,19.3,community,250
1233,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2021,18.9,6.0,community,150
1234,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2023,22.5,7.0,hospital,150
1235,Brazil,South America,Escherichia coli,Ciprofloxacin,2021,49.2,6.4,community,100
1236,USA,North America,Escherichia coli,Vancomycin,2018,22.0,7.1,community,200
1237,Nigeria,Africa,Staphylococcus aureus,Meropenem,2020,38.8,12.0,community,100
1238,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2020,17.1,0.5,community,150
1239,Brazil,South America,Escherichia coli,Ciprofloxacin,2018,46.2,6.0,community,100
1240,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,71.8,18.2,hospital,200
1241,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2018,35.8,6.6,hospital,300
1242,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2021,48.8,13.4,hospital,100
1243,Japan,East Asia,Staphylococcus aureus,Meropenem,2018,31.8,4.8,community,200
1244,Australia,Oceania,Staphylococcus aureus,Vancomycin,2022,25.0,4.8,community,100
1245,South Africa,Africa,Acinetobacter baumannii,Meropenem,2019,56.8,9.2,hospital,300
1246,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,15.3,3.0,community,150
1247,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2022,17.0,1.8,hospital,200
1248,China,East Asia,Acinetobacter baumannii,Meropenem,2019,37.6,11.7,community,300
1249,Brazil,South America,Escherichia coli,Vancomycin,2020,29.7,8.1,community,150
1250,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2021,24.4,5.6,hospital,300
1251,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,21.3,9.0,hospital,300
1252,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,31.3,8.8,community,300
1253,China,East Asia,Acinetobacter baumannii,Meropenem,2023,24.9,2.8,hospital,300
1254,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2022,23.7,0.5,community,100
1255,Brazil,South America,Escherichia coli,Vancomycin,2018,22.8,7.6,community,250
1256,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2020,49.5,8.1,hospital,100
1257,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2021,19.2,8.8,community,200
1258,USA,North America,Staphylococcus aureus,Meropenem,2020,8.5,3.9,community,250
1259,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2023,35.6,6.1,community,250
1260,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2019,26.2,2.4,hospital,300
1261,France,Europe,Staphylococcus aureus,Ciprofloxacin,2023,23.3,5.3,community,250
1262,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2018,55.5,15.2,community,250
1263,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2019,32.5,10.2,community,150
1264,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2018,51.2,5.6,hospital,100
1265,France,Europe,Pseudomonas aeruginosa,Meropenem,2022,34.6,11.4,community,100
1266,Brazil,South America,Staphylococcus aureus,Amoxicillin,2022,29.4,7.3,hospital,250
1267,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2018,28.8,9.2,community,200
1268,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2023,47.9,10.7,hospital,150
1269,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2023,50.5,6.6,community,300
1270,USA,North America,Staphylococcus aureus,Meropenem,2019,11.7,5.2,hospital,200
1271,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2022,34.1,6.4,community,150
1272,China,East Asia,Acinetobacter baumannii,Amoxicillin,2023,27.7,0.7,community,150
1273,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2018,31.8,7.9,community,150
1274,France,Europe,Acinetobacter baumannii,Ceftriaxone,2018,13.8,0.5,community,200
1275,China,East Asia,Escherichia coli,Ciprofloxacin,2020,22.0,5.4,community,200
1276,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2018,27.7,6.3,community,150
1277,Germany,Europe,Staphylococcus aureus,Vancomycin,2018,11.4,4.4,hospital,200
1278,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2020,60.2,15.5,hospital,100
1279,Germany,Europe,Staphylococcus aureus,Vancomycin,2018,14.1,7.1,community,300
1280,China,East Asia,Escherichia coli,Vancomycin,2022,42.4,11.4,community,200
1281,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2021,42.3,11.5,community,200
1282,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2020,34.0,2.1,community,100
1283,USA,North America,Klebsiella pneumoniae,Amoxicillin,2019,10.7,6.8,community,150
1284,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2023,69.8,14.6,hospital,300
1285,China,East Asia,Escherichia coli,Ciprofloxacin,2018,31.7,1.8,community,150
1286,France,Europe,Escherichia coli,Amoxicillin,2023,37.2,2.5,community,200
1287,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2021,22.6,2.1,community,150
1288,USA,North America,Staphylococcus aureus,Ciprofloxacin,2021,13.9,6.9,community,200
1289,Germany,Europe,Staphylococcus aureus,Amoxicillin,2019,21.9,2.2,hospital,100
1290,France,Europe,Escherichia coli,Meropenem,2019,27.7,8.2,hospital,150
1291,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2023,43.3,13.2,community,150
1292,Japan,East Asia,Escherichia coli,Meropenem,2021,35.2,3.5,community,100
1293,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2021,38.2,11.4,hospital,200
1294,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2022,32.0,3.5,hospital,200
1295,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2021,27.6,8.6,community,300
1296,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2018,34.3,3.8,community,200
1297,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2020,33.4,6.7,community,200
1298,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2023,56.1,9.8,community,100
1299,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2020,52.1,12.0,hospital,250
1300,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2018,44.3,8.4,community,200
1301,USA,North America,Escherichia coli,Ciprofloxacin,2022,28.6,9.6,hospital,300
1302,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2019,63.0,16.4,hospital,200
1303,Brazil,South America,Escherichia coli,Ciprofloxacin,2020,34.8,9.3,community,250
1304,France,Europe,Klebsiella pneumoniae,Amoxicillin,2018,29.7,1.6,community,250
1305,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2021,30.5,8.1,hospital,150
1306,Germany,Europe,Escherichia coli,Meropenem,2018,10.3,0.5,community,150
1307,USA,North America,Klebsiella pneumoniae,Vancomycin,2021,27.7,7.0,hospital,200
1308,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2021,60.4,14.6,hospital,250
1309,Japan,East Asia,Escherichia coli,Ceftriaxone,2022,34.3,4.9,hospital,300
1310,Brazil,South America,Staphylococcus aureus,Vancomycin,2022,30.7,5.6,community,250
1311,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,23.2,4.5,community,250
1312,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,17.0,1.2,hospital,200
1313,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2022,43.6,12.0,hospital,250
1314,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2023,42.3,5.8,hospital,200
1315,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2022,47.8,7.9,hospital,150
1316,Australia,Oceania,Acinetobacter baumannii,Meropenem,2020,17.9,7.8,hospital,300
1317,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2021,59.0,10.5,community,300
1318,Germany,Europe,Escherichia coli,Amoxicillin,2018,18.1,0.5,hospital,200
1319,USA,North America,Pseudomonas aeruginosa,Meropenem,2018,18.6,1.1,community,100
1320,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2022,55.0,14.8,community,150
1321,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2023,58.5,16.5,hospital,150
1322,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2023,49.8,14.0,hospital,300
1323,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2020,38.3,3.4,hospital,200
1324,USA,North America,Klebsiella pneumoniae,Meropenem,2021,20.8,8.8,hospital,150
1325,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2020,31.4,10.0,hospital,250
1326,USA,North America,Staphylococcus aureus,Meropenem,2021,24.4,6.5,community,250
1327,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2021,27.1,6.1,hospital,200
1328,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,55.6,12.1,community,200
1329,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2023,51.7,7.4,hospital,250
1330,France,Europe,Staphylococcus aureus,Ciprofloxacin,2021,34.4,10.0,hospital,200
1331,India,Southeast Asia,Escherichia coli,Meropenem,2021,49.7,7.4,community,250
1332,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2023,31.1,4.3,hospital,200
1333,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2018,30.5,5.1,community,150
1334,China,East Asia,Escherichia coli,Vancomycin,2019,41.2,6.0,community,200
1335,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2019,36.6,10.5,hospital,200
1336,China,East Asia,Staphylococcus aureus,Vancomycin,2020,34.6,8.8,community,200
1337,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,24.1,7.0,community,300
1338,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,35.3,9.4,hospital,150
1339,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2021,28.3,10.7,community,150
1340,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2020,40.0,6.6,hospital,200
1341,China,East Asia,Staphylococcus aureus,Meropenem,2023,46.5,8.8,community,250
1342,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2022,50.4,8.4,community,300
1343,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,20.1,4.4,community,200
1344,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2018,16.0,1.6,community,250
1345,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2018,18.4,8.1,community,300
1346,France,Europe,Escherichia coli,Vancomycin,2018,14.4,1.9,community,250
1347,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2020,28.5,8.5,hospital,300
1348,Nigeria,Africa,Escherichia coli,Amoxicillin,2019,43.4,13.1,hospital,150
1349,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2020,34.4,2.7,hospital,200
1350,France,Europe,Staphylococcus aureus,Vancomycin,2018,29.4,2.8,community,200
1351,USA,North America,Staphylococcus aureus,Amoxicillin,2018,19.7,1.5,community,300
1352,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2022,31.8,8.1,community,250
1353,China,East Asia,Acinetobacter baumannii,Vancomycin,2023,47.8,12.0,community,150
1354,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2022,48.2,13.9,hospital,100
1355,Australia,Oceania,Escherichia coli,Amoxicillin,2021,18.5,7.7,community,150
1356,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2019,27.4,4.3,community,100
1357,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2022,39.6,6.9,hospital,300
1358,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2021,58.6,16.5,community,100
1359,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2022,25.6,6.0,hospital,100
1360,USA,North America,Klebsiella pneumoniae,Meropenem,2020,20.0,2.0,community,150
1361,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2020,60.6,7.8,hospital,250
1362,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2022,77.3,16.4,community,200
1363,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2023,20.6,0.9,hospital,300
1364,Australia,Oceania,Escherichia coli,Ciprofloxacin,2020,13.3,0.7,hospital,250
1365,China,East Asia,Staphylococcus aureus,Meropenem,2020,36.6,3.0,hospital,200
1366,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2020,36.2,4.4,hospital,300
1367,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2019,18.9,7.6,hospital,150
1368,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2021,19.0,0.5,hospital,100
1369,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2019,54.3,13.4,community,100
1370,France,Europe,Acinetobacter baumannii,Amoxicillin,2023,36.9,8.6,hospital,200
1371,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2019,30.0,10.6,hospital,150
1372,Japan,East Asia,Staphylococcus aureus,Meropenem,2021,45.4,7.7,community,200
1373,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2020,16.8,3.5,hospital,150
1374,USA,North America,Acinetobacter baumannii,Amoxicillin,2023,39.3,9.0,community,100
1375,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2020,40.0,7.3,hospital,300
1376,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2021,8.6,6.1,community,250
1377,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2021,46.2,7.8,hospital,300
1378,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2023,20.7,5.0,hospital,100
1379,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2020,24.5,8.5,community,300
1380,USA,North America,Escherichia coli,Ciprofloxacin,2018,19.3,0.5,community,150
1381,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,10.0,3.3,community,250
1382,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,40.0,9.9,community,250
1383,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2022,14.0,4.4,community,200
1384,Brazil,South America,Escherichia coli,Meropenem,2022,36.9,4.8,community,150
1385,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2021,34.2,8.6,community,300
1386,South Africa,Africa,Escherichia coli,Ciprofloxacin,2023,42.6,4.2,community,250
1387,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2021,32.4,8.4,community,300
1388,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2019,30.3,4.9,hospital,200
1389,France,Europe,Staphylococcus aureus,Ciprofloxacin,2023,35.7,2.4,community,250
1390,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2018,28.4,4.8,hospital,300
1391,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2020,31.0,2.5,community,200
1392,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2023,49.9,11.7,hospital,100
1393,China,East Asia,Acinetobacter baumannii,Amoxicillin,2021,40.5,12.2,community,250
1394,USA,North America,Acinetobacter baumannii,Meropenem,2018,21.9,7.1,hospital,250
1395,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2018,7.8,4.7,hospital,250
1396,France,Europe,Staphylococcus aureus,Vancomycin,2023,20.9,0.5,community,250
1397,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,10.4,6.3,community,300
1398,Germany,Europe,Escherichia coli,Amoxicillin,2018,20.5,9.0,hospital,250
1399,France,Europe,Klebsiella pneumoniae,Vancomycin,2019,22.0,2.9,hospital,200
1400,Japan,East Asia,Escherichia coli,Ceftriaxone,2020,27.2,10.3,community,150
1401,India,Southeast Asia,Escherichia coli,Meropenem,2022,56.0,14.7,hospital,100
1402,Germany,Europe,Staphylococcus aureus,Vancomycin,2020,30.3,3.3,community,200
1403,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2023,52.2,5.7,hospital,100
1404,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2022,11.4,4.2,hospital,150
1405,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2018,27.9,3.3,community,250
1406,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2023,34.6,3.3,community,200
1407,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2019,41.2,5.6,hospital,200
1408,Brazil,South America,Escherichia coli,Ceftriaxone,2023,46.0,4.8,community,250
1409,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2021,34.0,6.8,community,250
1410,South Africa,Africa,Staphylococcus aureus,Meropenem,2019,50.1,13.8,hospital,300
1411,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2023,42.9,8.7,community,150
1412,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2023,68.7,16.6,hospital,250
1413,France,Europe,Staphylococcus aureus,Vancomycin,2020,22.1,8.8,community,300
1414,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2020,24.6,1.0,hospital,200
1415,USA,North America,Klebsiella pneumoniae,Vancomycin,2019,10.5,4.1,community,300
1416,China,East Asia,Escherichia coli,Ciprofloxacin,2020,36.9,5.8,community,250
1417,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2019,47.3,11.8,hospital,250
1418,China,East Asia,Escherichia coli,Ceftriaxone,2018,20.2,8.8,hospital,300
1419,Brazil,South America,Acinetobacter baumannii,Vancomycin,2018,42.3,13.3,hospital,300
1420,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2018,49.8,14.5,hospital,200
1421,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2018,62.7,15.3,community,300
1422,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2019,17.3,2.7,community,100
1423,Brazil,South America,Staphylococcus aureus,Amoxicillin,2023,28.3,9.0,hospital,250
1424,France,Europe,Acinetobacter baumannii,Amoxicillin,2023,37.5,10.1,community,300
1425,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2023,25.9,3.7,community,100
1426,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2021,57.4,11.8,community,200
1427,India,Southeast Asia,Staphylococcus aureus,Ciprofloxacin,2019,53.6,12.0,community,150
1428,Japan,East Asia,Escherichia coli,Ceftriaxone,2022,49.8,10.1,hospital,100
1429,Brazil,South America,Escherichia coli,Meropenem,2018,21.3,7.9,hospital,150
1430,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2021,60.7,11.7,community,150
1431,France,Europe,Escherichia coli,Ceftriaxone,2020,16.1,6.7,hospital,150
1432,France,Europe,Escherichia coli,Meropenem,2018,13.5,0.5,community,200
1433,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2023,46.4,10.5,community,250
1434,USA,North America,Staphylococcus aureus,Ciprofloxacin,2023,16.6,7.5,hospital,300
1435,Germany,Europe,Escherichia coli,Ceftriaxone,2022,38.9,9.3,community,300
1436,France,Europe,Staphylococcus aureus,Vancomycin,2022,19.3,0.5,hospital,300
1437,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2021,32.6,8.5,hospital,150
1438,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2023,19.5,5.0,community,250
1439,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2021,41.7,9.1,hospital,200
1440,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2021,65.7,17.8,hospital,100
1441,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2019,14.0,7.8,community,150
1442,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,70.9,16.0,community,150
1443,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2022,22.7,4.4,community,200
1444,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2020,47.9,12.1,hospital,250
1445,USA,North America,Staphylococcus aureus,Ceftriaxone,2020,13.3,4.2,hospital,100
1446,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,28.7,9.5,hospital,200
1447,Germany,Europe,Staphylococcus aureus,Amoxicillin,2022,30.5,8.1,community,300
1448,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2021,36.1,7.5,hospital,100
1449,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,49.2,4.8,hospital,200
1450,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,33.4,3.1,hospital,250
1451,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,32.0,6.2,hospital,300
1452,USA,North America,Klebsiella pneumoniae,Meropenem,2022,20.9,3.4,community,250
1453,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2020,48.8,8.0,community,250
1454,Australia,Oceania,Escherichia coli,Vancomycin,2018,8.6,0.5,community,200
1455,Brazil,South America,Escherichia coli,Meropenem,2021,41.2,10.0,community,250
1456,Germany,Europe,Escherichia coli,Meropenem,2023,29.2,10.4,community,150
1457,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2019,31.1,7.6,community,150
1458,China,East Asia,Escherichia coli,Vancomycin,2021,21.0,5.0,community,100
1459,Germany,Europe,Acinetobacter baumannii,Vancomycin,2023,40.4,9.7,hospital,100
1460,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2019,46.5,5.1,community,100
1461,France,Europe,Pseudomonas aeruginosa,Meropenem,2022,29.0,10.0,community,300
1462,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2021,24.4,7.6,hospital,250
1463,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2021,25.9,2.5,community,200
1464,Nigeria,Africa,Klebsiella pneumoniae,Amoxicillin,2023,66.1,13.9,community,200
1465,USA,North America,Escherichia coli,Amoxicillin,2023,25.7,4.1,community,250
1466,China,East Asia,Pseudomonas aeruginosa,Meropenem,2020,21.9,2.1,community,250
1467,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2019,37.6,2.9,community,150
1468,France,Europe,Escherichia coli,Ceftriaxone,2021,24.8,1.2,hospital,250
1469,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2022,64.2,13.4,community,150
1470,China,East Asia,Pseudomonas aeruginosa,Meropenem,2022,36.1,3.0,hospital,100
1471,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2020,59.9,7.7,hospital,250
1472,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2020,57.9,10.6,community,100
1473,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2018,22.1,8.5,community,200
1474,South Africa,Africa,Escherichia coli,Ceftriaxone,2022,46.6,8.6,community,150
1475,China,East Asia,Escherichia coli,Ceftriaxone,2019,38.1,5.5,hospital,200
1476,Australia,Oceania,Escherichia coli,Amoxicillin,2018,10.5,1.3,community,100
1477,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,27.5,4.0,community,100
1478,China,East Asia,Escherichia coli,Ciprofloxacin,2019,29.0,4.9,community,100
1479,France,Europe,Klebsiella pneumoniae,Meropenem,2020,30.1,4.5,community,250
1480,South Africa,Africa,Escherichia coli,Amoxicillin,2022,43.3,4.5,hospital,250
1481,France,Europe,Staphylococcus aureus,Ciprofloxacin,2019,29.9,1.2,community,200
1482,Germany,Europe,Staphylococcus aureus,Vancomycin,2021,29.6,6.2,community,150
1483,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,61.8,15.1,hospital,250
1484,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2023,42.8,5.2,community,200
1485,Japan,East Asia,Escherichia coli,Ciprofloxacin,2021,47.0,9.1,hospital,300
1486,France,Europe,Acinetobacter baumannii,Meropenem,2021,30.2,8.8,community,150
1487,Germany,Europe,Staphylococcus aureus,Meropenem,2022,31.8,3.0,community,300
1488,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2022,69.4,16.9,hospital,150
1489,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2023,21.7,2.5,hospital,250
1490,South Africa,Africa,Escherichia coli,Meropenem,2022,54.2,15.8,community,150
1491,Australia,Oceania,Escherichia coli,Vancomycin,2019,18.2,3.4,community,150
1492,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2020,30.9,7.4,hospital,200
1493,USA,North America,Staphylococcus aureus,Meropenem,2019,22.7,2.8,hospital,150
1494,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2023,37.1,4.0,community,300
1495,Japan,East Asia,Escherichia coli,Vancomycin,2019,36.2,3.1,hospital,200
1496,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2018,8.5,1.2,community,200
1497,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2022,28.1,7.3,community,100
1498,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2019,41.1,7.9,hospital,250
1499,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,26.0,6.8,hospital,100
1500,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2022,21.2,8.6,community,100
1501,France,Europe,Escherichia coli,Ciprofloxacin,2019,13.1,5.8,hospital,100
1502,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2020,70.3,17.6,community,300
1503,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2019,44.5,13.2,community,300
1504,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2018,34.7,8.2,community,250
1505,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2018,62.6,12.9,community,250
1506,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2020,60.1,16.2,hospital,200
1507,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2021,64.8,12.0,community,300
1508,Germany,Europe,Staphylococcus aureus,Amoxicillin,2020,30.5,3.1,community,300
1509,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2023,31.9,6.1,hospital,300
1510,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2023,29.2,6.7,hospital,150
1511,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2019,31.0,2.2,community,100
1512,China,East Asia,Escherichia coli,Ciprofloxacin,2023,37.2,6.7,hospital,100
1513,France,Europe,Acinetobacter baumannii,Meropenem,2019,32.8,2.1,community,150
1514,Japan,East Asia,Acinetobacter baumannii,Meropenem,2018,31.5,7.0,community,200
1515,France,Europe,Escherichia coli,Ciprofloxacin,2019,13.0,7.0,hospital,250
1516,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2022,28.8,3.3,hospital,200
1517,USA,North America,Acinetobacter baumannii,Amoxicillin,2022,34.7,6.4,hospital,150
1518,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,26.7,7.8,hospital,200
1519,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2022,49.7,8.3,community,250
1520,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2018,18.8,5.5,hospital,150
1521,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2022,24.8,5.0,hospital,300
1522,France,Europe,Escherichia coli,Amoxicillin,2018,18.8,6.2,community,150
1523,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2018,19.1,4.9,community,300
1524,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2020,50.8,10.3,community,100
1525,China,East Asia,Staphylococcus aureus,Amoxicillin,2021,30.6,2.4,hospital,250
1526,France,Europe,Pseudomonas aeruginosa,Vancomycin,2019,26.9,0.8,community,150
1527,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,27.2,3.1,hospital,250
1528,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2020,39.7,5.0,hospital,250
1529,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2023,26.3,8.4,community,150
1530,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,53.2,6.1,community,250
1531,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,22.8,8.0,community,200
1532,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2018,22.7,7.2,hospital,250
1533,USA,North America,Staphylococcus aureus,Ceftriaxone,2018,9.4,0.5,hospital,250
1534,Japan,East Asia,Acinetobacter baumannii,Meropenem,2019,23.4,8.7,community,300
1535,Japan,East Asia,Escherichia coli,Amoxicillin,2018,15.7,5.0,community,100
1536,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2019,35.1,10.5,community,300
1537,USA,North America,Escherichia coli,Meropenem,2019,10.4,0.5,hospital,250
1538,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,39.7,6.4,community,200
1539,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2019,67.2,15.0,community,100
1540,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2023,39.7,11.1,hospital,300
1541,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2019,13.3,1.3,community,200
1542,France,Europe,Pseudomonas aeruginosa,Vancomycin,2020,17.7,3.5,community,300
1543,China,East Asia,Escherichia coli,Ceftriaxone,2021,42.0,7.7,hospital,300
1544,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2023,50.1,5.3,hospital,250
1545,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2019,49.7,9.2,hospital,150
1546,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,32.8,1.6,community,250
1547,Germany,Europe,Acinetobacter baumannii,Vancomycin,2021,27.6,3.4,community,100
1548,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2019,11.6,0.5,community,100
1549,Brazil,South America,Acinetobacter baumannii,Meropenem,2020,51.2,9.4,hospital,200
1550,India,Southeast Asia,Escherichia coli,Amoxicillin,2020,44.1,9.3,hospital,200
1551,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2019,13.7,7.4,community,150
1552,USA,North America,Acinetobacter baumannii,Vancomycin,2018,12.6,1.7,community,250
1553,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2019,55.9,14.7,community,150
1554,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2023,26.7,8.5,hospital,150
1555,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2018,44.2,6.9,community,100
1556,USA,North America,Escherichia coli,Vancomycin,2019,10.1,2.4,community,200
1557,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,64.7,10.8,hospital,100
1558,China,East Asia,Staphylococcus aureus,Vancomycin,2021,28.3,5.1,community,100
1559,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2018,55.8,9.3,hospital,300
1560,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,12.9,3.7,community,100
1561,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2019,20.8,3.6,community,250
1562,USA,North America,Acinetobacter baumannii,Vancomycin,2018,19.4,2.9,community,200
1563,Australia,Oceania,Escherichia coli,Amoxicillin,2021,20.8,6.2,hospital,200
1564,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2022,10.8,0.5,community,150
1565,France,Europe,Staphylococcus aureus,Vancomycin,2018,21.9,1.9,hospital,250
1566,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2020,38.4,8.9,community,100
1567,France,Europe,Escherichia coli,Amoxicillin,2020,20.6,8.3,hospital,200
1568,India,Southeast Asia,Escherichia coli,Amoxicillin,2019,63.2,10.5,hospital,250
1569,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2023,33.4,10.9,community,200
1570,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,39.1,5.9,community,200
1571,India,Southeast Asia,Escherichia coli,Amoxicillin,2023,75.1,14.8,hospital,100
1572,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2022,38.9,9.2,hospital,300
1573,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2020,31.0,8.6,hospital,150
1574,Japan,East Asia,Escherichia coli,Amoxicillin,2020,20.9,4.1,community,300
1575,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2020,31.3,10.4,community,300
1576,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2023,61.1,9.5,community,100
1577,France,Europe,Klebsiella pneumoniae,Vancomycin,2019,17.5,0.5,hospital,250
1578,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2019,18.2,0.5,community,150
1579,Germany,Europe,Acinetobacter baumannii,Vancomycin,2021,30.1,1.2,community,250
1580,South Africa,Africa,Escherichia coli,Amoxicillin,2022,61.6,15.5,hospital,100
1581,Nigeria,Africa,Escherichia coli,Ceftriaxone,2023,48.6,12.9,hospital,300
1582,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2019,42.8,10.3,community,250
1583,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2020,34.4,9.1,hospital,100
1584,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2020,60.0,7.8,community,300
1585,Australia,Oceania,Escherichia coli,Amoxicillin,2021,16.7,7.5,hospital,100
1586,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2021,38.3,9.3,hospital,200
1587,South Africa,Africa,Staphylococcus aureus,Meropenem,2021,72.8,12.7,community,250
1588,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2019,38.7,8.2,community,300
1589,Germany,Europe,Acinetobacter baumannii,Meropenem,2022,24.8,5.5,community,100
1590,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2019,40.9,7.9,community,300
1591,China,East Asia,Pseudomonas aeruginosa,Meropenem,2019,18.7,6.9,community,150
1592,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2023,50.4,13.2,community,300
1593,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2023,46.1,4.4,community,100
1594,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2023,70.5,17.1,hospital,250
1595,Japan,East Asia,Escherichia coli,Ceftriaxone,2020,42.6,6.2,community,250
1596,Japan,East Asia,Staphylococcus aureus,Vancomycin,2019,33.6,2.6,hospital,300
1597,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2019,38.6,7.5,hospital,250
1598,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2023,78.5,18.1,community,200
1599,USA,North America,Escherichia coli,Meropenem,2020,14.3,3.1,community,300
1600,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2023,37.2,10.2,hospital,200
1601,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2018,20.4,5.0,hospital,100
1602,Germany,Europe,Escherichia coli,Amoxicillin,2018,26.0,4.3,community,200
1603,Nigeria,Africa,Escherichia coli,Amoxicillin,2021,57.8,12.2,community,200
1604,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2020,55.9,12.3,community,100
1605,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2020,42.7,12.1,hospital,300
1606,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2019,18.3,1.0,community,150
1607,Brazil,South America,Staphylococcus aureus,Meropenem,2021,48.2,7.9,hospital,100
1608,Australia,Oceania,Staphylococcus aureus,Vancomycin,2020,10.8,0.5,hospital,300
1609,Germany,Europe,Escherichia coli,Vancomycin,2020,13.9,0.5,community,150
1610,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2018,43.2,10.3,hospital,200
1611,Australia,Oceania,Escherichia coli,Meropenem,2023,18.6,6.0,hospital,300
1612,China,East Asia,Pseudomonas aeruginosa,Meropenem,2020,42.2,11.1,hospital,250
1613,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,19.7,4.9,community,250
1614,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2019,25.5,7.0,hospital,300
1615,India,Southeast Asia,Escherichia coli,Meropenem,2019,46.4,5.4,hospital,200
1616,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2020,19.7,1.8,hospital,100
1617,France,Europe,Escherichia coli,Ciprofloxacin,2022,21.9,8.8,community,200
1618,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,10.4,6.6,community,250
1619,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2021,14.5,4.8,community,250
1620,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,27.0,0.7,community,100
1621,Japan,East Asia,Acinetobacter baumannii,Amoxicillin,2018,27.6,7.7,community,100
1622,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2018,19.1,7.6,community,250
1623,Brazil,South America,Staphylococcus aureus,Amoxicillin,2018,39.9,11.1,hospital,100
1624,France,Europe,Acinetobacter baumannii,Ceftriaxone,2023,33.8,2.2,community,200
1625,USA,North America,Klebsiella pneumoniae,Meropenem,2018,7.9,1.0,hospital,150
1626,China,East Asia,Escherichia coli,Vancomycin,2023,41.5,6.2,community,100
1627,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2023,47.8,7.7,community,200
1628,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2021,16.3,1.8,hospital,300
1629,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2019,50.8,13.5,community,300
1630,Germany,Europe,Escherichia coli,Meropenem,2019,19.2,5.4,community,300
1631,Japan,East Asia,Escherichia coli,Ceftriaxone,2021,25.3,3.6,community,300
1632,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2020,39.5,5.5,hospital,150
1633,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,28.7,8.0,hospital,250
1634,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2018,48.9,9.7,hospital,300
1635,Germany,Europe,Escherichia coli,Meropenem,2021,26.1,8.7,hospital,100
1636,China,East Asia,Staphylococcus aureus,Meropenem,2018,34.9,3.8,community,300
1637,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2020,38.3,12.1,hospital,100
1638,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2023,44.3,4.2,community,200
1639,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2019,69.6,18.3,hospital,250
1640,Germany,Europe,Staphylococcus aureus,Amoxicillin,2020,17.5,5.0,community,100
1641,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2022,42.3,9.0,community,150
1642,Brazil,South America,Escherichia coli,Ceftriaxone,2020,37.8,3.4,hospital,250
1643,China,East Asia,Escherichia coli,Ciprofloxacin,2021,34.6,11.3,hospital,250
1644,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2022,48.4,6.2,community,200
1645,Nigeria,Africa,Escherichia coli,Ceftriaxone,2021,49.3,6.8,hospital,250
1646,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2023,39.7,3.6,hospital,300
1647,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2020,12.6,2.5,community,150
1648,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2021,32.4,4.9,hospital,150
1649,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2023,30.0,3.6,community,250
1650,USA,North America,Klebsiella pneumoniae,Amoxicillin,2021,14.1,4.5,hospital,250
1651,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2018,40.3,9.0,hospital,100
1652,China,East Asia,Staphylococcus aureus,Meropenem,2018,32.9,9.3,community,300
1653,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2023,51.4,13.6,hospital,200
1654,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2019,22.5,8.0,community,200
1655,France,Europe,Pseudomonas aeruginosa,Vancomycin,2019,27.8,10.3,community,250
1656,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2022,26.0,6.6,hospital,200
1657,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2022,37.0,10.3,hospital,100
1658,USA,North America,Escherichia coli,Ceftriaxone,2018,14.2,1.2,community,300
1659,Brazil,South America,Staphylococcus aureus,Vancomycin,2019,44.0,10.0,community,150
1660,Germany,Europe,Klebsiella pneumoniae,Ciprofloxacin,2018,22.3,7.4,hospital,100
1661,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2018,45.6,12.7,community,150
1662,South Africa,Africa,Acinetobacter baumannii,Meropenem,2022,50.6,10.1,hospital,100
1663,Brazil,South America,Staphylococcus aureus,Meropenem,2018,45.0,13.8,community,200
1664,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,36.9,5.8,hospital,100
1665,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,26.2,1.0,hospital,200
1666,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2019,24.7,5.8,hospital,150
1667,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2022,27.8,10.2,community,250
1668,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2018,10.1,5.6,community,100
1669,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2023,30.2,9.2,community,300
1670,USA,North America,Klebsiella pneumoniae,Amoxicillin,2023,34.4,10.7,hospital,100
1671,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2019,43.5,7.5,hospital,250
1672,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2023,48.9,7.6,community,150
1673,Australia,Oceania,Escherichia coli,Ciprofloxacin,2018,8.6,0.5,community,150
1674,Germany,Europe,Escherichia coli,Ciprofloxacin,2023,28.6,5.5,hospital,200
1675,China,East Asia,Acinetobacter baumannii,Amoxicillin,2022,42.2,11.1,community,150
1676,Germany,Europe,Staphylococcus aureus,Vancomycin,2023,27.4,10.0,hospital,150
1677,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2020,17.9,2.9,hospital,250
1678,China,East Asia,Escherichia coli,Meropenem,2022,23.6,1.4,community,150
1679,Nigeria,Africa,Escherichia coli,Ceftriaxone,2021,50.6,5.7,hospital,250
1680,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2018,22.4,4.0,community,100
1681,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,33.9,10.6,community,200
1682,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2021,38.6,9.5,community,250
1683,France,Europe,Escherichia coli,Ceftriaxone,2018,26.5,8.4,hospital,150
1684,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2019,19.3,4.7,community,300
1685,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2020,20.3,1.6,hospital,100
1686,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2023,57.0,12.5,hospital,150
1687,Australia,Oceania,Staphylococcus aureus,Vancomycin,2019,20.3,3.0,community,200
1688,France,Europe,Escherichia coli,Ceftriaxone,2022,30.1,10.0,community,100
1689,France,Europe,Pseudomonas aeruginosa,Meropenem,2018,19.6,7.6,hospital,300
1690,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2020,43.1,7.6,hospital,100
1691,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2018,13.6,1.3,community,100
1692,Germany,Europe,Staphylococcus aureus,Amoxicillin,2022,23.4,6.2,hospital,300
1693,Brazil,South America,Escherichia coli,Meropenem,2023,58.4,8.5,community,300
1694,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2019,20.5,4.2,community,250
1695,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,51.7,7.8,community,150
1696,Nigeria,Africa,Escherichia coli,Amoxicillin,2020,62.7,16.3,community,150
1697,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2019,38.6,8.5,community,100
1698,France,Europe,Acinetobacter baumannii,Ceftriaxone,2019,12.3,0.5,hospital,150
1699,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2019,27.3,5.1,hospital,300
1700,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2020,41.6,5.8,community,200
1701,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2018,30.8,1.7,community,300
1702,Brazil,South America,Escherichia coli,Ceftriaxone,2022,40.3,9.3,hospital,150
1703,South Africa,Africa,Escherichia coli,Vancomycin,2018,44.2,8.6,hospital,100
1704,Germany,Europe,Staphylococcus aureus,Vancomycin,2023,28.9,9.0,community,100
1705,South Africa,Africa,Escherichia coli,Ciprofloxacin,2018,25.9,1.8,hospital,250
1706,India,Southeast Asia,Escherichia coli,Amoxicillin,2019,69.5,11.0,hospital,300
1707,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2022,27.4,4.1,community,300
1708,Germany,Europe,Escherichia coli,Ciprofloxacin,2022,34.0,3.9,hospital,200
1709,Brazil,South America,Escherichia coli,Ciprofloxacin,2021,57.5,15.6,community,200
1710,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2022,38.3,6.1,community,200
1711,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2019,59.4,7.7,hospital,100
1712,China,East Asia,Acinetobacter baumannii,Amoxicillin,2018,38.3,9.6,community,200
1713,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2020,26.8,4.2,community,250
1714,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2022,43.4,11.1,community,150
1715,Germany,Europe,Escherichia coli,Ceftriaxone,2023,22.8,0.5,community,100
1716,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,33.3,11.2,community,100
1717,USA,North America,Acinetobacter baumannii,Vancomycin,2020,12.2,0.5,hospital,300
1718,Germany,Europe,Escherichia coli,Vancomycin,2019,20.5,0.5,community,100
1719,Germany,Europe,Acinetobacter baumannii,Meropenem,2019,16.8,8.3,community,100
1720,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,31.8,2.0,hospital,100
1721,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2019,7.7,6.0,community,300
1722,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2019,17.0,1.3,hospital,200
1723,China,East Asia,Escherichia coli,Ceftriaxone,2020,23.1,0.5,community,250
1724,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,49.0,9.0,hospital,250
1725,France,Europe,Escherichia coli,Meropenem,2018,27.3,9.8,community,150
1726,Germany,Europe,Acinetobacter baumannii,Vancomycin,2018,26.9,0.6,community,200
1727,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2023,36.9,2.9,community,250
1728,France,Europe,Klebsiella pneumoniae,Amoxicillin,2023,25.4,7.1,hospital,250
1729,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2021,25.1,6.0,hospital,250
1730,Brazil,South America,Pseudomonas aeruginosa,Ciprofloxacin,2023,51.9,15.1,community,300
1731,France,Europe,Klebsiella pneumoniae,Vancomycin,2020,29.8,8.0,hospital,300
1732,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2018,9.8,0.5,hospital,250
1733,USA,North America,Escherichia coli,Ciprofloxacin,2021,12.2,6.3,community,200
1734,China,East Asia,Acinetobacter baumannii,Vancomycin,2018,38.7,3.3,hospital,250
1735,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2022,27.6,1.4,hospital,250
1736,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2021,66.5,16.4,hospital,150
1737,Australia,Oceania,Staphylococcus aureus,Meropenem,2022,23.4,2.8,hospital,250
1738,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2022,36.2,9.7,community,100
1739,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2022,50.8,9.9,hospital,100
1740,India,Southeast Asia,Escherichia coli,Amoxicillin,2021,40.0,3.6,hospital,200
1741,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2019,20.3,1.9,hospital,150
1742,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2018,38.5,4.3,hospital,150
1743,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2022,30.1,9.9,community,150
1744,Australia,Oceania,Staphylococcus aureus,Meropenem,2020,24.4,2.2,hospital,250
1745,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2020,30.8,2.7,community,300
1746,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2020,24.2,4.5,hospital,150
1747,France,Europe,Acinetobacter baumannii,Ceftriaxone,2018,27.8,2.2,hospital,150
1748,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,58.8,14.2,hospital,200
1749,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2023,59.3,13.3,hospital,200
1750,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2023,28.7,10.4,community,100
1751,Germany,Europe,Klebsiella pneumoniae,Meropenem,2023,24.9,5.6,hospital,250
1752,Japan,East Asia,Staphylococcus aureus,Vancomycin,2021,31.2,10.2,hospital,300
1753,Brazil,South America,Acinetobacter baumannii,Vancomycin,2020,35.1,5.5,hospital,150
1754,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,53.2,11.4,community,300
1755,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2018,61.3,9.1,hospital,250
1756,Germany,Europe,Acinetobacter baumannii,Vancomycin,2020,28.8,2.6,hospital,250
1757,Nigeria,Africa,Escherichia coli,Vancomycin,2023,37.8,5.1,community,100
1758,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2019,56.9,8.8,hospital,150
1759,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2022,17.3,6.8,hospital,100
1760,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2018,15.2,7.6,hospital,150
1761,Australia,Oceania,Escherichia coli,Vancomycin,2020,14.0,5.8,community,150
1762,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2018,11.7,0.8,community,150
1763,China,East Asia,Staphylococcus aureus,Ceftriaxone,2022,22.8,0.6,hospital,200
1764,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2020,42.6,13.1,community,250
1765,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2019,22.5,8.0,community,250
1766,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2021,31.6,5.2,hospital,150
1767,France,Europe,Acinetobacter baumannii,Amoxicillin,2019,31.7,8.4,community,250
1768,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2022,33.9,8.1,hospital,250
1769,USA,North America,Pseudomonas aeruginosa,Vancomycin,2020,24.1,0.5,community,150
1770,France,Europe,Acinetobacter baumannii,Vancomycin,2021,35.9,5.4,hospital,100
1771,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2022,16.2,5.7,community,200
1772,Germany,Europe,Klebsiella pneumoniae,Meropenem,2023,26.6,5.4,hospital,200
1773,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,35.7,8.5,community,100
1774,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2022,19.2,4.1,community,300
1775,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2020,35.1,7.2,community,300
1776,Australia,Oceania,Acinetobacter baumannii,Meropenem,2021,24.1,4.8,community,100
1777,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2018,16.5,4.8,hospital,150
1778,Germany,Europe,Acinetobacter baumannii,Meropenem,2018,10.5,3.7,community,250
1779,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2020,65.3,9.3,hospital,250
1780,France,Europe,Acinetobacter baumannii,Amoxicillin,2018,19.8,7.4,community,300
1781,Japan,East Asia,Escherichia coli,Amoxicillin,2021,22.0,3.9,community,250
1782,France,Europe,Klebsiella pneumoniae,Amoxicillin,2021,23.4,8.3,community,300
1783,China,East Asia,Pseudomonas aeruginosa,Meropenem,2020,36.9,4.3,community,200
1784,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,25.1,3.6,hospital,300
1785,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2021,25.7,6.5,hospital,100
1786,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2022,75.3,17.4,community,250
1787,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2019,18.9,4.4,community,150
1788,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2021,52.3,7.7,community,150
1789,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2023,20.7,2.4,hospital,100
1790,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2019,34.1,6.4,community,150
1791,USA,North America,Klebsiella pneumoniae,Meropenem,2023,22.8,8.7,community,150
1792,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2019,28.8,8.5,hospital,100
1793,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2019,25.5,7.8,hospital,250
1794,USA,North America,Escherichia coli,Meropenem,2022,17.9,3.6,hospital,200
1795,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2019,30.3,9.4,community,300
1796,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2018,60.6,11.4,community,250
1797,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,45.9,13.7,community,300
1798,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2020,30.9,6.2,community,150
1799,Germany,Europe,Escherichia coli,Ciprofloxacin,2018,19.1,0.5,hospital,300
1800,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2020,19.8,1.5,community,200
1801,South Africa,Africa,Escherichia coli,Ceftriaxone,2021,64.6,10.1,hospital,150
1802,France,Europe,Klebsiella pneumoniae,Amoxicillin,2022,16.3,0.8,community,300
1803,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2020,38.3,6.1,hospital,300
1804,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2018,40.8,10.6,hospital,100
1805,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2020,63.3,15.6,community,150
1806,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2018,55.2,13.6,community,250
1807,Brazil,South America,Acinetobacter baumannii,Vancomycin,2019,33.2,10.6,community,150
1808,USA,North America,Staphylococcus aureus,Amoxicillin,2019,23.2,8.3,community,250
1809,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2021,11.0,5.0,hospital,250
1810,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2019,55.2,10.1,hospital,150
1811,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2023,35.5,7.5,community,250
1812,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2018,19.2,6.4,community,250
1813,Brazil,South America,Acinetobacter baumannii,Vancomycin,2019,37.3,8.3,hospital,300
1814,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2023,38.0,6.8,community,300
1815,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2022,54.4,6.7,hospital,200
1816,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2019,54.7,6.5,hospital,100
1817,China,East Asia,Escherichia coli,Vancomycin,2021,43.7,9.2,hospital,300
1818,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2022,51.3,15.1,hospital,150
1819,China,East Asia,Escherichia coli,Vancomycin,2018,15.4,0.5,hospital,100
1820,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2022,61.5,9.4,hospital,300
1821,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2021,39.0,8.8,community,200
1822,Germany,Europe,Escherichia coli,Amoxicillin,2021,18.1,2.0,community,300
1823,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2019,17.8,2.4,hospital,250
1824,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,12.7,2.7,community,100
1825,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2023,65.0,14.1,hospital,250
1826,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,16.1,6.6,community,300
1827,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,25.1,2.3,hospital,200
1828,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2022,21.5,0.6,community,150
1829,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2019,41.3,10.9,hospital,300
1830,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2019,52.2,9.8,hospital,300
1831,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2022,11.0,2.8,hospital,200
1832,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2021,18.1,0.5,community,150
1833,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2023,33.3,10.1,hospital,200
1834,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2018,43.7,4.3,community,200
1835,South Africa,Africa,Acinetobacter baumannii,Meropenem,2021,46.4,4.8,community,250
1836,Brazil,South America,Staphylococcus aureus,Amoxicillin,2019,32.3,9.8,hospital,250
1837,USA,North America,Staphylococcus aureus,Ciprofloxacin,2019,10.4,0.5,community,300
1838,Australia,Oceania,Escherichia coli,Meropenem,2021,11.8,0.5,community,300
1839,India,Southeast Asia,Escherichia coli,Amoxicillin,2020,70.3,14.9,hospital,300
1840,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2022,49.2,12.9,hospital,200
1841,Brazil,South America,Escherichia coli,Meropenem,2018,31.7,5.2,community,150
1842,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2019,25.8,8.5,community,150
1843,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2020,34.1,3.0,hospital,150
1844,USA,North America,Staphylococcus aureus,Amoxicillin,2019,10.7,4.7,community,300
1845,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2020,31.1,5.2,community,200
1846,France,Europe,Staphylococcus aureus,Amoxicillin,2021,14.9,6.5,community,250
1847,Brazil,South America,Acinetobacter baumannii,Meropenem,2019,39.5,8.3,hospital,100
1848,Germany,Europe,Escherichia coli,Meropenem,2020,25.4,8.5,community,100
1849,France,Europe,Staphylococcus aureus,Vancomycin,2019,27.3,4.1,hospital,200
1850,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2022,47.0,5.1,hospital,300
1851,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2023,52.7,13.0,community,250
1852,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2019,29.4,6.5,community,100
1853,China,East Asia,Escherichia coli,Amoxicillin,2018,31.9,3.5,hospital,300
1854,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2023,46.2,4.9,hospital,200
1855,France,Europe,Pseudomonas aeruginosa,Vancomycin,2020,24.9,8.0,community,300
1856,Nigeria,Africa,Escherichia coli,Ceftriaxone,2019,40.1,10.2,community,100
1857,China,East Asia,Klebsiella pneumoniae,Meropenem,2020,37.6,3.1,hospital,250
1858,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,17.8,5.7,hospital,300
1859,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2023,23.3,3.6,hospital,200
1860,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2021,23.3,0.5,community,300
1861,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2020,36.5,5.9,hospital,250
1862,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,63.7,15.4,hospital,150
1863,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2018,25.4,2.4,hospital,150
1864,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,37.8,11.6,community,200
1865,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2020,61.2,7.7,hospital,100
1866,Germany,Europe,Escherichia coli,Vancomycin,2023,20.3,0.5,community,100
1867,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2018,44.0,13.4,community,200
1868,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2022,39.3,12.0,community,300
1869,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2020,28.8,9.4,hospital,300
1870,Brazil,South America,Acinetobacter baumannii,Meropenem,2018,48.8,8.0,community,200
1871,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2022,39.9,3.6,community,250
1872,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2018,57.2,7.7,hospital,250
1873,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2021,22.3,2.1,community,150
1874,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2019,62.3,9.8,hospital,300
1875,Japan,East Asia,Staphylococcus aureus,Meropenem,2023,33.4,11.0,community,100
1876,USA,North America,Pseudomonas aeruginosa,Meropenem,2018,8.5,5.2,community,250
1877,USA,North America,Escherichia coli,Vancomycin,2021,15.7,0.5,hospital,300
1878,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2020,20.8,0.5,hospital,200
1879,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2023,21.1,1.3,community,200
1880,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2022,23.3,4.1,community,300
1881,Brazil,South America,Escherichia coli,Amoxicillin,2019,31.5,9.9,community,100
1882,India,Southeast Asia,Escherichia coli,Ceftriaxone,2023,73.4,10.9,hospital,150
1883,USA,North America,Acinetobacter baumannii,Meropenem,2018,12.7,1.3,hospital,150
1884,Nigeria,Africa,Klebsiella pneumoniae,Amoxicillin,2022,64.8,16.4,community,200
1885,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2021,24.0,3.7,hospital,300
1886,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2019,10.2,0.8,community,300
1887,Japan,East Asia,Acinetobacter baumannii,Meropenem,2022,41.6,12.2,hospital,100
1888,India,Southeast Asia,Staphylococcus aureus,Meropenem,2021,59.4,14.8,hospital,100
1889,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2019,22.7,5.6,community,200
1890,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2019,21.8,7.0,hospital,300
1891,Germany,Europe,Escherichia coli,Ceftriaxone,2021,36.4,3.9,community,300
1892,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2019,18.5,5.2,community,300
1893,Brazil,South America,Staphylococcus aureus,Amoxicillin,2018,49.5,13.5,community,250
1894,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2022,21.7,3.9,community,150
1895,Brazil,South America,Staphylococcus aureus,Vancomycin,2023,50.2,8.2,community,250
1896,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2019,37.2,11.3,hospital,150
1897,Germany,Europe,Escherichia coli,Amoxicillin,2020,14.3,0.5,community,150
1898,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2021,52.4,14.4,community,100
1899,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,24.1,5.2,community,300
1900,South Africa,Africa,Staphylococcus aureus,Meropenem,2019,34.7,4.5,hospital,250
1901,France,Europe,Klebsiella pneumoniae,Amoxicillin,2022,28.0,6.8,hospital,300
1902,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2019,16.3,3.5,hospital,200
1903,USA,North America,Escherichia coli,Ciprofloxacin,2022,14.7,0.5,hospital,150
1904,Brazil,South America,Escherichia coli,Amoxicillin,2018,43.2,7.1,community,300
1905,Brazil,South America,Acinetobacter baumannii,Vancomycin,2023,54.9,15.8,community,250
1906,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2021,22.2,6.7,community,150
1907,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2019,13.8,1.7,community,200
1908,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2021,60.4,13.2,community,250
1909,USA,North America,Staphylococcus aureus,Ceftriaxone,2022,13.8,6.3,community,200
1910,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2019,8.2,0.5,community,200
1911,USA,North America,Klebsiella pneumoniae,Meropenem,2018,21.9,6.2,hospital,200
1912,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2020,28.3,7.0,community,250
1913,Australia,Oceania,Acinetobacter baumannii,Meropenem,2023,22.0,4.4,community,200
1914,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2021,31.5,9.9,hospital,100
1915,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2018,49.0,9.5,hospital,150
1916,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,54.5,6.4,hospital,250
1917,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,34.9,5.8,hospital,300
1918,China,East Asia,Acinetobacter baumannii,Amoxicillin,2022,38.7,6.6,hospital,250
1919,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2018,38.0,9.9,community,150
1920,India,Southeast Asia,Escherichia coli,Ceftriaxone,2021,54.6,9.4,hospital,250
1921,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,40.2,10.9,community,250
1922,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2023,71.4,18.9,community,150
1923,France,Europe,Klebsiella pneumoniae,Amoxicillin,2020,32.7,2.8,community,200
1924,USA,North America,Staphylococcus aureus,Ciprofloxacin,2018,14.9,7.5,hospital,300
1925,China,East Asia,Staphylococcus aureus,Meropenem,2023,49.6,5.5,hospital,150
1926,Australia,Oceania,Staphylococcus aureus,Meropenem,2021,27.4,7.3,community,100
1927,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2021,40.9,7.0,hospital,300
1928,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2021,25.6,3.0,community,200
1929,Germany,Europe,Acinetobacter baumannii,Vancomycin,2018,28.9,9.9,community,250
1930,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2022,49.7,12.9,community,100
1931,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,40.7,7.2,hospital,300
1932,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2019,47.9,14.3,hospital,200
1933,South Africa,Africa,Staphylococcus aureus,Meropenem,2018,47.1,13.1,hospital,200
1934,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2022,21.8,1.5,community,200
1935,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2022,57.2,13.1,community,150
1936,China,East Asia,Escherichia coli,Amoxicillin,2018,22.0,9.1,community,300
1937,France,Europe,Staphylococcus aureus,Ciprofloxacin,2022,17.4,5.7,hospital,150
1938,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2020,32.5,7.7,hospital,300
1939,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2019,16.4,1.5,community,300
1940,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2021,23.5,7.0,community,200
1941,China,East Asia,Escherichia coli,Ciprofloxacin,2020,42.1,12.0,hospital,200
1942,France,Europe,Klebsiella pneumoniae,Vancomycin,2018,27.5,7.7,community,100
1943,France,Europe,Escherichia coli,Amoxicillin,2021,33.7,4.7,community,300
1944,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2023,49.8,12.1,hospital,200
1945,USA,North America,Escherichia coli,Amoxicillin,2020,23.0,3.6,community,100
1946,Germany,Europe,Staphylococcus aureus,Meropenem,2022,25.8,6.5,community,250
1947,China,East Asia,Klebsiella pneumoniae,Vancomycin,2021,36.7,8.2,hospital,200
1948,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2022,43.8,8.6,community,200
1949,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2023,61.7,9.0,community,250
1950,France,Europe,Pseudomonas aeruginosa,Meropenem,2023,17.9,4.4,hospital,200
1951,China,East Asia,Staphylococcus aureus,Ceftriaxone,2022,50.2,5.9,hospital,100
1952,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2018,26.2,8.0,community,200
1953,Japan,East Asia,Staphylococcus aureus,Meropenem,2018,31.0,9.0,community,250
1954,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2018,24.1,2.7,community,150
1955,France,Europe,Pseudomonas aeruginosa,Meropenem,2019,20.2,2.1,community,200
1956,India,Southeast Asia,Escherichia coli,Vancomycin,2019,64.6,12.3,community,300
1957,Australia,Oceania,Staphylococcus aureus,Vancomycin,2019,17.7,3.6,community,200
1958,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2023,12.2,2.3,hospital,150
1959,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2020,14.9,0.8,community,300
1960,South Africa,Africa,Escherichia coli,Ceftriaxone,2018,31.4,5.9,hospital,100
1961,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2020,21.4,6.4,community,300
1962,USA,North America,Klebsiella pneumoniae,Amoxicillin,2023,15.3,0.5,community,200
1963,India,Southeast Asia,Escherichia coli,Ceftriaxone,2019,55.6,10.4,community,200
1964,USA,North America,Klebsiella pneumoniae,Vancomycin,2023,26.5,4.9,hospital,100
1965,South Africa,Africa,Staphylococcus aureus,Vancomycin,2022,61.7,11.7,community,150
1966,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2020,20.6,5.4,community,200
1967,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2020,43.9,10.7,community,300
1968,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2021,20.3,8.9,community,150
1969,Nigeria,Africa,Staphylococcus aureus,Meropenem,2021,36.8,12.1,hospital,250
1970,China,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,39.9,7.4,hospital,250
1971,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2021,65.8,15.7,hospital,200
1972,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2018,68.1,12.2,hospital,300
1973,South Africa,Africa,Escherichia coli,Ciprofloxacin,2022,65.5,11.8,hospital,250
1974,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2019,19.6,0.5,hospital,200
1975,Nigeria,Africa,Escherichia coli,Ceftriaxone,2022,36.4,3.5,hospital,150
1976,Australia,Oceania,Acinetobacter baumannii,Meropenem,2022,23.6,7.2,community,100
1977,South Africa,Africa,Escherichia coli,Meropenem,2023,68.3,12.1,hospital,150
1978,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2019,40.9,12.9,community,300
1979,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2018,43.5,5.0,hospital,150
1980,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2023,63.1,15.7,hospital,250
1981,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,57.2,16.2,hospital,200
1982,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,74.0,14.6,hospital,150
1983,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2020,8.6,0.5,community,300
1984,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2021,21.0,0.5,community,250
1985,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2022,34.2,7.9,community,100
1986,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2019,44.0,10.2,community,300
1987,Japan,East Asia,Staphylococcus aureus,Meropenem,2021,27.4,8.9,community,150
1988,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2018,10.1,0.5,community,150
1989,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2020,26.4,2.8,community,250
1990,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2018,56.0,14.0,hospital,200
1991,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2018,25.2,2.9,community,150
1992,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2018,20.5,7.1,hospital,100
1993,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2019,19.8,0.5,community,100
1994,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2022,45.8,11.1,hospital,150
1995,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2022,55.1,8.0,community,250
1996,Germany,Europe,Klebsiella pneumoniae,Meropenem,2019,27.2,2.0,community,200
1997,Australia,Oceania,Escherichia coli,Meropenem,2020,14.2,0.5,hospital,250
1998,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2022,46.0,12.4,community,300
1999,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2022,34.0,10.5,hospital,100
2000,Australia,Oceania,Staphylococcus aureus,Vancomycin,2020,15.2,0.6,hospital,100
2001,China,East Asia,Acinetobacter baumannii,Vancomycin,2023,46.7,7.4,community,300
2002,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2023,41.9,6.3,hospital,100
2003,Japan,East Asia,Acinetobacter baumannii,Meropenem,2019,31.3,8.7,community,250
2004,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2018,32.0,10.6,community,150
2005,USA,North America,Acinetobacter baumannii,Meropenem,2022,12.4,7.2,community,300
2006,South Africa,Africa,Staphylococcus aureus,Meropenem,2018,63.5,15.7,hospital,200
2007,France,Europe,Pseudomonas aeruginosa,Meropenem,2018,16.6,0.5,community,300
2008,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2021,72.0,16.3,hospital,100
2009,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2022,63.9,12.8,hospital,250
2010,India,Southeast Asia,Acinetobacter baumannii,Meropenem,2023,55.2,7.8,community,250
2011,China,East Asia,Acinetobacter baumannii,Vancomycin,2018,35.2,9.0,community,300
2012,Japan,East Asia,Staphylococcus aureus,Meropenem,2018,35.2,7.7,community,100
2013,Germany,Europe,Staphylococcus aureus,Amoxicillin,2023,20.5,5.2,community,100
2014,USA,North America,Escherichia coli,Amoxicillin,2018,15.9,3.2,community,100
2015,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2018,23.4,0.5,hospital,300
2016,France,Europe,Staphylococcus aureus,Ceftriaxone,2022,31.3,7.7,community,250
2017,India,Southeast Asia,Escherichia coli,Meropenem,2018,34.7,5.0,hospital,150
2018,Japan,East Asia,Escherichia coli,Meropenem,2022,22.4,9.2,community,100
2019,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2023,61.7,14.4,community,100
2020,South Africa,Africa,Escherichia coli,Ceftriaxone,2023,66.4,11.6,community,200
2021,South Africa,Africa,Staphylococcus aureus,Meropenem,2022,65.5,10.2,community,150
2022,Nigeria,Africa,Klebsiella pneumoniae,Meropenem,2018,30.8,7.1,hospital,250
2023,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2022,39.9,5.1,community,250
2024,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2023,54.1,7.7,hospital,150
2025,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2023,24.4,4.1,hospital,250
2026,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2019,19.8,2.8,community,150
2027,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2022,30.5,11.0,community,250
2028,Germany,Europe,Escherichia coli,Amoxicillin,2023,28.9,7.8,hospital,250
2029,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2020,32.1,6.6,hospital,300
2030,China,East Asia,Acinetobacter baumannii,Vancomycin,2018,29.5,1.5,community,300
2031,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2019,25.3,8.4,community,250
2032,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2022,17.1,4.2,hospital,100
2033,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2020,19.9,5.3,hospital,300
2034,China,East Asia,Pseudomonas aeruginosa,Meropenem,2020,35.1,2.5,hospital,300
2035,Japan,East Asia,Escherichia coli,Ciprofloxacin,2020,39.9,5.3,community,100
2036,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2022,32.0,3.9,community,200
2037,Japan,East Asia,Escherichia coli,Meropenem,2022,39.1,6.9,hospital,200
2038,China,East Asia,Klebsiella pneumoniae,Vancomycin,2022,41.5,7.5,community,100
2039,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,72.2,12.1,hospital,300
2040,France,Europe,Escherichia coli,Meropenem,2020,29.9,6.7,community,200
2041,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2022,54.8,8.1,hospital,250
2042,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2022,41.9,3.5,community,200
2043,Germany,Europe,Escherichia coli,Meropenem,2018,10.8,3.6,community,100
2044,India,Southeast Asia,Pseudomonas aeruginosa,Ceftriaxone,2018,50.5,10.5,community,250
2045,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2018,35.3,11.1,hospital,250
2046,USA,North America,Escherichia coli,Ceftriaxone,2022,24.6,0.5,community,300
2047,China,East Asia,Klebsiella pneumoniae,Meropenem,2019,25.3,8.9,community,200
2048,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2021,15.8,0.5,community,300
2049,France,Europe,Acinetobacter baumannii,Vancomycin,2018,12.1,5.7,community,300
2050,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2023,72.2,11.2,community,300
2051,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2021,26.0,3.8,community,250
2052,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2021,27.4,8.8,community,250
2053,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2018,52.5,8.2,hospital,200
2054,Japan,East Asia,Escherichia coli,Amoxicillin,2020,35.4,12.1,community,250
2055,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2020,35.2,7.6,hospital,150
2056,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2018,42.6,12.8,hospital,250
2057,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2021,44.9,12.3,community,300
2058,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2023,35.7,11.8,hospital,300
2059,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2018,6.0,0.5,hospital,300
2060,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2021,50.4,10.5,community,250
2061,Australia,Oceania,Escherichia coli,Vancomycin,2021,18.2,0.5,hospital,200
2062,Japan,East Asia,Escherichia coli,Vancomycin,2018,29.3,5.3,community,100
2063,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2019,59.4,9.7,hospital,300
2064,Australia,Oceania,Escherichia coli,Ceftriaxone,2023,23.2,2.5,community,150
2065,China,East Asia,Acinetobacter baumannii,Vancomycin,2023,33.2,7.5,community,150
2066,Brazil,South America,Acinetobacter baumannii,Vancomycin,2021,30.0,7.6,community,100
2067,Japan,East Asia,Escherichia coli,Ciprofloxacin,2022,23.7,0.5,community,150
2068,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2019,29.9,7.8,community,250
2069,China,East Asia,Acinetobacter baumannii,Vancomycin,2019,35.8,10.4,hospital,200
2070,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2020,23.0,0.6,community,150
2071,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2021,33.9,3.8,hospital,100
2072,India,Southeast Asia,Escherichia coli,Amoxicillin,2022,73.0,15.5,community,200
2073,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2020,49.6,10.6,community,250
2074,Japan,East Asia,Escherichia coli,Vancomycin,2020,24.3,7.5,community,250
2075,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2022,28.4,9.9,hospital,300
2076,Brazil,South America,Klebsiella pneumoniae,Meropenem,2018,44.7,11.8,community,250
2077,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2022,40.2,10.9,community,300
2078,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2022,40.3,8.0,community,100
2079,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,44.0,6.1,community,200
2080,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2019,60.7,12.5,community,100
2081,Brazil,South America,Staphylococcus aureus,Vancomycin,2022,27.1,7.9,community,150
2082,China,East Asia,Pseudomonas aeruginosa,Amoxicillin,2018,28.8,1.9,hospital,200
2083,Brazil,South America,Pseudomonas aeruginosa,Ciprofloxacin,2021,44.1,8.7,hospital,200
2084,Germany,Europe,Escherichia coli,Ceftriaxone,2023,40.8,12.2,hospital,250
2085,Japan,East Asia,Escherichia coli,Vancomycin,2020,27.2,10.3,community,150
2086,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2021,12.5,7.5,community,150
2087,Brazil,South America,Escherichia coli,Ciprofloxacin,2021,35.9,2.3,community,150
2088,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2019,31.2,8.2,hospital,250
2089,France,Europe,Acinetobacter baumannii,Meropenem,2022,24.8,8.3,hospital,200
2090,India,Southeast Asia,Staphylococcus aureus,Meropenem,2020,32.6,10.9,hospital,150
2091,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2021,55.1,13.1,hospital,200
2092,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2021,36.4,8.1,community,250
2093,South Africa,Africa,Escherichia coli,Meropenem,2023,59.9,7.6,community,300
2094,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2021,68.0,15.4,hospital,100
2095,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2018,32.3,8.6,hospital,200
2096,China,East Asia,Acinetobacter baumannii,Amoxicillin,2023,26.2,3.0,community,100
2097,Australia,Oceania,Staphylococcus aureus,Meropenem,2018,6.5,3.3,community,300
2098,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2022,46.8,11.1,hospital,300
2099,France,Europe,Klebsiella pneumoniae,Meropenem,2023,31.1,10.7,community,150
2100,Japan,East Asia,Escherichia coli,Vancomycin,2019,21.1,3.2,hospital,100
2101,Japan,East Asia,Staphylococcus aureus,Meropenem,2019,16.7,6.6,community,300
2102,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2021,22.5,3.9,hospital,300
2103,China,East Asia,Staphylococcus aureus,Meropenem,2020,44.3,7.2,hospital,300
2104,Japan,East Asia,Staphylococcus aureus,Vancomycin,2020,36.5,4.6,hospital,250
2105,Germany,Europe,Acinetobacter baumannii,Vancomycin,2023,37.5,4.3,community,250
2106,Japan,East Asia,Escherichia coli,Vancomycin,2019,22.8,0.5,community,150
2107,France,Europe,Pseudomonas aeruginosa,Meropenem,2019,19.1,5.8,community,250
2108,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2020,51.7,7.4,hospital,100
2109,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2018,38.9,6.3,community,150
2110,USA,North America,Staphylococcus aureus,Amoxicillin,2018,25.0,9.3,community,100
2111,USA,North America,Acinetobacter baumannii,Ceftriaxone,2021,15.7,0.9,hospital,300
2112,Germany,Europe,Acinetobacter baumannii,Vancomycin,2020,21.5,5.3,community,100
2113,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,40.3,8.2,hospital,300
2114,USA,North America,Staphylococcus aureus,Meropenem,2021,24.1,6.0,hospital,100
2115,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,39.7,11.0,hospital,250
2116,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2021,66.8,17.0,hospital,250
2117,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2019,18.4,3.9,hospital,100
2118,South Africa,Africa,Acinetobacter baumannii,Meropenem,2020,46.3,8.4,community,150
2119,France,Europe,Staphylococcus aureus,Vancomycin,2021,30.4,1.3,community,200
2120,South Africa,Africa,Escherichia coli,Ciprofloxacin,2018,36.6,8.1,community,150
2121,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2018,31.8,7.2,community,250
2122,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2023,44.4,11.8,community,200
2123,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2019,30.2,9.3,hospital,100
2124,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2022,22.5,1.8,community,300
2125,USA,North America,Klebsiella pneumoniae,Vancomycin,2022,14.4,2.0,community,200
2126,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2019,11.3,0.5,community,250
2127,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2021,44.5,12.0,community,150
2128,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2020,41.1,5.7,community,150
2129,France,Europe,Acinetobacter baumannii,Vancomycin,2021,18.6,1.2,hospital,300
2130,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2022,62.4,13.1,community,100
2131,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,41.9,5.7,community,100
2132,China,East Asia,Escherichia coli,Vancomycin,2019,30.3,10.3,community,150
2133,South Africa,Africa,Escherichia coli,Ciprofloxacin,2023,68.2,16.1,hospital,200
2134,China,East Asia,Staphylococcus aureus,Meropenem,2023,36.3,11.8,community,300
2135,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,25.2,7.3,hospital,250
2136,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2021,27.4,1.4,community,100
2137,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2018,30.5,2.1,hospital,100
2138,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2022,14.8,0.5,community,100
2139,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2021,19.5,3.2,hospital,300
2140,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,39.8,10.3,hospital,200
2141,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2023,20.7,6.0,community,150
2142,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2020,36.8,10.8,community,100
2143,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2022,15.2,4.9,hospital,200
2144,France,Europe,Escherichia coli,Ciprofloxacin,2021,23.3,6.7,community,100
2145,USA,North America,Escherichia coli,Meropenem,2019,6.9,3.9,community,100
2146,USA,North America,Escherichia coli,Ceftriaxone,2022,17.9,3.9,community,300
2147,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,41.0,8.6,hospital,150
2148,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2021,47.6,10.8,community,100
2149,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2021,42.2,12.7,community,300
2150,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2023,59.3,15.4,hospital,250
2151,France,Europe,Staphylococcus aureus,Ciprofloxacin,2022,23.4,0.5,community,300
2152,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2023,74.9,10.3,community,300
2153,USA,North America,Acinetobacter baumannii,Ceftriaxone,2021,21.2,0.5,community,100
2154,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2022,57.7,9.7,hospital,100
2155,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2023,49.8,11.6,hospital,150
2156,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2018,59.3,12.5,hospital,250
2157,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2019,16.9,8.2,community,100
2158,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2018,49.6,13.4,hospital,100
2159,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2022,24.0,9.1,hospital,200
2160,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2023,43.9,7.2,community,250
2161,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2019,15.7,1.6,hospital,200
2162,France,Europe,Acinetobacter baumannii,Vancomycin,2021,18.1,0.5,hospital,300
2163,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2023,45.6,9.9,hospital,300
2164,Nigeria,Africa,Pseudomonas aeruginosa,Amoxicillin,2021,68.8,14.0,community,250
2165,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2021,39.4,6.8,community,200
2166,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2019,19.4,4.5,community,100
2167,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2020,32.5,7.1,community,150
2168,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2022,42.7,6.8,hospital,200
2169,Germany,Europe,Escherichia coli,Vancomycin,2022,30.2,7.6,community,100
2170,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2023,27.1,0.8,hospital,200
2171,USA,North America,Staphylococcus aureus,Vancomycin,2022,26.5,1.9,hospital,250
2172,France,Europe,Escherichia coli,Meropenem,2022,35.1,7.0,hospital,100
2173,China,East Asia,Acinetobacter baumannii,Amoxicillin,2018,28.2,1.2,community,200
2174,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,33.0,11.2,community,100
2175,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,10.6,5.8,community,200
2176,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2022,40.3,6.7,community,300
2177,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2018,58.9,14.4,hospital,200
2178,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2020,53.8,12.0,hospital,200
2179,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2022,27.1,9.0,hospital,300
2180,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2021,16.0,0.5,hospital,300
2181,South Africa,Africa,Escherichia coli,Ceftriaxone,2021,70.3,10.2,hospital,300
2182,Australia,Oceania,Escherichia coli,Meropenem,2022,19.3,5.2,community,300
2183,USA,North America,Acinetobacter baumannii,Meropenem,2020,11.4,2.2,hospital,150
2184,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2019,22.9,9.2,community,250
2185,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,23.1,8.2,community,200
2186,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2020,47.5,7.5,hospital,200
2187,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2020,18.3,5.2,hospital,150
2188,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2020,21.9,0.5,hospital,150
2189,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,41.6,7.9,hospital,150
2190,Brazil,South America,Staphylococcus aureus,Amoxicillin,2021,34.7,5.1,hospital,100
2191,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2018,38.0,12.3,community,150
2192,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2022,72.6,18.2,hospital,300
2193,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2023,37.6,2.6,community,300
2194,Brazil,South America,Klebsiella pneumoniae,Meropenem,2020,47.3,4.9,community,250
2195,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2020,72.7,17.6,hospital,250
2196,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2022,41.5,8.6,hospital,300
2197,France,Europe,Escherichia coli,Ceftriaxone,2020,27.2,10.0,community,200
2198,China,East Asia,Escherichia coli,Ceftriaxone,2020,26.7,1.2,community,300
2199,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2019,23.2,6.1,hospital,250
2200,Germany,Europe,Escherichia coli,Ceftriaxone,2021,21.6,6.0,hospital,150
2201,Germany,Europe,Escherichia coli,Vancomycin,2019,24.0,3.2,community,250
2202,Australia,Oceania,Escherichia coli,Amoxicillin,2019,10.7,2.2,community,100
2203,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2023,18.7,5.0,community,150
2204,France,Europe,Staphylococcus aureus,Ciprofloxacin,2018,23.3,9.1,community,150
2205,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2020,39.7,11.2,community,100
2206,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2021,21.4,0.5,community,250
2207,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,31.0,8.0,community,250
2208,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2019,10.7,5.5,community,250
2209,China,East Asia,Acinetobacter baumannii,Vancomycin,2021,31.4,5.5,community,250
2210,France,Europe,Pseudomonas aeruginosa,Meropenem,2021,30.2,6.7,community,200
2211,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,24.8,8.8,hospital,300
2212,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2022,21.0,3.3,hospital,250
2213,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,48.2,13.3,community,250
2214,France,Europe,Escherichia coli,Vancomycin,2023,30.9,8.3,community,200
2215,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2019,12.0,4.8,hospital,150
2216,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2023,36.5,11.0,hospital,200
2217,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2022,41.2,7.6,hospital,100
2218,USA,North America,Klebsiella pneumoniae,Vancomycin,2019,14.0,2.7,community,250
2219,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2019,25.3,0.5,community,100
2220,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2018,7.0,6.1,community,200
2221,China,East Asia,Pseudomonas aeruginosa,Meropenem,2019,32.9,6.7,community,200
2222,Germany,Europe,Acinetobacter baumannii,Meropenem,2018,14.6,5.1,hospital,200
2223,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2021,72.6,10.8,hospital,300
2224,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2019,18.6,8.0,community,250
2225,Australia,Oceania,Escherichia coli,Meropenem,2019,17.5,7.9,community,300
2226,Australia,Oceania,Acinetobacter baumannii,Meropenem,2022,24.7,3.2,community,150
2227,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2022,26.0,8.0,hospital,150
2228,Brazil,South America,Escherichia coli,Meropenem,2022,45.1,10.0,community,250
2229,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2020,15.4,7.6,hospital,100
2230,France,Europe,Klebsiella pneumoniae,Amoxicillin,2022,16.6,7.2,community,100
2231,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2018,32.9,6.3,hospital,300
2232,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2021,73.2,11.2,community,100
2233,USA,North America,Pseudomonas aeruginosa,Vancomycin,2021,16.6,2.3,community,150
2234,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2021,71.1,10.3,hospital,100
2235,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2020,22.0,3.0,community,150
2236,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,76.3,17.7,community,100
2237,China,East Asia,Escherichia coli,Meropenem,2021,42.4,5.7,community,100
2238,France,Europe,Escherichia coli,Ciprofloxacin,2019,14.4,2.9,community,200
2239,USA,North America,Acinetobacter baumannii,Vancomycin,2018,14.6,0.5,hospital,200
2240,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2021,11.4,6.0,community,200
2241,Nigeria,Africa,Staphylococcus aureus,Meropenem,2019,40.9,6.2,hospital,250
2242,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2019,35.3,2.5,community,100
2243,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,7.4,3.2,hospital,300
2244,USA,North America,Acinetobacter baumannii,Amoxicillin,2018,21.4,4.4,hospital,300
2245,USA,North America,Staphylococcus aureus,Vancomycin,2020,27.6,4.4,hospital,200
2246,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2023,28.0,2.2,hospital,100
2247,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2018,29.9,6.3,community,200
2248,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2021,53.1,12.1,hospital,150
2249,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2018,52.6,14.9,community,300
2250,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2021,28.8,7.6,hospital,200
2251,China,East Asia,Staphylococcus aureus,Amoxicillin,2021,43.1,11.2,community,100
2252,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2023,36.4,3.5,community,100
2253,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2021,27.4,8.1,hospital,100
2254,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2021,18.6,5.6,community,150
2255,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2023,40.3,6.7,hospital,200
2256,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2019,19.0,0.8,hospital,300
2257,Japan,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,27.5,8.3,community,300
2258,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2022,17.1,3.3,hospital,300
2259,Australia,Oceania,Escherichia coli,Ceftriaxone,2018,7.0,5.2,hospital,300
2260,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2023,70.7,12.1,hospital,150
2261,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2020,32.9,10.9,hospital,150
2262,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2018,37.7,6.6,hospital,300
2263,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2021,36.7,6.0,hospital,250
2264,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2021,30.4,9.5,community,200
2265,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2019,39.2,6.6,community,300
2266,Germany,Europe,Acinetobacter baumannii,Vancomycin,2021,29.6,3.3,hospital,100
2267,Australia,Oceania,Escherichia coli,Amoxicillin,2020,13.0,2.7,community,100
2268,Brazil,South America,Escherichia coli,Ceftriaxone,2021,36.1,5.4,community,250
2269,Japan,East Asia,Staphylococcus aureus,Vancomycin,2023,27.3,5.2,community,300
2270,USA,North America,Escherichia coli,Ceftriaxone,2023,15.8,0.8,community,200
2271,Germany,Europe,Escherichia coli,Amoxicillin,2022,38.7,4.6,community,100
2272,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2021,69.3,10.3,hospital,300
2273,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2019,37.7,8.0,community,150
2274,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2018,33.8,2.2,community,300
2275,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2019,50.4,12.8,hospital,200
2276,France,Europe,Escherichia coli,Amoxicillin,2018,23.2,3.7,hospital,100
2277,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2021,53.2,6.8,community,250
2278,Germany,Europe,Staphylococcus aureus,Vancomycin,2023,41.7,3.7,community,150
2279,France,Europe,Escherichia coli,Amoxicillin,2018,24.4,8.6,community,100
2280,France,Europe,Staphylococcus aureus,Ceftriaxone,2023,25.8,8.2,community,250
2281,France,Europe,Klebsiella pneumoniae,Meropenem,2018,12.0,2.4,community,300
2282,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2018,59.8,14.3,hospital,150
2283,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2022,22.3,0.5,community,250
2284,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2020,33.5,9.7,community,200
2285,Nigeria,Africa,Escherichia coli,Meropenem,2023,70.6,13.2,hospital,200
2286,Australia,Oceania,Escherichia coli,Ciprofloxacin,2018,16.6,5.9,community,300
2287,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2022,73.8,11.5,community,150
2288,China,East Asia,Escherichia coli,Meropenem,2021,26.1,5.8,community,300
2289,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2020,34.1,11.6,community,200
2290,France,Europe,Klebsiella pneumoniae,Vancomycin,2023,25.1,1.3,hospital,200
2291,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2019,11.8,2.3,hospital,250
2292,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2022,28.0,5.2,community,250
2293,India,Southeast Asia,Acinetobacter baumannii,Amoxicillin,2019,66.0,11.5,community,100
2294,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2021,70.2,13.5,community,250
2295,South Africa,Africa,Acinetobacter baumannii,Meropenem,2019,46.1,10.8,hospital,250
2296,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2023,43.6,12.5,community,100
2297,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2021,34.6,3.7,community,300
2298,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2019,66.1,11.8,community,100
2299,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2021,28.4,7.1,community,100
2300,Brazil,South America,Escherichia coli,Ciprofloxacin,2021,27.1,8.6,hospital,300
2301,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2019,41.7,4.9,hospital,300
2302,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2019,18.6,3.4,community,300
2303,Japan,East Asia,Staphylococcus aureus,Meropenem,2019,38.7,12.7,hospital,150
2304,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2020,10.7,0.5,community,300
2305,Germany,Europe,Staphylococcus aureus,Meropenem,2023,37.4,7.0,hospital,150
2306,Germany,Europe,Escherichia coli,Vancomycin,2021,21.1,3.5,hospital,200
2307,China,East Asia,Escherichia coli,Amoxicillin,2019,20.6,1.1,community,300
2308,South Africa,Africa,Pseudomonas aeruginosa,Ceftriaxone,2018,27.6,9.3,community,150
2309,Germany,Europe,Acinetobacter baumannii,Meropenem,2021,21.1,3.2,hospital,200
2310,China,East Asia,Escherichia coli,Ceftriaxone,2018,24.7,4.3,community,200
2311,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2022,32.5,2.2,community,300
2312,Brazil,South America,Staphylococcus aureus,Meropenem,2020,52.4,15.1,hospital,150
2313,China,East Asia,Acinetobacter baumannii,Vancomycin,2019,24.8,3.8,community,150
2314,Brazil,South America,Acinetobacter baumannii,Vancomycin,2020,26.2,8.6,community,100
2315,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2019,29.8,3.2,hospital,300
2316,France,Europe,Escherichia coli,Ceftriaxone,2019,20.0,1.8,hospital,200
2317,India,Southeast Asia,Klebsiella pneumoniae,Vancomycin,2019,62.6,9.1,hospital,200
2318,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2023,46.9,5.2,hospital,250
2319,Brazil,South America,Escherichia coli,Amoxicillin,2023,46.9,5.6,hospital,300
2320,USA,North America,Staphylococcus aureus,Meropenem,2021,14.1,6.5,community,250
2321,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2019,22.4,5.6,community,250
2322,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2021,73.3,13.0,community,300
2323,South Africa,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,73.7,11.4,hospital,100
2324,USA,North America,Staphylococcus aureus,Meropenem,2018,24.2,3.6,hospital,150
2325,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,43.3,13.1,hospital,250
2326,China,East Asia,Staphylococcus aureus,Meropenem,2019,18.6,2.9,hospital,300
2327,Nigeria,Africa,Escherichia coli,Vancomycin,2021,34.4,2.2,hospital,250
2328,Australia,Oceania,Escherichia coli,Ciprofloxacin,2020,13.7,0.5,hospital,300
2329,China,East Asia,Klebsiella pneumoniae,Meropenem,2023,48.2,11.3,community,300
2330,Australia,Oceania,Escherichia coli,Meropenem,2022,28.8,7.8,community,100
2331,Japan,East Asia,Escherichia coli,Vancomycin,2023,33.6,7.1,community,250
2332,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2018,34.0,7.5,community,100
2333,Brazil,South America,Klebsiella pneumoniae,Meropenem,2018,24.8,7.8,hospital,150
2334,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2022,35.2,9.0,community,300
2335,Nigeria,Africa,Staphylococcus aureus,Meropenem,2019,44.6,11.4,community,250
2336,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2022,39.7,7.6,hospital,300
2337,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2018,39.1,7.3,community,250
2338,China,East Asia,Staphylococcus aureus,Amoxicillin,2019,37.7,10.3,hospital,250
2339,Germany,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2022,34.2,2.9,hospital,200
2340,Japan,East Asia,Escherichia coli,Vancomycin,2021,43.6,6.4,community,200
2341,Australia,Oceania,Escherichia coli,Vancomycin,2018,8.6,1.8,community,300
2342,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2022,26.0,5.6,community,200
2343,Germany,Europe,Klebsiella pneumoniae,Ciprofloxacin,2018,16.5,0.9,hospital,250
2344,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2020,30.0,2.7,community,300
2345,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2022,28.4,5.2,community,150
2346,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2020,52.8,10.9,hospital,300
2347,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2021,24.1,9.4,community,150
2348,South Africa,Africa,Acinetobacter baumannii,Meropenem,2020,55.3,9.2,hospital,200
2349,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2019,27.5,8.8,community,200
2350,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2021,24.6,4.6,community,250
2351,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2021,43.0,9.0,hospital,100
2352,France,Europe,Klebsiella pneumoniae,Vancomycin,2021,19.1,3.1,community,200
2353,South Africa,Africa,Acinetobacter baumannii,Meropenem,2022,32.8,10.6,hospital,200
2354,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2020,62.9,10.0,hospital,150
2355,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2020,17.9,0.5,hospital,200
2356,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2021,35.3,6.2,community,150
2357,Japan,East Asia,Acinetobacter baumannii,Meropenem,2022,35.7,7.2,community,100
2358,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2020,16.3,6.0,hospital,150
2359,USA,North America,Acinetobacter baumannii,Ceftriaxone,2019,25.2,3.0,community,250
2360,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,46.3,8.9,hospital,150
2361,China,East Asia,Acinetobacter baumannii,Vancomycin,2022,31.6,5.7,community,100
2362,France,Europe,Klebsiella pneumoniae,Meropenem,2021,36.6,7.6,hospital,150
2363,China,East Asia,Acinetobacter baumannii,Amoxicillin,2022,51.3,11.5,hospital,250
2364,USA,North America,Escherichia coli,Ciprofloxacin,2023,35.2,5.2,hospital,300
2365,Brazil,South America,Escherichia coli,Meropenem,2019,38.4,5.5,community,250
2366,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2021,27.1,8.9,community,200
2367,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2018,54.3,13.0,hospital,150
2368,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2018,7.3,2.3,community,250
2369,China,East Asia,Acinetobacter baumannii,Meropenem,2023,22.0,3.1,hospital,250
2370,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2022,56.0,7.5,community,100
2371,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2020,38.6,11.2,hospital,250
2372,Brazil,South America,Escherichia coli,Ciprofloxacin,2020,48.8,6.2,community,150
2373,Germany,Europe,Escherichia coli,Vancomycin,2018,29.5,5.4,community,100
2374,Japan,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2022,25.1,4.2,community,300
2375,South Africa,Africa,Escherichia coli,Ciprofloxacin,2022,48.6,9.3,hospital,200
2376,China,East Asia,Acinetobacter baumannii,Meropenem,2020,27.4,4.8,hospital,150
2377,Brazil,South America,Staphylococcus aureus,Meropenem,2023,52.9,7.6,hospital,100
2378,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2020,14.5,5.7,community,150
2379,India,Southeast Asia,Escherichia coli,Amoxicillin,2022,38.0,2.9,hospital,100
2380,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2022,30.6,4.9,community,250
2381,Brazil,South America,Staphylococcus aureus,Amoxicillin,2020,31.2,6.9,hospital,150
2382,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2019,17.3,3.9,hospital,100
2383,India,Southeast Asia,Escherichia coli,Vancomycin,2021,44.0,9.6,community,250
2384,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2018,58.3,13.3,hospital,250
2385,Brazil,South America,Acinetobacter baumannii,Meropenem,2018,27.7,0.8,community,300
2386,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2019,39.1,8.4,hospital,200
2387,France,Europe,Staphylococcus aureus,Amoxicillin,2019,15.6,4.3,community,250
2388,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2021,61.6,14.8,community,300
2389,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2019,26.1,7.0,community,200
2390,Australia,Oceania,Staphylococcus aureus,Vancomycin,2022,18.2,0.6,community,100
2391,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2022,48.4,5.6,hospital,100
2392,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2019,20.4,1.0,community,150
2393,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2020,42.9,13.0,community,100
2394,USA,North America,Escherichia coli,Ciprofloxacin,2020,18.7,5.1,community,300
2395,China,East Asia,Acinetobacter baumannii,Meropenem,2023,40.6,5.8,community,300
2396,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2019,16.6,4.8,hospital,150
2397,Brazil,South America,Escherichia coli,Ciprofloxacin,2019,23.9,1.0,community,100
2398,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2022,20.0,1.2,community,250
2399,France,Europe,Klebsiella pneumoniae,Amoxicillin,2020,30.1,1.6,community,250
2400,Germany,Europe,Pseudomonas aeruginosa,Vancomycin,2022,29.5,1.9,hospital,250
2401,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2019,48.1,12.6,hospital,200
2402,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2021,29.8,10.6,hospital,250
2403,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2023,18.7,1.0,hospital,250
2404,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2022,13.4,5.2,community,300
2405,Germany,Europe,Staphylococcus aureus,Meropenem,2020,29.8,2.6,community,100
2406,France,Europe,Klebsiella pneumoniae,Meropenem,2022,26.5,3.1,hospital,150
2407,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2020,70.0,14.0,community,150
2408,Brazil,South America,Staphylococcus aureus,Meropenem,2019,38.2,4.5,community,250
2409,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2022,21.5,3.3,hospital,200
2410,Australia,Oceania,Staphylococcus aureus,Meropenem,2021,23.6,4.1,community,100
2411,France,Europe,Escherichia coli,Meropenem,2021,17.5,0.5,community,100
2412,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2022,44.0,12.8,community,250
2413,France,Europe,Pseudomonas aeruginosa,Meropenem,2023,36.2,10.5,community,100
2414,Nigeria,Africa,Acinetobacter baumannii,Ciprofloxacin,2022,58.7,11.0,community,100
2415,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2021,51.5,7.1,hospital,300
2416,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2022,28.0,4.3,hospital,300
2417,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2018,16.5,2.5,community,250
2418,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2022,55.0,12.0,community,100
2419,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2023,24.1,0.5,community,250
2420,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,24.7,1.2,community,250
2421,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2021,26.2,6.5,hospital,100
2422,USA,North America,Acinetobacter baumannii,Meropenem,2020,14.4,4.4,community,250
2423,Japan,East Asia,Escherichia coli,Ceftriaxone,2020,21.8,0.5,community,250
2424,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2022,56.9,11.0,community,200
2425,Brazil,South America,Escherichia coli,Ciprofloxacin,2018,47.8,9.9,hospital,200
2426,Australia,Oceania,Escherichia coli,Amoxicillin,2023,22.9,8.2,community,250
2427,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2021,67.5,13.7,hospital,200
2428,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2022,67.9,16.0,community,300
2429,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2019,52.9,9.2,community,100
2430,Nigeria,Africa,Escherichia coli,Amoxicillin,2019,33.7,5.3,hospital,200
2431,Germany,Europe,Staphylococcus aureus,Vancomycin,2020,22.2,0.5,hospital,150
2432,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2023,31.2,8.2,community,200
2433,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2022,45.1,6.2,hospital,200
2434,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,23.9,9.1,hospital,300
2435,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2018,32.8,5.3,community,200
2436,France,Europe,Escherichia coli,Vancomycin,2019,18.6,0.5,hospital,100
2437,South Africa,Africa,Acinetobacter baumannii,Meropenem,2023,52.8,11.1,hospital,150
2438,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2021,27.9,5.6,hospital,200
2439,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2018,10.3,0.5,community,250
2440,South Africa,Africa,Escherichia coli,Ceftriaxone,2019,60.4,12.6,community,150
2441,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2019,32.4,1.9,hospital,150
2442,USA,North America,Klebsiella pneumoniae,Vancomycin,2023,31.0,11.0,hospital,200
2443,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2020,36.1,5.9,hospital,150
2444,Brazil,South America,Escherichia coli,Amoxicillin,2021,56.6,8.0,hospital,250
2445,Brazil,South America,Escherichia coli,Vancomycin,2022,38.0,5.8,hospital,100
2446,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2022,23.3,0.9,hospital,100
2447,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,53.8,6.1,hospital,200
2448,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2018,36.9,6.1,community,300
2449,China,East Asia,Acinetobacter baumannii,Amoxicillin,2021,27.1,1.6,community,100
2450,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,37.5,9.3,hospital,100
2451,Brazil,South America,Escherichia coli,Amoxicillin,2020,44.5,8.3,hospital,300
2452,South Africa,Africa,Acinetobacter baumannii,Vancomycin,2020,38.8,3.9,community,100
2453,France,Europe,Escherichia coli,Ciprofloxacin,2023,40.5,10.0,hospital,250
2454,China,East Asia,Klebsiella pneumoniae,Meropenem,2023,20.3,8.5,community,250
2455,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2018,26.3,4.3,community,100
2456,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2018,38.3,5.6,community,250
2457,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2022,70.5,11.0,hospital,100
2458,Brazil,South America,Escherichia coli,Meropenem,2019,29.1,5.9,community,300
2459,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2022,35.4,8.9,community,150
2460,France,Europe,Pseudomonas aeruginosa,Vancomycin,2022,28.1,8.4,community,250
2461,France,Europe,Klebsiella pneumoniae,Amoxicillin,2022,27.5,2.1,community,150
2462,Nigeria,Africa,Klebsiella pneumoniae,Amoxicillin,2023,40.6,9.9,community,100
2463,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2023,53.9,9.8,community,300
2464,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,36.7,8.3,hospital,200
2465,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2018,59.6,11.3,hospital,250
2466,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,67.7,16.4,community,250
2467,France,Europe,Escherichia coli,Ceftriaxone,2022,28.2,5.2,community,250
2468,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2023,66.9,17.4,hospital,300
2469,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2019,36.1,11.8,hospital,150
2470,France,Europe,Escherichia coli,Ciprofloxacin,2019,14.2,0.5,hospital,300
2471,Brazil,South America,Acinetobacter baumannii,Vancomycin,2022,51.6,5.5,community,150
2472,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2023,44.6,11.9,community,150
2473,China,East Asia,Escherichia coli,Meropenem,2022,47.4,14.0,community,150
2474,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2019,49.0,13.4,community,150
2475,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2023,20.4,0.5,hospital,150
2476,USA,North America,Acinetobacter baumannii,Ceftriaxone,2022,16.1,7.6,hospital,250
2477,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2023,45.8,5.0,community,200
2478,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2021,46.3,10.4,hospital,150
2479,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2021,44.8,10.3,community,150
2480,South Africa,Africa,Acinetobacter baumannii,Meropenem,2018,30.7,10.7,community,300
2481,Australia,Oceania,Escherichia coli,Amoxicillin,2018,18.5,3.5,community,200
2482,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,57.8,9.0,hospital,150
2483,China,East Asia,Acinetobacter baumannii,Meropenem,2023,47.9,5.4,hospital,250
2484,France,Europe,Escherichia coli,Ciprofloxacin,2018,26.5,8.9,community,100
2485,Australia,Oceania,Acinetobacter baumannii,Meropenem,2023,18.6,8.5,hospital,100
2486,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2021,21.2,3.6,community,150
2487,USA,North America,Acinetobacter baumannii,Meropenem,2021,26.2,4.0,community,250
2488,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2022,42.6,8.7,hospital,300
2489,Nigeria,Africa,Klebsiella pneumoniae,Amoxicillin,2023,40.2,6.1,hospital,300
2490,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2019,28.1,6.5,community,100
2491,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2020,39.4,2.9,community,100
2492,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,50.8,15.1,community,150
2493,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2022,36.2,8.0,community,150
2494,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2019,41.8,6.4,hospital,100
2495,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2019,29.0,4.3,community,100
2496,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2020,37.6,6.7,community,300
2497,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2020,20.4,4.6,hospital,100
2498,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2019,27.1,2.3,community,100
2499,Germany,Europe,Staphylococcus aureus,Amoxicillin,2020,31.6,6.8,hospital,250
2500,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2018,34.8,4.7,hospital,250
2501,South Africa,Africa,Staphylococcus aureus,Vancomycin,2022,53.9,11.4,community,200
2502,France,Europe,Acinetobacter baumannii,Meropenem,2023,43.7,12.7,community,200
2503,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2019,13.6,3.8,hospital,300
2504,Brazil,South America,Escherichia coli,Meropenem,2022,60.0,8.7,hospital,250
2505,Germany,Europe,Escherichia coli,Vancomycin,2023,21.9,3.9,community,100
2506,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2021,42.6,6.3,hospital,250
2507,India,Southeast Asia,Escherichia coli,Vancomycin,2021,51.3,6.4,hospital,150
2508,Australia,Oceania,Acinetobacter baumannii,Meropenem,2020,18.4,5.3,hospital,250
2509,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2023,26.3,2.1,community,200
2510,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2020,33.9,6.9,community,300
2511,USA,North America,Staphylococcus aureus,Vancomycin,2018,8.3,5.6,community,300
2512,Japan,East Asia,Pseudomonas aeruginosa,Vancomycin,2023,30.4,1.7,community,300
2513,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2023,24.0,1.3,community,200
2514,USA,North America,Acinetobacter baumannii,Meropenem,2018,20.3,8.8,community,200
2515,Japan,East Asia,Staphylococcus aureus,Meropenem,2021,46.5,9.8,hospital,150
2516,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2021,68.1,10.7,hospital,250
2517,Germany,Europe,Escherichia coli,Ceftriaxone,2019,13.4,3.2,hospital,250
2518,Germany,Europe,Staphylococcus aureus,Meropenem,2021,31.8,7.4,community,100
2519,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2023,58.8,11.1,community,100
2520,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2023,24.8,1.2,community,250
2521,USA,North America,Klebsiella pneumoniae,Vancomycin,2020,18.8,7.5,community,250
2522,USA,North America,Staphylococcus aureus,Vancomycin,2021,19.2,1.5,community,300
2523,Brazil,South America,Escherichia coli,Amoxicillin,2022,33.3,11.6,hospital,250
2524,USA,North America,Staphylococcus aureus,Ceftriaxone,2020,13.2,0.5,community,100
2525,USA,North America,Staphylococcus aureus,Ciprofloxacin,2019,10.2,6.9,community,200
2526,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2020,42.9,7.8,hospital,150
2527,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,34.9,2.7,community,250
2528,China,East Asia,Klebsiella pneumoniae,Meropenem,2018,32.3,8.9,hospital,100
2529,Japan,East Asia,Escherichia coli,Vancomycin,2020,25.6,4.3,hospital,250
2530,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2023,17.7,0.5,hospital,150
2531,USA,North America,Klebsiella pneumoniae,Meropenem,2022,28.7,2.0,community,250
2532,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2019,43.8,11.4,hospital,250
2533,China,East Asia,Staphylococcus aureus,Meropenem,2020,28.7,10.0,community,100
2534,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2022,69.7,18.4,community,200
2535,South Africa,Africa,Escherichia coli,Meropenem,2019,64.0,17.5,community,250
2536,India,Southeast Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,51.2,12.8,hospital,250
2537,Australia,Oceania,Escherichia coli,Vancomycin,2019,11.6,3.8,community,150
2538,Germany,Europe,Escherichia coli,Ciprofloxacin,2023,27.0,3.8,community,200
2539,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2018,33.6,2.8,hospital,250
2540,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2019,50.2,5.9,community,250
2541,South Africa,Africa,Staphylococcus aureus,Vancomycin,2018,62.8,15.2,community,300
2542,China,East Asia,Staphylococcus aureus,Meropenem,2023,25.1,6.5,community,100
2543,France,Europe,Escherichia coli,Meropenem,2020,27.2,2.4,hospital,150
2544,Nigeria,Africa,Klebsiella pneumoniae,Ceftriaxone,2019,53.0,10.9,community,100
2545,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2020,18.1,0.5,hospital,250
2546,Brazil,South America,Escherichia coli,Ceftriaxone,2022,47.9,12.1,community,150
2547,USA,North America,Pseudomonas aeruginosa,Meropenem,2022,13.9,3.3,community,200
2548,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2018,9.7,0.5,community,150
2549,Japan,East Asia,Staphylococcus aureus,Meropenem,2023,31.7,4.6,community,100
2550,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2019,14.8,6.5,community,200
2551,China,East Asia,Escherichia coli,Ceftriaxone,2018,20.1,4.5,community,300
2552,South Africa,Africa,Staphylococcus aureus,Amoxicillin,2021,35.1,11.2,hospital,200
2553,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2021,56.4,13.0,community,100
2554,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2018,38.5,8.9,community,300
2555,Australia,Oceania,Staphylococcus aureus,Vancomycin,2018,6.6,0.5,hospital,200
2556,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2023,29.6,10.1,hospital,100
2557,Nigeria,Africa,Escherichia coli,Amoxicillin,2020,61.0,14.5,community,300
2558,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2023,20.6,0.5,community,250
2559,Japan,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,39.0,4.9,community,150
2560,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2018,31.0,9.1,hospital,150
2561,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2018,37.6,11.6,community,100
2562,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2020,54.8,10.4,hospital,150
2563,USA,North America,Escherichia coli,Vancomycin,2021,9.8,1.0,community,300
2564,USA,North America,Pseudomonas aeruginosa,Ceftriaxone,2022,17.0,7.1,hospital,200
2565,Brazil,South America,Pseudomonas aeruginosa,Vancomycin,2021,36.5,10.0,hospital,300
2566,China,East Asia,Staphylococcus aureus,Ceftriaxone,2022,32.3,8.0,community,200
2567,USA,North America,Escherichia coli,Amoxicillin,2023,29.0,10.2,hospital,200
2568,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2023,30.8,10.3,community,100
2569,Nigeria,Africa,Escherichia coli,Amoxicillin,2023,60.9,10.6,hospital,150
2570,USA,North America,Escherichia coli,Ciprofloxacin,2022,11.5,0.5,hospital,150
2571,Japan,East Asia,Acinetobacter baumannii,Meropenem,2023,53.0,12.8,hospital,150
2572,France,Europe,Staphylococcus aureus,Amoxicillin,2020,22.7,5.7,hospital,300
2573,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2021,20.1,4.9,community,200
2574,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2021,45.2,11.7,community,100
2575,USA,North America,Staphylococcus aureus,Ceftriaxone,2018,12.2,0.5,community,100
2576,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2020,72.2,17.4,community,200
2577,France,Europe,Escherichia coli,Ciprofloxacin,2019,26.6,10.2,community,250
2578,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2020,15.9,1.6,hospital,100
2579,Germany,Europe,Escherichia coli,Vancomycin,2020,23.7,1.3,hospital,150
2580,Germany,Europe,Escherichia coli,Vancomycin,2020,29.0,3.4,community,150
2581,Brazil,South America,Acinetobacter baumannii,Vancomycin,2021,32.0,10.6,community,250
2582,USA,North America,Pseudomonas aeruginosa,Meropenem,2023,17.7,0.5,community,300
2583,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2023,25.2,3.6,hospital,100
2584,Australia,Oceania,Escherichia coli,Amoxicillin,2023,32.1,2.1,hospital,150
2585,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2020,58.2,9.8,community,100
2586,Japan,East Asia,Acinetobacter baumannii,Meropenem,2020,26.3,4.7,community,300
2587,USA,North America,Staphylococcus aureus,Vancomycin,2020,18.8,8.3,community,250
2588,Brazil,South America,Acinetobacter baumannii,Meropenem,2019,48.9,6.9,community,150
2589,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2022,61.9,8.7,hospital,300
2590,South Africa,Africa,Escherichia coli,Ceftriaxone,2022,59.9,14.8,community,300
2591,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2022,21.8,6.0,community,250
2592,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2022,18.8,3.7,community,100
2593,India,Southeast Asia,Pseudomonas aeruginosa,Meropenem,2022,39.4,7.4,hospital,150
2594,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2021,54.9,13.5,community,200
2595,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2020,29.6,8.8,community,100
2596,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2022,18.7,4.4,community,300
2597,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2023,60.8,11.7,hospital,300
2598,USA,North America,Klebsiella pneumoniae,Ceftriaxone,2018,18.1,0.5,hospital,200
2599,Nigeria,Africa,Escherichia coli,Ceftriaxone,2018,32.4,8.0,hospital,300
2600,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2021,25.4,8.0,hospital,300
2601,Brazil,South America,Escherichia coli,Vancomycin,2019,43.6,8.1,community,300
2602,USA,North America,Pseudomonas aeruginosa,Meropenem,2020,21.4,6.4,community,150
2603,France,Europe,Staphylococcus aureus,Meropenem,2022,23.1,8.0,hospital,200
2604,Australia,Oceania,Staphylococcus aureus,Meropenem,2023,22.8,6.1,hospital,250
2605,Germany,Europe,Klebsiella pneumoniae,Meropenem,2019,26.9,8.2,community,250
2606,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2020,34.7,10.7,hospital,150
2607,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2018,37.4,7.5,community,100
2608,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2020,14.5,7.2,community,300
2609,USA,North America,Escherichia coli,Ciprofloxacin,2018,7.0,3.8,community,100
2610,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2019,33.9,10.3,hospital,100
2611,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2023,38.9,5.4,hospital,100
2612,South Africa,Africa,Acinetobacter baumannii,Meropenem,2018,35.5,11.8,community,150
2613,Australia,Oceania,Acinetobacter baumannii,Meropenem,2019,15.8,0.5,community,300
2614,Nigeria,Africa,Staphylococcus aureus,Meropenem,2021,50.6,11.8,community,250
2615,South Africa,Africa,Klebsiella pneumoniae,Vancomycin,2020,55.2,6.3,hospital,150
2616,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2020,20.4,2.6,community,100
2617,Brazil,South America,Escherichia coli,Ciprofloxacin,2020,51.3,8.5,hospital,100
2618,USA,North America,Escherichia coli,Ciprofloxacin,2023,25.0,6.2,community,100
2619,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2023,43.7,9.4,hospital,200
2620,Australia,Oceania,Staphylococcus aureus,Ciprofloxacin,2018,19.1,1.6,community,150
2621,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2020,25.8,6.1,community,100
2622,USA,North America,Staphylococcus aureus,Ciprofloxacin,2019,14.1,3.7,community,300
2623,China,East Asia,Escherichia coli,Meropenem,2020,33.4,6.0,hospital,300
2624,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2022,45.8,7.2,community,150
2625,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2018,21.2,6.4,hospital,150
2626,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2018,6.4,2.6,hospital,100
2627,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2019,21.7,5.1,hospital,250
2628,Brazil,South America,Pseudomonas aeruginosa,Ceftriaxone,2019,42.5,10.9,community,200
2629,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2018,65.8,13.4,hospital,100
2630,Brazil,South America,Escherichia coli,Ciprofloxacin,2021,33.4,4.4,community,100
2631,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2021,34.7,9.4,community,300
2632,Japan,East Asia,Acinetobacter baumannii,Meropenem,2023,28.7,7.1,community,150
2633,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2019,66.3,16.0,hospital,150
2634,Australia,Oceania,Pseudomonas aeruginosa,Meropenem,2023,15.8,7.0,community,150
2635,France,Europe,Pseudomonas aeruginosa,Amoxicillin,2021,20.9,5.1,hospital,200
2636,Germany,Europe,Staphylococcus aureus,Vancomycin,2022,19.1,0.5,hospital,150
2637,Japan,East Asia,Pseudomonas aeruginosa,Meropenem,2023,50.3,12.2,community,300
2638,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2021,30.9,8.0,hospital,200
2639,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2020,23.1,9.0,community,300
2640,China,East Asia,Escherichia coli,Ceftriaxone,2020,30.0,3.9,hospital,100
2641,France,Europe,Acinetobacter baumannii,Ceftriaxone,2022,32.3,9.2,hospital,100
2642,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2019,63.7,8.4,community,250
2643,India,Southeast Asia,Escherichia coli,Meropenem,2019,56.4,7.1,community,150
2644,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2019,17.6,0.5,hospital,100
2645,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2018,44.8,4.6,hospital,200
2646,USA,North America,Klebsiella pneumoniae,Amoxicillin,2020,20.6,7.2,hospital,200
2647,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2019,8.7,3.3,hospital,250
2648,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2018,37.7,2.8,community,200
2649,South Africa,Africa,Escherichia coli,Ceftriaxone,2022,52.5,13.1,community,200
2650,India,Southeast Asia,Acinetobacter baumannii,Meropenem,2023,74.8,12.1,community,100
2651,Australia,Oceania,Acinetobacter baumannii,Ciprofloxacin,2021,18.9,4.5,hospital,150
2652,China,East Asia,Pseudomonas aeruginosa,Meropenem,2022,32.4,7.2,hospital,300
2653,China,East Asia,Acinetobacter baumannii,Meropenem,2022,32.0,4.3,hospital,150
2654,USA,North America,Acinetobacter baumannii,Vancomycin,2023,25.2,0.9,hospital,300
2655,India,Southeast Asia,Acinetobacter baumannii,Vancomycin,2023,78.5,14.1,community,250
2656,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2020,47.8,12.0,community,250
2657,Australia,Oceania,Pseudomonas aeruginosa,Vancomycin,2022,23.7,2.1,hospital,100
2658,USA,North America,Acinetobacter baumannii,Meropenem,2023,25.0,0.5,community,200
2659,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2021,40.7,6.1,community,100
2660,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2022,62.9,15.4,community,250
2661,USA,North America,Escherichia coli,Vancomycin,2021,16.0,1.0,community,250
2662,USA,North America,Acinetobacter baumannii,Meropenem,2018,13.8,5.9,community,150
2663,USA,North America,Staphylococcus aureus,Ceftriaxone,2021,24.2,4.5,community,100
2664,India,Southeast Asia,Staphylococcus aureus,Amoxicillin,2020,55.3,15.9,hospital,300
2665,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,33.3,8.7,hospital,150
2666,Brazil,South America,Acinetobacter baumannii,Vancomycin,2022,55.9,11.2,community,100
2667,USA,North America,Staphylococcus aureus,Vancomycin,2020,14.0,1.3,community,100
2668,Germany,Europe,Staphylococcus aureus,Meropenem,2021,32.5,10.2,community,300
2669,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2023,27.0,5.0,community,150
2670,Germany,Europe,Escherichia coli,Meropenem,2023,33.8,10.7,community,200
2671,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2021,68.2,11.8,hospital,150
2672,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2019,33.0,7.2,hospital,250
2673,Japan,East Asia,Escherichia coli,Ceftriaxone,2018,37.2,7.5,community,250
2674,USA,North America,Staphylococcus aureus,Meropenem,2022,27.9,8.5,community,100
2675,Australia,Oceania,Acinetobacter baumannii,Amoxicillin,2018,9.4,6.6,community,250
2676,Japan,East Asia,Escherichia coli,Meropenem,2018,28.1,5.0,hospital,100
2677,Japan,East Asia,Staphylococcus aureus,Ciprofloxacin,2020,43.5,9.1,hospital,300
2678,Japan,East Asia,Staphylococcus aureus,Meropenem,2023,38.3,5.7,hospital,250
2679,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2020,36.6,2.4,hospital,250
2680,Nigeria,Africa,Escherichia coli,Ceftriaxone,2020,63.6,16.8,hospital,100
2681,Brazil,South America,Acinetobacter baumannii,Amoxicillin,2021,51.0,14.1,community,250
2682,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2018,21.4,2.8,community,250
2683,South Africa,Africa,Staphylococcus aureus,Ceftriaxone,2022,62.6,16.6,hospital,100
2684,USA,North America,Acinetobacter baumannii,Vancomycin,2018,21.3,0.5,community,150
2685,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2022,56.6,9.5,community,250
2686,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2021,53.1,6.8,community,200
2687,USA,North America,Staphylococcus aureus,Ceftriaxone,2022,15.0,0.5,hospital,150
2688,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2019,36.0,9.1,community,300
2689,South Africa,Africa,Acinetobacter baumannii,Meropenem,2021,45.0,6.5,hospital,300
2690,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2018,45.2,9.7,hospital,150
2691,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2023,45.9,10.4,hospital,250
2692,Nigeria,Africa,Escherichia coli,Ceftriaxone,2023,47.7,6.2,hospital,300
2693,India,Southeast Asia,Acinetobacter baumannii,Ceftriaxone,2023,62.3,9.0,hospital,100
2694,South Africa,Africa,Escherichia coli,Meropenem,2019,31.3,7.6,community,150
2695,Germany,Europe,Acinetobacter baumannii,Amoxicillin,2023,33.6,1.8,community,100
2696,Nigeria,Africa,Staphylococcus aureus,Ciprofloxacin,2022,35.9,12.0,community,250
2697,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2022,24.4,9.0,hospital,250
2698,Germany,Europe,Escherichia coli,Amoxicillin,2019,24.1,4.1,community,300
2699,Australia,Oceania,Acinetobacter baumannii,Vancomycin,2023,19.3,4.7,community,150
2700,Australia,Oceania,Pseudomonas aeruginosa,Ceftriaxone,2021,13.6,5.2,hospital,150
2701,USA,North America,Staphylococcus aureus,Amoxicillin,2018,8.1,4.8,hospital,250
2702,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2018,56.3,10.8,community,200
2703,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2019,38.4,4.7,community,100
2704,France,Europe,Escherichia coli,Ciprofloxacin,2021,18.0,8.0,community,250
2705,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2023,44.0,4.0,community,200
2706,Germany,Europe,Acinetobacter baumannii,Vancomycin,2019,13.5,0.5,community,300
2707,Germany,Europe,Acinetobacter baumannii,Vancomycin,2020,26.3,6.2,community,100
2708,USA,North America,Acinetobacter baumannii,Vancomycin,2022,21.7,5.5,community,250
2709,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2020,27.4,0.9,community,150
2710,South Africa,Africa,Escherichia coli,Ceftriaxone,2021,66.9,17.0,hospital,200
2711,China,East Asia,Acinetobacter baumannii,Vancomycin,2021,43.9,5.8,hospital,300
2712,India,Southeast Asia,Staphylococcus aureus,Vancomycin,2019,53.2,12.8,community,150
2713,China,East Asia,Escherichia coli,Meropenem,2018,17.5,7.4,hospital,300
2714,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2018,27.4,8.9,hospital,200
2715,France,Europe,Klebsiella pneumoniae,Ciprofloxacin,2021,23.2,0.8,community,150
2716,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2018,68.3,17.8,hospital,250
2717,Brazil,South America,Acinetobacter baumannii,Vancomycin,2022,58.0,11.4,community,200
2718,Australia,Oceania,Acinetobacter baumannii,Meropenem,2022,18.4,4.4,hospital,250
2719,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2018,22.1,3.9,community,150
2720,Australia,Oceania,Staphylococcus aureus,Ceftriaxone,2018,8.7,1.0,community,100
2721,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2022,31.0,10.5,community,300
2722,Brazil,South America,Escherichia coli,Meropenem,2020,50.2,5.7,hospital,100
2723,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2018,10.5,0.5,community,250
2724,France,Europe,Acinetobacter baumannii,Amoxicillin,2020,26.4,8.1,community,250
2725,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2022,28.2,5.1,community,200
2726,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2018,9.4,3.0,community,100
2727,Australia,Oceania,Escherichia coli,Ceftriaxone,2022,16.9,4.3,hospital,100
2728,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2021,31.2,7.6,community,200
2729,South Africa,Africa,Staphylococcus aureus,Vancomycin,2018,43.6,11.5,hospital,200
2730,China,East Asia,Klebsiella pneumoniae,Ciprofloxacin,2020,25.2,6.4,community,150
2731,Nigeria,Africa,Escherichia coli,Ceftriaxone,2019,57.9,7.4,hospital,200
2732,Brazil,South America,Staphylococcus aureus,Amoxicillin,2023,52.9,11.2,community,250
2733,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2023,16.0,0.5,community,150
2734,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2018,42.1,8.5,hospital,100
2735,China,East Asia,Acinetobacter baumannii,Amoxicillin,2021,28.4,3.4,hospital,150
2736,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2021,64.5,16.0,hospital,150
2737,China,East Asia,Escherichia coli,Ceftriaxone,2020,28.8,1.1,community,300
2738,France,Europe,Klebsiella pneumoniae,Meropenem,2022,24.1,4.6,community,300
2739,Germany,Europe,Acinetobacter baumannii,Ciprofloxacin,2020,20.0,7.7,community,150
2740,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2019,33.5,2.4,hospital,200
2741,India,Southeast Asia,Acinetobacter baumannii,Ciprofloxacin,2020,47.9,6.0,hospital,250
2742,India,Southeast Asia,Acinetobacter baumannii,Meropenem,2020,57.7,8.6,community,300
2743,USA,North America,Staphylococcus aureus,Ciprofloxacin,2019,24.1,8.8,community,300
2744,China,East Asia,Pseudomonas aeruginosa,Meropenem,2020,26.8,0.7,hospital,300
2745,France,Europe,Staphylococcus aureus,Ceftriaxone,2022,31.8,4.3,hospital,250
2746,South Africa,Africa,Acinetobacter baumannii,Ciprofloxacin,2023,34.0,9.1,community,250
2747,Japan,East Asia,Escherichia coli,Meropenem,2023,33.8,11.4,hospital,250
2748,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2021,17.6,6.5,community,150
2749,Germany,Europe,Pseudomonas aeruginosa,Meropenem,2019,19.9,0.5,community,100
2750,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2019,13.2,1.0,hospital,100
2751,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2022,56.1,12.6,community,300
2752,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2022,25.5,5.0,hospital,300
2753,India,Southeast Asia,Escherichia coli,Amoxicillin,2021,51.5,12.0,hospital,150
2754,India,Southeast Asia,Escherichia coli,Ceftriaxone,2021,54.8,13.5,community,300
2755,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2022,54.9,10.0,community,200
2756,China,East Asia,Acinetobacter baumannii,Amoxicillin,2018,33.6,5.0,hospital,100
2757,Japan,East Asia,Acinetobacter baumannii,Vancomycin,2019,27.9,6.0,community,100
2758,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2023,26.3,4.7,hospital,250
2759,China,East Asia,Staphylococcus aureus,Ceftriaxone,2021,29.6,2.8,community,150
2760,China,East Asia,Escherichia coli,Amoxicillin,2018,35.7,11.1,hospital,100
2761,Japan,East Asia,Pseudomonas aeruginosa,Amoxicillin,2020,43.4,5.7,community,150
2762,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2021,51.4,9.1,hospital,250
2763,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2020,38.6,7.0,hospital,300
2764,Australia,Oceania,Escherichia coli,Vancomycin,2023,16.9,5.9,community,150
2765,China,East Asia,Escherichia coli,Meropenem,2020,28.0,8.3,community,250
2766,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2019,37.4,10.1,hospital,300
2767,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2020,54.3,13.7,community,300
2768,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2018,35.7,9.5,hospital,100
2769,India,Southeast Asia,Pseudomonas aeruginosa,Amoxicillin,2018,64.7,8.2,community,200
2770,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2022,65.1,17.9,community,300
2771,USA,North America,Klebsiella pneumoniae,Amoxicillin,2018,20.3,3.2,community,250
2772,Germany,Europe,Pseudomonas aeruginosa,Amoxicillin,2018,19.7,7.0,community,300
2773,China,East Asia,Staphylococcus aureus,Meropenem,2023,30.8,8.0,community,300
2774,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2021,56.4,16.1,community,100
2775,China,East Asia,Klebsiella pneumoniae,Amoxicillin,2023,31.1,7.6,community,300
2776,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2022,28.2,9.4,community,300
2777,South Africa,Africa,Escherichia coli,Amoxicillin,2023,46.2,9.9,hospital,150
2778,Germany,Europe,Escherichia coli,Vancomycin,2022,32.5,4.5,hospital,200
2779,Brazil,South America,Klebsiella pneumoniae,Meropenem,2019,34.0,7.0,community,150
2780,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2020,27.8,6.8,hospital,150
2781,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2020,29.1,6.6,community,100
2782,Japan,East Asia,Escherichia coli,Ceftriaxone,2018,18.0,3.5,community,100
2783,India,Southeast Asia,Escherichia coli,Vancomycin,2021,55.1,11.5,hospital,300
2784,Brazil,South America,Escherichia coli,Amoxicillin,2020,43.0,5.9,hospital,250
2785,China,East Asia,Escherichia coli,Ceftriaxone,2018,27.9,9.7,hospital,150
2786,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2019,48.7,6.9,community,250
2787,Nigeria,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,39.2,10.9,community,150
2788,USA,North America,Acinetobacter baumannii,Amoxicillin,2020,21.6,5.8,community,100
2789,USA,North America,Staphylococcus aureus,Amoxicillin,2022,29.5,1.1,community,100
2790,Germany,Europe,Staphylococcus aureus,Amoxicillin,2019,21.3,7.5,community,150
2791,India,Southeast Asia,Escherichia coli,Meropenem,2023,56.5,8.3,hospital,250
2792,China,East Asia,Klebsiella pneumoniae,Ceftriaxone,2021,32.1,9.5,hospital,100
2793,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2022,45.4,12.7,hospital,300
2794,China,East Asia,Escherichia coli,Amoxicillin,2019,19.7,4.7,hospital,100
2795,Nigeria,Africa,Escherichia coli,Meropenem,2021,48.4,7.0,hospital,250
2796,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2019,24.4,1.0,community,200
2797,China,East Asia,Acinetobacter baumannii,Amoxicillin,2023,24.2,2.3,community,250
2798,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2022,39.7,12.2,hospital,200
2799,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2019,10.0,0.5,hospital,300
2800,India,Southeast Asia,Staphylococcus aureus,Ceftriaxone,2020,70.3,12.6,community,200
2801,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2020,38.1,10.8,community,300
2802,USA,North America,Staphylococcus aureus,Ciprofloxacin,2019,10.3,0.5,hospital,150
2803,China,East Asia,Pseudomonas aeruginosa,Vancomycin,2021,34.8,4.4,hospital,200
2804,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2020,33.5,10.8,community,250
2805,Japan,East Asia,Klebsiella pneumoniae,Vancomycin,2023,30.9,9.2,community,100
2806,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2018,33.0,3.2,community,100
2807,Australia,Oceania,Escherichia coli,Ceftriaxone,2020,20.8,1.5,hospital,100
2808,USA,North America,Pseudomonas aeruginosa,Meropenem,2019,14.6,6.7,community,250
2809,Germany,Europe,Staphylococcus aureus,Vancomycin,2020,25.5,0.5,hospital,150
2810,Germany,Europe,Escherichia coli,Meropenem,2022,18.3,0.5,hospital,100
2811,China,East Asia,Escherichia coli,Ceftriaxone,2018,22.6,3.4,hospital,300
2812,Germany,Europe,Staphylococcus aureus,Ceftriaxone,2020,34.0,9.9,community,100
2813,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2018,18.7,2.3,community,250
2814,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2021,56.2,11.1,hospital,200
2815,USA,North America,Escherichia coli,Ciprofloxacin,2019,20.5,7.5,hospital,200
2816,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2023,25.4,1.1,community,250
2817,Brazil,South America,Pseudomonas aeruginosa,Meropenem,2023,60.4,8.7,hospital,300
2818,USA,North America,Escherichia coli,Vancomycin,2020,11.3,5.2,community,150
2819,USA,North America,Staphylococcus aureus,Ciprofloxacin,2022,31.6,1.9,community,200
2820,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2022,38.3,7.8,community,100
2821,China,East Asia,Staphylococcus aureus,Ceftriaxone,2023,32.5,9.8,hospital,150
2822,USA,North America,Klebsiella pneumoniae,Vancomycin,2018,7.7,1.5,community,100
2823,Japan,East Asia,Staphylococcus aureus,Vancomycin,2020,23.6,2.8,hospital,200
2824,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2020,49.1,5.1,hospital,300
2825,USA,North America,Escherichia coli,Ciprofloxacin,2021,25.8,6.6,community,100
2826,USA,North America,Escherichia coli,Amoxicillin,2018,22.0,1.8,community,250
2827,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2019,32.6,8.3,hospital,150
2828,USA,North America,Pseudomonas aeruginosa,Vancomycin,2023,24.5,6.1,community,250
2829,Brazil,South America,Escherichia coli,Ciprofloxacin,2020,32.7,9.8,community,100
2830,USA,North America,Staphylococcus aureus,Vancomycin,2020,25.4,4.0,hospital,150
2831,India,Southeast Asia,Klebsiella pneumoniae,Meropenem,2018,58.5,15.0,hospital,250
2832,South Africa,Africa,Pseudomonas aeruginosa,Amoxicillin,2023,38.8,12.5,community,300
2833,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2019,13.6,2.2,community,300
2834,South Africa,Africa,Staphylococcus aureus,Meropenem,2021,34.4,5.0,hospital,200
2835,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2020,28.7,8.0,hospital,300
2836,Brazil,South America,Klebsiella pneumoniae,Ceftriaxone,2021,53.9,14.9,community,150
2837,France,Europe,Klebsiella pneumoniae,Ceftriaxone,2020,30.3,2.6,hospital,300
2838,Nigeria,Africa,Pseudomonas aeruginosa,Ciprofloxacin,2022,47.8,7.2,community,250
2839,Brazil,South America,Acinetobacter baumannii,Ciprofloxacin,2022,58.1,12.8,community,150
2840,Australia,Oceania,Klebsiella pneumoniae,Amoxicillin,2018,10.3,0.5,community,150
2841,USA,North America,Acinetobacter baumannii,Ciprofloxacin,2022,22.0,5.1,community,200
2842,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2020,12.1,2.4,hospital,150
2843,South Africa,Africa,Klebsiella pneumoniae,Ciprofloxacin,2023,33.0,8.1,hospital,150
2844,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2022,36.1,6.3,hospital,150
2845,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2019,36.1,9.8,hospital,150
2846,USA,North America,Acinetobacter baumannii,Ceftriaxone,2020,24.2,7.4,hospital,150
2847,Germany,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,23.5,8.1,community,300
2848,China,East Asia,Staphylococcus aureus,Amoxicillin,2021,42.9,13.5,hospital,300
2849,India,Southeast Asia,Klebsiella pneumoniae,Amoxicillin,2023,67.5,13.1,hospital,300
2850,Brazil,South America,Klebsiella pneumoniae,Ciprofloxacin,2021,49.3,11.4,community,100
2851,USA,North America,Staphylococcus aureus,Ceftriaxone,2023,31.6,11.1,community,250
2852,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2019,21.3,3.5,hospital,150
2853,Nigeria,Africa,Staphylococcus aureus,Ceftriaxone,2018,57.3,7.2,community,100
2854,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2019,25.3,1.9,community,300
2855,China,East Asia,Escherichia coli,Ciprofloxacin,2018,34.9,10.5,community,250
2856,South Africa,Africa,Escherichia coli,Meropenem,2018,61.5,13.8,hospital,200
2857,South Africa,Africa,Escherichia coli,Ceftriaxone,2019,50.8,8.7,community,100
2858,China,East Asia,Acinetobacter baumannii,Ceftriaxone,2019,31.6,2.5,hospital,250
2859,USA,North America,Staphylococcus aureus,Meropenem,2018,24.5,5.9,community,200
2860,South Africa,Africa,Escherichia coli,Ceftriaxone,2021,47.3,11.5,community,300
2861,France,Europe,Staphylococcus aureus,Ciprofloxacin,2021,25.2,6.9,hospital,100
2862,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2020,33.3,1.9,hospital,150
2863,USA,North America,Escherichia coli,Ceftriaxone,2021,17.9,2.2,community,150
2864,Brazil,South America,Staphylococcus aureus,Vancomycin,2018,27.8,6.8,community,100
2865,USA,North America,Acinetobacter baumannii,Meropenem,2019,11.3,6.2,hospital,150
2866,USA,North America,Staphylococcus aureus,Amoxicillin,2018,12.6,0.5,hospital,200
2867,Nigeria,Africa,Staphylococcus aureus,Amoxicillin,2020,60.2,8.9,community,100
2868,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2019,12.5,6.7,community,200
2869,South Africa,Africa,Klebsiella pneumoniae,Amoxicillin,2018,37.5,6.8,hospital,300
2870,France,Europe,Pseudomonas aeruginosa,Ciprofloxacin,2021,14.0,4.9,hospital,100
2871,Japan,East Asia,Staphylococcus aureus,Vancomycin,2019,17.2,0.5,hospital,300
2872,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2019,19.8,0.6,hospital,100
2873,USA,North America,Klebsiella pneumoniae,Vancomycin,2023,33.8,7.7,community,100
2874,China,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2023,49.0,12.3,community,100
2875,Japan,East Asia,Acinetobacter baumannii,Ciprofloxacin,2019,41.0,9.5,community,250
2876,France,Europe,Pseudomonas aeruginosa,Ceftriaxone,2018,15.8,0.5,community,100
2877,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2023,39.8,5.0,hospital,300
2878,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2023,31.8,1.6,community,150
2879,South Africa,Africa,Pseudomonas aeruginosa,Vancomycin,2020,33.7,5.6,hospital,200
2880,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2022,22.5,7.5,community,250
2881,Australia,Oceania,Escherichia coli,Amoxicillin,2021,17.2,0.5,hospital,250
2882,Nigeria,Africa,Pseudomonas aeruginosa,Meropenem,2018,54.2,15.6,community,250
2883,France,Europe,Staphylococcus aureus,Vancomycin,2023,41.4,6.1,hospital,250
2884,Nigeria,Africa,Klebsiella pneumoniae,Vancomycin,2019,62.0,13.7,community,150
2885,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2018,42.7,11.1,community,300
2886,Australia,Oceania,Klebsiella pneumoniae,Ciprofloxacin,2022,21.7,3.0,community,300
2887,Brazil,South America,Escherichia coli,Ciprofloxacin,2020,41.2,8.3,hospital,100
2888,France,Europe,Staphylococcus aureus,Amoxicillin,2018,25.7,6.9,hospital,300
2889,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2020,47.0,13.6,hospital,150
2890,South Africa,Africa,Acinetobacter baumannii,Meropenem,2020,51.1,8.3,hospital,250
2891,Australia,Oceania,Klebsiella pneumoniae,Vancomycin,2019,17.8,4.9,community,150
2892,China,East Asia,Escherichia coli,Amoxicillin,2022,39.0,11.2,community,250
2893,USA,North America,Escherichia coli,Amoxicillin,2020,22.0,0.5,community,200
2894,USA,North America,Pseudomonas aeruginosa,Meropenem,2022,24.6,8.3,community,150
2895,Australia,Oceania,Staphylococcus aureus,Amoxicillin,2023,32.1,3.0,hospital,300
2896,China,East Asia,Escherichia coli,Meropenem,2019,23.0,6.4,hospital,100
2897,France,Europe,Acinetobacter baumannii,Ciprofloxacin,2021,20.5,0.5,hospital,200
2898,France,Europe,Acinetobacter baumannii,Amoxicillin,2021,33.5,9.8,community,300
2899,Australia,Oceania,Pseudomonas aeruginosa,Ciprofloxacin,2021,9.2,6.1,hospital,100
2900,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2018,17.4,2.1,community,250
2901,France,Europe,Escherichia coli,Amoxicillin,2019,31.3,8.0,community,300
2902,South Africa,Africa,Escherichia coli,Ceftriaxone,2021,44.6,4.6,hospital,300
2903,China,East Asia,Staphylococcus aureus,Amoxicillin,2020,28.0,2.1,community,150
2904,Germany,Europe,Escherichia coli,Ceftriaxone,2023,32.0,3.8,hospital,300
2905,USA,North America,Pseudomonas aeruginosa,Amoxicillin,2021,30.4,10.3,community,300
2906,Germany,Europe,Klebsiella pneumoniae,Amoxicillin,2020,21.5,0.7,community,200
2907,China,East Asia,Klebsiella pneumoniae,Vancomycin,2019,29.2,6.7,community,200
2908,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2019,42.2,10.5,community,100
2909,Nigeria,Africa,Acinetobacter baumannii,Ceftriaxone,2018,25.5,1.2,hospital,100
2910,India,Southeast Asia,Klebsiella pneumoniae,Ciprofloxacin,2019,55.4,9.9,hospital,200
2911,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2020,20.8,7.5,hospital,300
2912,Nigeria,Africa,Escherichia coli,Amoxicillin,2018,25.3,8.1,hospital,300
2913,France,Europe,Escherichia coli,Vancomycin,2022,30.2,5.1,community,250
2914,China,East Asia,Pseudomonas aeruginosa,Ciprofloxacin,2021,40.2,9.3,hospital,100
2915,South Africa,Africa,Escherichia coli,Vancomycin,2018,30.2,10.8,hospital,300
2916,Brazil,South America,Acinetobacter baumannii,Ceftriaxone,2020,38.9,11.8,community,200
2917,Australia,Oceania,Pseudomonas aeruginosa,Amoxicillin,2023,21.0,8.4,community,100
2918,Germany,Europe,Klebsiella pneumoniae,Meropenem,2023,32.6,1.7,community,100
2919,USA,North America,Acinetobacter baumannii,Amoxicillin,2021,11.1,5.4,community,300
2920,Nigeria,Africa,Pseudomonas aeruginosa,Ceftriaxone,2023,63.9,15.5,hospital,300
2921,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2021,16.8,4.6,hospital,200
2922,Germany,Europe,Acinetobacter baumannii,Vancomycin,2022,27.0,2.5,community,300
2923,Nigeria,Africa,Acinetobacter baumannii,Amoxicillin,2019,56.3,8.5,hospital,300
2924,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2021,66.9,13.5,hospital,150
2925,India,Southeast Asia,Escherichia coli,Ciprofloxacin,2023,47.1,5.7,community,100
2926,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2018,62.8,13.0,community,250
2927,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2022,76.2,19.2,hospital,300
2928,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2022,26.8,1.8,community,150
2929,Germany,Europe,Acinetobacter baumannii,Ceftriaxone,2018,14.0,1.3,community,100
2930,South Africa,Africa,Klebsiella pneumoniae,Meropenem,2021,51.6,13.9,community,200
2931,Brazil,South America,Escherichia coli,Ciprofloxacin,2023,51.7,6.5,hospital,250
2932,France,Europe,Staphylococcus aureus,Meropenem,2021,30.9,8.9,community,200
2933,Japan,East Asia,Klebsiella pneumoniae,Amoxicillin,2018,17.3,3.1,hospital,250
2934,Brazil,South America,Escherichia coli,Amoxicillin,2018,26.1,1.4,hospital,300
2935,China,East Asia,Acinetobacter baumannii,Vancomycin,2021,27.6,9.7,hospital,100
2936,Australia,Oceania,Klebsiella pneumoniae,Ceftriaxone,2022,22.5,0.5,hospital,300
2937,Japan,East Asia,Acinetobacter baumannii,Ceftriaxone,2020,40.2,12.4,community,200
2938,South Africa,Africa,Escherichia coli,Vancomycin,2023,44.9,4.7,community,300
2939,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2019,56.2,14.6,hospital,200
2940,Australia,Oceania,Acinetobacter baumannii,Ceftriaxone,2023,24.2,2.3,community,150
2941,USA,North America,Acinetobacter baumannii,Vancomycin,2020,19.5,0.5,community,200
2942,Germany,Europe,Klebsiella pneumoniae,Ciprofloxacin,2023,36.1,7.6,community,250
2943,France,Europe,Staphylococcus aureus,Vancomycin,2020,15.4,1.6,hospital,150
2944,South Africa,Africa,Escherichia coli,Ceftriaxone,2021,64.0,11.6,hospital,150
2945,Germany,Europe,Klebsiella pneumoniae,Vancomycin,2021,32.0,8.6,community,100
2946,Germany,Europe,Klebsiella pneumoniae,Meropenem,2018,15.5,7.5,community,300
2947,France,Europe,Klebsiella pneumoniae,Amoxicillin,2019,22.1,3.0,community,200
2948,France,Europe,Staphylococcus aureus,Ceftriaxone,2020,30.1,8.1,community,250
2949,India,Southeast Asia,Escherichia coli,Ceftriaxone,2021,41.0,12.6,hospital,200
2950,Nigeria,Africa,Pseudomonas aeruginosa,Vancomycin,2018,44.3,11.8,community,100
2951,Japan,East Asia,Staphylococcus aureus,Ceftriaxone,2022,48.2,5.5,community,250
2952,Australia,Oceania,Acinetobacter baumannii,Meropenem,2023,22.1,0.5,community,300
2953,Japan,East Asia,Staphylococcus aureus,Ciprofloxacin,2019,33.8,11.2,hospital,250
2954,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2020,44.8,13.0,hospital,100
2955,Nigeria,Africa,Acinetobacter baumannii,Vancomycin,2021,50.5,13.3,hospital,300
2956,USA,North America,Pseudomonas aeruginosa,Ciprofloxacin,2022,33.6,4.6,hospital,200
2957,Japan,East Asia,Klebsiella pneumoniae,Meropenem,2020,37.8,6.6,hospital,300
2958,South Africa,Africa,Staphylococcus aureus,Ciprofloxacin,2020,49.9,10.4,hospital,300
2959,Germany,Europe,Escherichia coli,Ciprofloxacin,2021,15.8,8.0,hospital,250
2960,Japan,East Asia,Pseudomonas aeruginosa,Ceftriaxone,2018,25.5,6.0,hospital,100
2961,France,Europe,Klebsiella pneumoniae,Meropenem,2020,23.2,3.5,community,250
2962,South Africa,Africa,Acinetobacter baumannii,Ceftriaxone,2018,60.0,11.6,hospital,200
2963,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2021,38.5,7.7,community,150
2964,Brazil,South America,Klebsiella pneumoniae,Amoxicillin,2021,49.2,13.2,community,100
2965,South Africa,Africa,Klebsiella pneumoniae,Ceftriaxone,2019,35.5,2.9,hospital,150
2966,Brazil,South America,Staphylococcus aureus,Ceftriaxone,2023,32.5,5.4,hospital,300
2967,USA,North America,Klebsiella pneumoniae,Ciprofloxacin,2020,18.9,8.1,community,250
2968,Germany,Europe,Escherichia coli,Vancomycin,2021,32.9,5.1,community,250
2969,China,East Asia,Klebsiella pneumoniae,Vancomycin,2020,22.0,2.5,community,250
2970,Germany,Europe,Staphylococcus aureus,Vancomycin,2021,31.2,5.4,hospital,150
2971,South Africa,Africa,Staphylococcus aureus,Meropenem,2022,48.4,11.1,hospital,100
2972,Japan,East Asia,Staphylococcus aureus,Vancomycin,2021,30.0,4.1,community,100
2973,Brazil,South America,Staphylococcus aureus,Ciprofloxacin,2022,36.7,10.3,hospital,150
2974,USA,North America,Escherichia coli,Ceftriaxone,2023,26.1,2.6,community,300
2975,India,Southeast Asia,Pseudomonas aeruginosa,Vancomycin,2018,32.4,5.5,hospital,100
2976,Nigeria,Africa,Escherichia coli,Ciprofloxacin,2020,38.4,10.1,community,250
2977,Brazil,South America,Staphylococcus aureus,Amoxicillin,2018,26.7,8.5,hospital,300
2978,Brazil,South America,Pseudomonas aeruginosa,Amoxicillin,2020,42.0,4.7,community,150
2979,India,Southeast Asia,Escherichia coli,Ceftriaxone,2018,47.7,6.0,community,250
2980,France,Europe,Staphylococcus aureus,Vancomycin,2020,34.7,7.4,hospital,300
2981,Nigeria,Africa,Acinetobacter baumannii,Meropenem,2019,53.6,8.0,hospital,150
2982,South Africa,Africa,Staphylococcus aureus,Vancomycin,2021,53.1,14.3,hospital,200
2983,India,Southeast Asia,Acinetobacter baumannii,Meropenem,2020,60.1,12.2,hospital,250
2984,Nigeria,Africa,Staphylococcus aureus,Vancomycin,2020,41.0,7.2,community,250
2985,Germany,Europe,Staphylococcus aureus,Amoxicillin,2019,30.6,2.9,hospital,200
2986,India,Southeast Asia,Klebsiella pneumoniae,Ceftriaxone,2018,68.2,11.6,community,300
2987,Japan,East Asia,Escherichia coli,Amoxicillin,2019,35.9,10.8,hospital,250
2988,Australia,Oceania,Klebsiella pneumoniae,Meropenem,2023,29.7,2.1,community,150
2989,USA,North America,Escherichia coli,Ceftriaxone,2021,18.5,3.9,community,200
2990,Germany,Europe,Staphylococcus aureus,Meropenem,2022,27.5,9.4,hospital,200
2991,Japan,East Asia,Staphylococcus aureus,Amoxicillin,2018,35.8,7.8,community,250
2992,South Africa,Africa,Escherichia coli,Ceftriaxone,2018,54.0,7.9,community,250
2993,Germany,Europe,Escherichia coli,Amoxicillin,2019,13.5,2.0,community,200
2994,Germany,Europe,Klebsiella pneumoniae,Ceftriaxone,2023,22.0,1.3,hospital,300
2995,Brazil,South America,Klebsiella pneumoniae,Vancomycin,2020,48.2,6.4,community,300
2996,South Africa,Africa,Pseudomonas aeruginosa,Meropenem,2022,58.8,11.7,hospital,300
2997,Germany,Europe,Staphylococcus aureus,Ciprofloxacin,2021,28.6,6.2,community,300
2998,India,Southeast Asia,Escherichia coli,Amoxicillin,2020,65.7,9.3,community,100
2999,China,East Asia,Staphylococcus aureus,Ciprofloxacin,2019,39.9,9.5,community,100
3000,South Africa,Africa,Acinetobacter baumannii,Amoxicillin,2022,41.6,6.7,hospital,250
